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Abstract
Rab proteins are small GTPases of the Ras superfamily implicated in the 
control of membrane trafficking. Secretory granule exocytosis is a highly 
regulated process by which various molecules and macromolecules may 
be expelled from secretory cells. The Rab proteins most directly linked to 
roles in the trafficking and tethering/docking of secretory granules, and in 
their fusion with the plasma membrane, are isoforms of Rab3 and Rab27. 
In this study, the recruitment of Rab3A and Rab27A and several of their 
effectors to granules, the dynamics of their granule association, their 
function, and their regulation, were explored in PC12 cells.
Endogenous Rab3A colocalised with the secretory granule marker 
secretogranin II (SGII) and expressed EGFP-Rab3A and ECFP-Rab27A 
colocalised with one another. The extent of colocalisation between EGFP- 
Rab3A or EGFP-Rab27 and SGII increased after longer times post 
transfection suggesting that these Rab proteins are preferentially recruited 
to newly synthesised granules. Following the release of immature 
secretory granules from the trans-Golgi network, Rab3A and Rab27A 
became associated with the immature granules after a lag period of 
around 20 minutes. Fluorescence recovery after photobleaching (FRAP) 
experiments indicated that Rab3A but not Rab27A appears to be 
continually exchanged between granules and cytosol, and that this 
exchange occurs in an HSP90-independent manner. The Rab proteins 
were not found to disperse from exocytotic sites on cellular stimulation.
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EGFP-tagged forms of the Rab effectors Rabphilin, Granuphilin and Noc2 
were found to colocalise with secretory granules labelled with either 
mRFP-Rab3A or mRFP-Rab27A. Rabphilin but not Granuphilin or Noc2 
was rapidly exchanged between granules and cytosol. Granuphilin, but not 
Rabphilin or Noc2, was predominantly localised to granules at the 
periphery of cells. Noc2, but not Rabphilin or Granuphilin, was found to 
inhibit secretion on moderate overexpression, and this inhibition was 
attenuated when its binding to Rab proteins was disrupted. 
Overexpression of a ‘gain of function’ mutant of the novel Rab interactor 
Munc18-1 was found to increase the density of EGFP-Rab3A and EGFP- 
Rab27A labelled secretory granules at the periphery of cells, while it did 
not appear to affect cortical actin. This effect was not seen where a ‘double 
mutant’ with reduced affinity for the ‘closed’ form of Syntaxin was 
expressed.
The properties of a series of putative GTPase activating proteins (GAPs) 
for Rab3A and Rab27A were analysed by screening for their capacity to 
disperse EGFP-tagged Rabs from secretory granule membranes. A GAP 
previously reported to act on Rab3A, p130 Rab3GAP, was found to lack 
this capacity, while GAPs reported to act on Rab27A, TBC1D10A and 
TBC1D10B, were found to act non-specifically. In contrast, a candidate 
Rab3GAP, RUTBC1, was found to specifically disperse EGFP-Rab3A, to 
colocalise with Rab27A on secretory granules, and to suppress the 
inhibitory effects of EGFP-Rab3A overexpression on secretion.
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Chapter 1: 
Introduction
1.1 Origins of exocvtotic pathways
Membranes composed of phospholipid bilayers serve to compartmentalise 
cellular function in eukaryotes (Lowe and Barr, 2007). It is hypothesised 
that the eukaryotic cytomembrane system developed from a process of 
reversible plasma membrane invagination and vésiculation used by early 
relatives of protoeukaryotes for endocytotic import and intracellular 
digestion of extracellular materials and the subsequent exocytotic 
expulsion of the resulting residues (De Duve and Wattiaux, 1966; de Duve, 
2007). Further, it is thought that the selective advantages conferred by this 
process on heterotrophic cells, reliant on these materials for nutrition, were 
significant. Not only might the internalisation of nutrients have led to 
improved efficiency in their utilisation, endocytosed material might also 
have provided a source of nourishment for cells where this became scarce 
externally (Cavalier-Smith, 2002; de Duve, 2007).
The refinement of early endomembrane systems of nutrient uptake and 
processing, and the emergence of specialised membrane compartments 
serving wider cellular roles, are suggested to have been intrinsic to 
eukaryote evolution (Dacks and Field, 2007; de Duve, 2007). Had they 
been peripheral to the process, eukaryotic lineages lacking basic 
membrane trafficking componentry might exist. However, the available 
phylogenetic evidence indicates that in addition to the digestive and 
recycling machinery of endosomes and lysosomes, the last common 
eukaryotic ancestor (LCEA) also possessed the biosynthetic and secretory
10
machinery of endoplasmic reticulum (ER) and Golgi (Dacks and Field, 
2007). Several theories of eukaryogenesis implicate complex membrane 
trafficking, and in particular the process of phagocytosis, in the adoption by 
protoeukaryotes of the endosymbiont progenitors of mitochondria and 
plastids, critical events thought to have occurred after levels of 
atmospheric oxygen began to rise on Earth ~2.4 billion years ago 
(Cavalier-Smith, 2002; Bekker etal., 2004; de Duve, 2007).
A recently proposed hypothesis suggests that an ancestral secretory 
pathway predates the emergence of the phagosomal pathway in 
protoeukaryote evolution, and may therefore explain its presence in LCEA 
(Jekely, 2003). This hypothesis is based on the phylogeny of small 
GTPases, and analysis suggesting that Sar1/Arf proteins diverged from 
other GTPases prior to the divergence of Ran, and the later divergence of 
Rab and Ras/Rho proteins (Jekely, 2003). Since modern Sari and Arf 
proteins are most strongly associated with regulation of coat proteins, and 
vesicular trafficking from the ER and the Golgi respectively, this may 
indicate their ancestors evolved alongside the progenitors of these 
organelles (Aridor et a/., 2001; Jekely, 2003; D'Souza-Schorey and 
Chavrier, 2006).
The function of the primitive exocytotic secretion may have initially been in 
the release of lytic enzymes for the extracellular digestion of neighbouring 
cells in dense bacterial colonies, and systems may have developed for 
transport and targeting of secretory vesicles to specific sites (Jekely,
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2003). While ancestral endocytotic pathways may have had a role in 
nutrient uptake, the more complex systems required to orchestrate 
identification, active engulfment, and intracellular digestion of prey through 
phagocytosis, may have evolved later (Jekely, 2003; Stuart and Ezekowitz, 
2005; de Duve, 2007). Indeed, regulated focal exocytotic membrane 
insertion is directly involved in phagocytosis by macrophages, and it is 
possible that this involvement dates back to phagocytosis by a 
phagotrophic LCEA (Cavalier-Smith, 2002; Chieregatti and Meldolesi, 
2005).
1.2 Regulated exocvtosis
As discussed above, it is possible that specialised exocytotic pathways 
evolved even prior to the emergence of eukaryotic life. Today, exocytosis 
occurs in all eukaryotic cells capable of growth and division, because the 
fusion of exocytotic vesicles with the plasma membrane is essential for the 
addition of lipid and membrane to this organelle, its maintenance, and its 
expansion (Burgoyne and Morgan, 2003). It is usual to distinguish 
constitutive exocytosis, which may serve this purpose, and which is 
common to all eukaryotes, and regulated exocytosis, which occurs only in 
response to specific stimuli (Burgoyne and Morgan, 2003).
The wide functional potential of regulated exocytosis is reflected by the 
considerable variety of its roles (Burgoyne and Morgan, 2003; Chieregatti
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and Meldolesi, 2005). Examples of non-secretory regulated exocytosis 
include that underlying the translocation of GLUT4 transporters to the 
plasma membranes of adipocytes in response to signalling downstream of 
insulin receptor activation, and that underlying cytokinesis (Danilchik et al., 
2003; Watson et al., 2004). Examples of regulated secretory exocytosis 
include that underlying release of insulin by pancreatic (5-cells, and 
acrosomal exocytosis in sperm (Ramalho-Santos et al., 2002; Rutter and 
Hill, 2006). The contrasting roles and dramatic functional specialisation of 
different forms of regulated exocytosis are illustrated well at the synapse. 
At a typical presynaptic terminal, the major exocytotic pathway is highly 
specialised for the very rapid release of the contents of small synaptic 
vesicles in response calcium influx (Wojcik and Brose, 2007). At the 
postsynaptic terminal, raised calcium can lead to exocytotic insertion of 
receptors into the plasma membrane. For example, postsynaptic insertion 
of the AMPA receptor subunit GluR1 is stimulated during long-term 
potentiation (LTP) in a process requiring the calcium-Calmodulin-activated 
kinase CaMKII (Hayashi et al., 2000).
The pathway of regulated exocytosis is often described as a multi-step 
process, in which following their biogenesis, vesicles are sequentially 
trafficked, tethered and docked, prior to their fusion with the target 
membrane in response to a specific trigger. Since this study is focused on 
regulated secretion, and in particular on the function and regulation of Rab 
protein isoforms found to associate with secretory granules and synaptic
13
vesicles, particular emphasis will be placed on these organelles in 
discussion of each step.
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Figure 1.1. Steps in membrane traffic. A vesicle first buds from its donor compartment and is then 
transported in a cytoskeleton-dependent manner to its target membrane at which it is sequentially 
tethered and docked, and may then fuse.
1.2.1 Vesicle biogenesis
Protein constituents of secretory granules and synaptic vesicles are 
synthesised at ribosomes bound to the ER, and translocated into the 
lumen of this organelle through protein-conducting channels (Rapoport, 
1992). Within the ER, chaperone molecules may aid the correct folding of 
nascent polypeptide, and enzymes may catalyse its initial post- 
translational modification by glycosylation (Hammond and Helenius, 1995). 
In higher eukaryotes, protein may exit the ER at ER exit sites (ERES) via 
vesicles formed through COPII coat-driven budding, and post-ER sorting 
may occur following fusion of these vesicles with ER-Golgi intermediate 
compartments (ERGICs)(Appenzeller-Herzog and Hauri, 2006). The 
anterograde transport of secretory protein to the cis-Golgi within ERGIC- 
derived carriers is thought to occur in a microtubule-dependent manner 
(Appenzeller-Herzog and Hauri, 2006).
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In the Golgi, protein may undergo further post-translational modification 
and sorting as it progresses through the ordered compartments of this 
organelle through cisternal or vesicular transport (Glick, 2000). The exit of 
proteins from the Golgi occurs at the trans-Golgi network (TGN). It is 
thought that the constituents of secretory granules aggregate at the TGN, 
possibly initiating granule formation and budding (Burgoyne and Morgan, 
2003; Borgonovo et al., 2006). Once released from the TGN, immature 
secretory granules may be rapidly transported to a localisation consistent 
with their particular function. Missorted material may be removed from 
these granules in a Clathrin-dependent manner, and they may undergo 
homotypic fusion in the course of their maturation (Tooze et al., 1991; 
Dittie et al., 1997; Rudolf et al., 2001). In contrast to this, the transport 
vesicle(s) carrying constituents of synaptic and synaptic-like vesicles from 
the TGN are not thought to constitute their precursors. Instead, it is 
thought that these organelles may be later derived from either early 
endosomes or plasma membrane (Hannah et al., 1999). Since synaptic 
vesicles may take up their neurotransmitter cargo directly from the cytosol 
via integral membrane transporters, they may be formed de novo in the 
same manner as they are recycled (Hannah etal., 1999).
1.2.2 Vesicle trafficking
In common with vesicles in several other membrane trafficking pathways, 
secretory granules and synaptic vesicles may be directed to their target 
membrane along microtubules and actin filaments, and these modes of 
transport may be sequential and coordinated (Goodson etal., 1997; Rudolf
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et al., 2001). In many cases, it is thought that Rab proteins associated with 
particular types of vesicle may specify the route taken through the 
cytoskeleton by direct or indirect interaction with appropriate motor 
proteins (Jordens et al., 2005). In anterograde secretory granule 
trafficking, kinesin-driven transport along microtubules can deliver granules 
to F-actin-rich regions of cells, while myosins can then facilitate their 
recruitment to, and regulate their movement within these regions (Rose et 
al., 2002).
In PC12 cells, it is found that secretory granules within the cortical actin 
network are segregated into differently mobile populations during 
maturation, with a large proportion characterised as becoming immobile 
(Rudolf et al., 2001). It is likely that interactions with cortical actin underlie 
this apparent system of granule storage, since overexpression of the 
Rab27A effector MyRIP, which links this protein to actin via MyosinVIla, 
further reduces granule mobility, and does so in a manner sensitive to 
changes in actin stability (Desnos et al., 2003). Conversely, where 
Rab27A, its effector Melanophilin, or the motor protein MyosinVa are 
absent from melanocytes, melanosomes are found to cluster in central 
regions of cells and are also excluded from the actin-rich dendrites of 
these cells (Wu et al., 1998; Wilson et al., 2000; Provance et al., 2002).
In that secretory granules can be sequestered in F-actin networks in a 
subcellular localisation appropriate to their function, while they may also 
move within these networks, it may be suggested that their progress
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towards the plasma membrane is precisely choreographed by factors that 
define their cytoskeletal interactions. In support of this view, movement of 
granules located close to the plasma membrane in adrenal chromaffin and 
PC12 cells, is not only reduced by pharmacological stabilisation of actin, 
but also by its destabilisation (Lang et al., 2000; Oheim and Stuhmer, 
2000). Furthermore, where mobile granules are seen to approach the 
plasma membrane in these cells, they often show a characteristic linear 
trajectory, indicative of their motor-driven trafficking along single actin 
filaments (Allersma et al., 2006). In adrenal chromaffin cells, it has been 
shown that granules approaching the plasma membrane in this manner 
can contribute more to secretory responses than those already membrane- 
associated prior to stimulation, underlining the regulatory importance of 
this active trafficking (Han, 1999; Allersma et al., 2006).
F-actin networks should not be seen as static substrates for the factors 
directing granule traffic, since actin filaments are subject to continual, 
polarised, assembly and disassembly, and their organisation is continually 
subject to local and global remodelling (Lanzetti, 2007). Further, these 
processes have broad significance for granule trafficking, because actin 
stabilising and destabilising drugs respectively reduce and enhance 
secretory responses in a wide range of secretory cell types (Burgoyne and 
Morgan, 2003). Indeed, in many of these cells, physiological stimuli have 
been shown to cause actin filament disassembly (Cheek and Burgoyne, 
1992). In concert with the other systems involved, this may serve to
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promote exocytosis and replenishment of secretory granules at exocytotic 
sites (Burgoyne and Morgan, 2003).
1.2.3 Tethering
Vesicles or granules attached to the plasma membrane are said to be 
either ‘tethered’ or ‘docked’. In initial studies with electron microscopy, it 
was found that among a population synaptic vesicles located within 10nm 
of the presynaptic membrane, a fraction appear to remain associated in 
isolated membrane preparations, and these may be termed 
‘morphologically docked’ (Burgoyne and Morgan, 2003). ‘Morphologically 
docked’ vesicles were at first thought to be membrane-associated as a 
result of the engagement of the core machinery of membrane fusion, the 
SNAP-receptor (SNARE) proteins (Sollner et a i, 1993). Therefore, the 
term ‘tethered’ was applied to vesicles closely associated to membranes 
through protein-protein interactions occurring prior to this engagement. 
However, protein-protein interactions mediating ‘tethering’, as defined in 
this way, have been found to be extremely diverse, ranging from those 
linking vesicles or granules to membrane-associated actin filaments at 
points very close to the plasma membrane, to those mediating much 
tighter vesicle-membrane association. In fact, ‘tethered’ vesicles may be 
morphologically indistinguishable from vesicles associated with the 
membrane via SNAREs (Burgoyne and Morgan, 2003).
A well characterised tethering complex in the exocytotic pathway is the 
exocyst, an eight-subunit complex that multimerises to form a quatrefoil
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(Novick et al., 1980; TerBush et al., 1996; Munson and Novick, 2006). In 
yeast, the exocyst is localised to sites of polarised exocytosis, and 
mutations in its subunits can lead to defective exocytosis and 
accumulation of secretory vesicles (TerBush et al., 1996). The protein 
components of the exocyst are conserved in higher eukaryotes, and are 
present at secretory sites in various cell types (Kee et al., 1997). In one 
model of mammalian exocyst function, exocyst components are suggested 
to be recycled between the TGN and plasma membrane, and therefore to 
have a multifunctional role in targeted vesicle trafficking. Treatment of 
epithelial-like NRK-52E cells with antibodies against epitopes of the 
exocyst component Sec6 specifically accessible at the TGN and the 
plasma membrane, was found to cause retention of exocytotic vesicles at 
a perinuclear region and within the cytosol and cortical areas of cells 
respectively (Yeaman et al., 2001). This data suggests that the exocyst is 
required for vesicle trafficking from the TGN, while it may also be required 
in their tethering prior to fusion, since the experiments showed reduced 
insertion of a fluorescent marker protein into the plasma membrane 
(Yeaman et al., 2001).
In mammalian neurones, the exocyst is localised to areas of neurite 
outgrowth and developing synapses (Hazuka et al., 1999). Further, it has 
been found that NGF-stimulation of PC12 cells leads to translocation of the 
exocyst to nascent neurites, while overexpression of dominant negative 
exocyst component sec10 impairs their development (Vega and Hsu, 
2001). In Sec5 null Drosophila neurones, growth of neuromuscular
19
junctions was arrested on the depletion of maternally provided Sec5, and 
protein trafficking to the plasma membrane was reduced. Furthermore, the 
traffic of a GFP tagged version of the synaptic vesicle protein 
Synaptotagmin to synaptic boutons was dramatically impaired (Murthy et 
al., 2003). Despite this however, synaptic transmission at single boutons 
was normal, and in other cell types such as PC12 cells, acute disruption of 
exocyst assembly was not found to affect calcium-triggered secretory 
responses (Murthy et al., 2003; Wang et a/., 2004).
It has been demonstrated in MDCK cells that exocyst disruption can 
differentially affect the trafficking and exocytosis of different subsets of 
exocytotic vesicle (Grindstaff et al., 1998). Therefore, in the Drosophila 
neurones discussed above, it may function in the targeting of transport 
vesicles carrying Synaptotagmin, but not in that of synaptic vesicles, which 
as previously discussed, may be locally synthesised at endosomal or 
plasma membranes (Flannah et al., 1999). Similarly, its involvement in the 
trafficking and tethering of secretory granules may differ according to the 
type of granule involved, while evidence suggests that here, this 
involvement may also differ according the mode by which exocytosis is 
regulated. It was shown in one study that while the calcium-triggered 
secretory responses of PC 12 cells were not affected by exocyst disruption, 
those triggered with the non-hydrolysable GTP analogue, GppNHp, were 
reduced (Wang et al., 2004). In contrast, another study showed that 
exocyst disruption in the MIN6 pancreatic (3-cell line led to a reduction in 
numbers of secretory granules close to the plasma membrane, and
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corresponding reductions in secretory responses to several different stimuli 
(Tsuboi et al., 2005).
The tethering of synaptic vesicles at the presynaptic nerve terminal may 
best be understood as one function of the highly ordered arrays of 
multimolecular complexes that form the active zone (Zhai and Bellen, 
2004). The cytomatrix underlying the plasma membrane at the active zone 
is highly electron dense, and is comprised of various cytoskeletal proteins 
arrayed in a web like pattern, and scaffolding proteins which link this 
structure to ion channels and the fusion machinery (Phillips et al., 2001). 
While many proteins within this matrix may have a tethering function, this 
is most easily ascribed to electron dense structures projecting from it, 
known as synaptic ribbons (Prescott and Zenisek, 2005). Large synaptic 
ribbons were first identified at sensory synapses, where they can adopt 
various forms, and may extend far from the plasma membrane (Prescott 
and Zenisek, 2005). These ‘ribbons’ sequester synaptic vesicles in the 
vicinity of the active zone, and are suggested to function where sustained 
or high intensity neurotransmitter output is required (Lenzi et al., 2002). 
Less prominent projections in mammalian central synapses are very likely 
to fulfil a similar purpose (Phillips etal., 2001; Zhai and Bellen, 2004).
In secretory cells where neither the exocyst nor the neurone-specific 
components of the active zone limit exocytosis, the molecular identity of 
tethering proteins is less well characterised. However, TIRF microscopy 
has been used to directly visualise what may be the tethering of secretory
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granules in the adrenal chromaffin cell (Toonen et al., 2006). Because 
Munc18-1 is thought to be required for efficient assembly of exocytotic 
SNARE complexes in chromaffin cells, any association between secretory 
granules and the plasma membrane in the absence of this protein is likely 
to reflect the activity of a tethering mechanism (Voets et al., 2001b; Zilly et 
al., 2006). In Muncl8-1-deficient cells, granule density close to the plasma 
membrane is reported to be reduced (Voets et al., 2001b). However, when 
the movements of labeled granules in these cells were recorded using 
TIRFM, it was found that numbers of granules transiently entering the 
evanescent field in the course of experiments were lower than those in 
controls (Toonen et al., 2006). Thus, reduced granule density at the 
membrane may result from impaired granule delivery, rather than tethering 
or docking deficits. In fact, the numbers of granules entering the 
evanescent field and associating with the plasma membrane for periods of 
time longer than ~5 seconds were comparable between control and 
M uncl8-1-deficient cells (Toonen et al., 2006). It may therefore be 
suggested that such granules are tethered in a Muncl 8-1 -independent 
manner.
While the numbers of granules adopting a sustained interaction with the 
plasma membrane in the course of the experiments described was low, the 
authors provided additional evidence for the above suggestion. Where the 
average responsiveness of granules to movement of the plasma 
membrane was calculated, it was reduced four-fold in the Muncl8-1- 
deficient cells, indicating that these granules were less closely membrane-
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associated (Toonen et al., 2006). The implication of this finding is that 
tethered granules may become more closely membrane-associated 
through the action of Munc18-1. Interestingly, since data was derived from 
granules associating with, and then dissociating from the plasma 
membrane, this finding also suggests that under resting conditions, 
Muncl 8-1-dependent tight membrane-association is reversible. Further, 
the similar distribution of granule-membrane association times of between 
5 and 100 seconds in the data sets from the control and Muncl 8-1- 
deficient cells may suggest that Muncl 8-1 expression, at least at 
endogenous levels, has minimal effects on these times, though the 
authors’ interpretation of this data differs (Toonen et al., 2006).
1.2.4 Docking
As discussed above, the term ‘docked’ may be used to describe 
associations between vesicular or granular, and plasma membranes, that 
involve interactions between combinations of SNARE proteins required in 
the their subsequent fusion. In this section, discussion will focus on these 
interactions, and on the suggested role of the SM proteins in their 
promotion.
36 SNAP-receptor (SNARE) proteins, characterised by a heptad repeat 
SNARE motif, are identified in the human genome (Jahn and Scheller, 
2006). These proteins may be denoted v-SNAREs or t-SNAREs according 
to their presence on the vesicular or target membrane, and are thought to 
drive membrane fusion by formation of stable, coiled-coil, heteroligomeric
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complexes comprised of four parallel a-helices (Hanson et al., 1997a; 
Sutton et al., 1998). Each a-helix corresponds to a particular SNARE motif, 
and typically, but not exclusively, one is contributed by a v-SNARE, while 
the remaining three are contributed by t-SNAREs (Jahn and Scheller, 
2006). Amino acid side chains interacting within the centre of the coiled- 
coil bundle are usually hydrophobic, while conserved hydrophilic residues 
in each a-helix contribute to interactions at a central, ‘zero’, layer that is 
shielded within each complex (Fasshauer et al., 1998). In each SNARE 
complex, one of these residues is arginine (R), and three are glutamine 
(Q). Thus, in order to classify SNARE proteins in a manner that allows for 
clarity in the discussion of atypical and homotypic fusion events, each 
contributory SNARE motif may denoted R, Q a , Q b  or Q c , and each SNARE 
protein may be denoted an R-SNARE or a Q-SNARE (Fasshauer et al., 
1998; Jahn and Scheller, 2006).
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Figure 1.2. SNARE protein combinations with identified function in traffic between specific 
membrane compartments in mammalian cells. SNARE proteins contributing Q a, Qb, Qc and R 
helices to each complex are indicated. Diagram is taken from Jahn and Scheller, 2006.
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Particular combinations of SNARE proteins contribute to the specificity of 
fusion between specific vesicular and target membranes, while the extent 
of this contribution is a subject of debate (Burgoyne and Morgan, 2003; 
Jahn and Scheller, 2006). The best-characterised SNARE complex 
associated with exocytotic fusion is that formed by the R-SNARE vesicle- 
associated membrane protein-2 (VAMP2/Synaptobrevin), and the Q- 
SNAREs SyntaxinIA and synaptosomal associated protein of 25kDa 
(SNAP-25)(Sutton et al., 1998; Ernst and Brunger, 2003). VAMP and 
Syntaxin are single pass transmembrane proteins, and respectively 
contribute R and Qa helices to the complex. SNAP-25 is membrane- 
associated as a result of its palmitoylation, and contributes the remaining 
two helices Qbc (Sutton et al., 1998; Ernst and Brunger, 2003).
Figure 1.3. Crystal structure of a truncated form of the assembled neuronal SNARE complex. 
SyntaxinIA, SNAP-25 and VAMP2 are shown in blue, green and red respectively. Molecular 
coordinates taken from Ernst and Brunger, 2003 (RCSB PDB Structure ID 1N7S).
It has been shown that the assembled neuronal SNARE complex is highly 
stable, and resistant to proteolytic cleavage and SDS denaturation, and so 
its assembly is unlikely to be readily reversible (Fasshauer, 2003). 
However, several lines of evidence point to the suggestion that vesicular 
VAMP, and Syntaxin and SNAP-25 on the plasma membrane, may form 
only a partially assembled SNARE complex where granules are ‘docked’
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(Burgoyne and Morgan, 2003; Jahn and Scheller, 2006). It has been 
suggested that antibodies unlikely, or unable to bind to the assembled 
SNARE complex in vivo are nonetheless capable of inhibiting exocytosis of 
the most rapidly released secretory granules in adrenal chromaffin cells 
(Xu et a/., 1999b). Further, it has been shown that SNARE complexes are 
likely to assemble in an N- to C-terminal manner, with the N-terminal, 
membrane distal end, able to assemble independently of the C-terminal, 
membrane proximal end (Pobbati et at., 2006; Sorensen et at., 2006). 
Where mutations likely to affect assembly of the final membrane proximal 
layer of the complex were made, there was a reduction in the fast 
component of chromaffin cell secretory responses, but not their final 
magnitude, as judged by capacitance (Sorensen et al., 2006). This is 
consistent with a reduced rate in the relatively fast formation of fusogenic 
SNARE complexes in vivo, in the absence of any reduction in the slower 
formation of ‘intermediate’, non-fusogenic complexes. Where mutations 
likely to affect assembly of the middle layers of the complex were made, 
there was a reduction in the rate and magnitude of secretory responses 
(Sorensen et al., 2006). This is consistent with a reduction in both fast 
fusogenic SNARE complex formation, and also in slow ‘intermediate’ 
SNARE complex formation.
As discussed in ‘Tethering’, above, TIRF microscopy appears to show that 
in the presence of Munc18-1, secretory granules can form closer, albeit 
reversible, associations with the plasma membrane in chromaffin cells 
(Toonen et al., 2006). This would be consistent with its promotion of the
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formation of SNARE complex intermediates and ‘docking’, and evidence 
for this suggestion has recently been presented. It has been reported that 
VAMP is most readily incorporated into SNARE complexes through 
interaction with a Qabc ‘acceptor’ complex containing Syntaxin and SNAP- 
25 (Pobbati et a/., 2006). However, it is thought that in vitro, such 
complexes are formed only transiently because a second Syntaxin may be 
incorporated into such complexes to form a Q aabc complex, and VAMP 
cannot displace this additional Syntaxin (Zhang et al., 2002). Indeed, in in 
vitro fusion experiments, membranes are routinely cooled to 4°C 
ostensibly in order to maximise levels of VAMP ‘acceptors’ (Schaub et at., 
2006; Shen et al., 2007). In a recent study, it was shown that Munc18-1 
could interact with Syntaxin on membranes isolated from PC12 cells, while 
it could be displaced by soluble recombinant VAMP, only in the presence 
of endogenous SNAP-25 (Zilly et al., 2006). This suggested that Munc18-1 
might interact with and stabilise the binary Syntaxin/SNAP-25 ‘acceptor’ 
complex, and such an interaction was subsequently demonstrated in vitro 
when Syntaxin was mutated to adopt an ‘open’ conformation (Rickman et 
al., 2007). Further, data from conventional confocal microscopy, as well as 
fluorescence lifetime imaging experiments, is consistent with the existence 
of these ‘acceptor’ complexes at the plasma membrane in live cells 
(Rickman et al., 2007). The dramatic acceleration of in vitro liposome 
fusion seen where Munc18-1 was added to liposomes containing the 
SNARE complex components supports the suggestion that Munc18-1 is 
crucial for efficient SNARE complex formation (Shen et al., 2007). The
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absence of neuretransmission in Munc18-1 knockout mice also supports 
this suggestion (Verhage et al., 2000).
1.2.5 Priming
The term ‘priming’ has been used to describe various steps in the 
secretory and neurosecretory pathways (Burgoyne and Morgan, 2003). 
Originally, it was used to describe an ATP-dependent process(es) required 
to maintain exocytotic responses in secretory cells (Holz et al., 1989). 
However, it also became used to describe a theoretical mechanism 
underlying the observation that a fraction of the synaptic vesicles at an 
active zone are responsive to a given action potential and undergo fusion, 
while their neighbours do not (Goda and Sudhof, 1997). There are diverse 
range of ATP-dependent processes thought to maintain secretory 
responses (Burgoyne and Morgan, 2003). Further, it has been suggested 
that ‘docking’ and ‘priming of synaptic vesicles may not be mechanistically 
distinct (Wojcik and Brose, 2007). Therefore, discussion here will be 
limited to the well-characterised, ATP-dependent role of N-ethylmaleimide- 
sensitive fusion protein (NSF) and its essential cofactor a-soluble NSF 
attachment protein (a-SNAP) in exocytosis.
Where v- and t-SNAREs on apposing membranes assemble, the resulting 
complex is known as a trans-SNARE. Where such complexes are present 
on a single membrane, following SNARE-mediated fusion for example, 
they are referred to as cis-SNAREs. Because of the very high stability of 
cis-SNAREs, the ATP-dependent machinery of NSF and a-SNAP is
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required for their disassembly and subsequent recycling (May et al., 2001). 
These proteins are not thought to disassemble trans-SNARE complexes, 
however, as they operate as components in a large multimeric complex to 
which trans-SNAREs are likely to be inaccessible. NSF was first 
discovered through its ability to reconstitute N-ethylmaleimide-blocked 
intra-Golgi traffic in vitro (Block et al., 1988). It was found to possess two 
ATPase domains, one a functional ATPase, and the other involved in 
formation of a ring-like homohexamer (Hanson et al., 1997b; Furst et al., 
2003). Two such homohexameric complexes are thought to associate in 
an antiparallel manner to form a barrel-like structure, while this complex 
associates with cis-SNAREs via molecules of a-SNAP (May et al., 2001; 
Furst et al., 2003). a-SNAP aligns the SNARE complexes with the central 
‘pore’ of the structure, stimulates the ATPase activity of the NSF, and ATP- 
hydrolysis drives cis-SNARE disassembly, possibly through hydration of 
the SNARE zero layer (Scales et al., 2001).
Despite the likely specificity of NSF and a-SNAP for cis-SNAREs, there is 
strong experimental evidence to suggest that they serve a pre-fusion as 
well as a post-fusion role. Introduction of recombinant a-SNAP into adrenal 
chromaffin cells was found to proportionately increase the magnitude of 
the fast and sustained components of their secretory response to elevated 
calcium (Xu et al., 1999a). Therefore, it is likely that NSF/a-SNAP can in 
some way increase the probability that any given granule will undergo 
exocytosis in these cells. Inhibition of NSF in the same system using NEM 
was found to reduce the sustained component of secretory responses to a
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greater extent than their fast component (Xu et a/., 1999a). This indicates 
that NSF/a-SNAP may act to increase the probability of some event 
upstream of granule fusion rather than the fusion event itself. In view of the 
of the characterised activity of NSF/a-SNAP, both of these findings are 
compatible with the suggestion that its continual disassembly of cis- 
SNARE complexes dynamically determines levels of trans-SNARE 
complex formation (Xu eta!., 1999a; Burgoyne and Morgan, 2003).
How may the suggested function of NSF/a-SNAP be incorporated into a 
model for the function of the exocytotic machinery already discussed? It 
has been suggested that vesicular VAMP may be incorporated into cis- 
SNAREs, and that these must be disassembled prior to the formation of 
trans-SNAREs (Xu et al., 1999a; Burgoyne and Morgan, 2003). It is also 
plausible that NSF/a-SNAP disassembles ‘functionally inert’ plasma 
membrane Syntaxin/SNAP-25 complexes, and thereby promotes formation 
of the Munc18/Syntaxin/SNAP-25 Qabc complexes that serve as the 
‘acceptors’ for the vesicular VAMP (Jahn and Scheller, 2006). This would 
be consistent with the suggestion that Qabc SNAREs are required for 
Munc18-1 to promote membrane fusion in vitro, and with the report that 
Munc18-1 gradually dissociates from isolated plasma membranes, and so 
may slow but not prevent Qaabc-SNARE formation in vivo (Zilly et al., 2006; 
Shen et al., 2007).
If, as implied above, levels of ‘free VAMP’ and/or ‘acceptor complex’ 
determine the magnitude of secretory responses, then this would support
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the previous suggestion that the probability of triggered exocytosis is 
directly governed by the extent of ‘intermediate’ trans-SNARE formation 
(Sorensen et al., 2006). If this suggestion is accepted, however, the finding 
that introduction of a-SNAP into cells caused proportionate increases in 
the fast and the sustained components of their exocytotic responses must 
also be explained in these terms. One possibility is that this finding reflects 
proportionate increases in trans-SNARE formation at granules tethered 
prior to stimulation, and at granules that become tethered during 
stimulation. This interpretation might support previous suggestions made 
here on the basis of TIRF data, that tethering governs granule-plasma 
membrane association, while trans-SNARE formation is reversible 
(Toonen et al., 2006)(see 1.2.3 ‘tethering’ above). If trans-SNARE 
formation could affect membrane-association, or if it were irreversible, it is 
likely that increased trans-SNARE assembly would have a greater effect 
on the fast component of responses than on their sustained component.
The effects of NSF inhibition on secretory responses are similar to those 
produced where SNARE proteins were mutated in a manner proposed to 
affect ‘intermediate’ trans-SNARE assembly (Xu et al., 1999a; Sorensen et 
al., 2006). This further supports the suggestion that NSF/a-SNAP activity 
determines the cellular levels of VAMP and/or ‘acceptor’ complex, which 
then determine the likelihood of ‘intermediate’ trans-SNARE formation, 
subsequent ‘fusogenic’ trans-SNARE formation and exocytosis (Xu et al., 
1999a; Zilly et al., 2006). However, the finding that NSF-inhibition 
disproportionately affects the sustained component of exocytotic
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responses may at first appear to suggest that trans-SNAREs formed prior 
to stimulation are resistant to the effects of this treatment. Since this 
explanation would indicate that trans-SNAREs could be formed stably 
rather than reversibly, it might not be consistent with those suggested for 
the other findings discussed here.
An alternative explanation for the apparently selective effects of NSF- 
inhibition might be that prior to stimulation, it has only a small effect on the 
levels of ‘free VAMP’ and/or ’acceptor complexes’ present in cells. While 
these levels may be raised rapidly by increased NSF/a-SNAP activity, 
reduced NSF/a-SNAP activity may not produce a correspondingly rapid 
fall. The depletion of ’acceptor complexes’, for example, might depend on 
the slow dissociation of Munc18 (Zilly et al., 2006). In this situation, the 
initial phase of a given secretory response may be relatively unaffected by 
NSF-inhibition, with its effect becoming more pronounced over time. The 
results of experiments in which NEM-treated cells were stimulated twice 
may support this idea. It was found that in NEM-treated cells, secretory 
responses to the second stimulation were much more dramatically reduced 
compared to controls, and that the rapid, as well as the sustained release 
was affected (Xu et al., 1999a). Thus, the depletion of 'free VAMP’ and/or 
'acceptor complex’ levels during the first response must have strongly 
compounded the effects of NEM on the second.
In conclusion, it is evident that NSF/a-SNAP activity can determine both 
the size of exocytotic responses, and the capacity of the exocytotic
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systems to recover following use. It is likely that the individual components 
of the secretory machinery are subject to continual change and turnover, 
while the ATP-dependent ‘Priming’ reactions catalysed by the NSF/a- 
SNAP complex maintain the function of the secretory pathway as a whole.
1.2.6 Triggering
It is the ‘triggering’ step in exocytosis that distinguishes regulated, from 
constitutive exocytotic pathways. A wide variety of extracellular stimuli can 
evoke exocytotic responses, while defined exocytotic triggers are a small 
group of second messengers including cAMP, GTP and calcium. Elevated 
cAMP can modulate exocytosis in many cell types, while it can trigger 
exocytosis in cells including pancreatic [3-cells and pituitary cells, and may 
be the primary trigger in parotid acinar cells and submandibular gland cells 
(Ashby and Tepikin, 2002; Burgoyne and Morgan, 2003). At least in 
parotid acinar cells, the nucleotide must activate protein kinase A (PKA) in 
order to trigger an exocytotic response (Fujita-Yoshigaki et at., 1999). 
Elevated GTP can also trigger exocytosis in a range of cell types including 
adrenal chromaffin cells and some neurones, although it has not been 
identified as the primary trigger for exocytosis in these cells (Burgoyne and 
Morgan, 2003). While a large number of GTP-binding proteins have 
characterised roles in exocytosis, it has recently been reported that Ral 
proteins act as GTP sensors in GTP-dependent secretion (Vitale et a/., 
2005; Li et at., 2007). Calcium is by far the most widespread trigger for 
exocytosis, and is the primary trigger in neurones, PC 12 cells, adrenal 
chromaffin cells and many other cell types (Burgoyne and Morgan, 2003;
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Wojcik and Brose, 2007). Therefore, further discussion here will be 
restricted to calcium-triggered exocytosis.
Although calcium is a trigger for regulated exocytosis in diverse cell types, 
the source of this ‘calcium-trigger’ can vary (Burgoyne and Morgan, 2003). 
In neuronal cells, and other cell types including adrenal chromaffin cells, 
calcium influx through voltage-gated channels precipitates the exocytotic 
response, while in pancreatic acinar cells, for example, it is triggered by 
the calcium release from internal stores (Ashby and Tepikin, 2002; Wojcik 
and Brose, 2007). In some other cell types such as pituitary corticotrophs, 
a combination of calcium influx and release from stores is required to 
evoke a maximal response (Burgoyne and Morgan, 2003).
Not only may the ‘calcium-trigger’ take various forms, it is also known to 
act at a very wide range of proteins known to be involved in the regulation 
of the exocytotic pathways. These include EF-hand domain-containing 
calcium-binding proteins such as Calmodulin and the neuronal calcium 
sensor (NCS) proteins, as well as C2 domain-containing calcium- 
dependent phospholipid-binding proteins including such as protein kinase 
C (PKC), and various Rab effector proteins (Fukuda, 2005; Morgan et at., 
2005; Burgoyne, 2007). However, it is the C2 domain-containing protein 
Synaptotagmin that is most widely regarded as the major transducer of the 
calcium trigger, and it is this protein that discussion will focus on.
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The Synaptotagmins are a group of transmembrane proteins each carrying 
two C2 domains denoted C2A and C2B (Sutton et al., 1995; Sutton, 1999; 
Yoshihara and Montana, 2004). These domains may function in calcium- 
dependent interactions with phospholipids or in protein-protein interactions 
(Nalefski and Falke, 1996). Evidence that Synaptotagmin is important in 
regulated exocytosis includes findings showing that loss of the protein can 
impair secretion in a number of animal models. C. elegans lacking the 
Synaptotagmin-encoding gene snt-1 were found to display behaviour, and 
responses to pharmacological agents, consistent with impaired 
neurotransmission (Nonet et al., 1993). Such impairment was observed 
directly in Drosophila lacking a functional syt gene, and in mice lacking 
functional Synaptotagmin I (Littleton et al., 1993; Geppert et al., 1994b). 
Evidence that Synaptotagmin functions as a calcium sensor in exocytosis 
includes the finding that where mouse Synaptotagmin I is mutated to 
reduce its affinity for calcium, the calcium sensitivity of neurotransmission 
is reduced to a similar extent (Fernandez-Chacon et al., 2001).
Figure 1.4. Crystal structure of the C2A and C2B domains of Synaptotagmin III. The C2A domain is 
shown interacting with three metal ions, while the C2B domain is shown interacting with only one. 
Molecular coordinates taken from Sutton e ta l., 1999 (RCSB PDB Structure ID 1DQV).
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Mammalian Synaptotagmin isoforms, of which there are at least 16, show 
a range of calcium affinities, and may adopt distinct subcellular 
localisations. For example, Synaptotagmins I, II and IV predominantly 
localise to the membranes of synaptic vesicles or secretory granules, and 
have a lower affinity for calcium than Synaptotagmins III and VII, which 
predominantly localise to the plasma membrane (Butz et al., 1999; Berton 
etal., 2000; Sugita et al., 2001; Sugita et al., 2002). It has been suggested 
that the involvement of different Synaptotagmin isoforms in different 
exocytotic events might determine the calcium-sensitivity of these events 
(Sugita et al., 2002). For instance, their involvement might underlie the 
finding that in neutrophils, progressively greater levels of intracellular 
calcium are required to trigger exocytosis of secretory vesicles, gelatinase 
granules, specific granules and azurophil granules (Sengelov et al., 1993). 
Further, it might underlie the finding that in the neurones and adrenal 
chromaffin cells of Synaptotagmin I knockout mice, the rapid components 
of secretory responses are lost, while their sustained component is 
relatively unaffected (Geppert et al., 1994b; Voets etal., 2001a).
Synaptotagmin I has a comparatively low affinity for calcium, and this is 
consistent with its functioning as the calcium sensor in rapid responses. In 
different neurones, the delay between calcium influx and transmitter 
release is reported to be between 60ps and 300ps (Sabatini and Regehr, 
1996; Bollmann et al., 2000). Since the movement of calcium is limited by 
the rate of its diffusion, this suggests that a calcium sensor must be 
located close to the point of calcium entry. Indeed, in theoretical analysis
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of quantal secretion at the active zone, it is suggested that the probability 
of synaptic vesicle exocytosis is reduced threefold with a doubling of the 
distance to the nearest calcium channel from 25nm to 50nm (Bennett et 
al., 2000). Thus, it is likely that the sensor operates in microdomains of 
high calcium concentration produced close to an open channel mouth, and 
so its affinity for the ion may be lower than if it were required to respond to 
a more global calcium elevation.
The molecular mechanism by which calcium binding to Synaptotagmin I 
can lead to virtually instant synaptic vesicle exocytosis is the subject of 
continued debate (Carr and Munson, 2007; Wojcik and Brose, 2007). 
However, it has been shown to bind to phospholipids, and to C-terminal 
regions of SNAP-25, in a calcium-dependent manner (Gerona et al., 
2000). Its binding to SNAP-25 is very likely to be significant in its function, 
as it binds to an exposed region of the protein that forms part of the C- 
terminal end of the QabcR SNARE complex, and which is important in 
defining the calcium-dependency of the exocytotic response (Gerona et 
al., 2000; Sorensen et al., 2006). Further, several recent studies have 
indicated that its function is related to that of another protein, Complexin 
(Giraudo et al., 2006; Schaub etal., 2006; Tang eta!., 2006).
Complexins I and II are implicated in rapid exocytotic responses in 
neurones because their absence results in reduced calcium-triggered 
synchronous neurotransmitter release (Reim et al., 2001; Xue et al., 2007). 
It is found that their central a-helical domains within these proteins can
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bind to assembled SNARE complexes in the ‘groove’ formed between the 
Syntaxin and VAMP SNARE motifs (QaR), while their function also 
depends on their adjacent N-terminal domains (Bracher et al., 2002; Chen 
et at., 2002; Xue et al., 2007). Microinjection of recombinant Complexin 
into Aplysia neurones inhibits evoked neurotransmitter release, and a 
similar effect is produced where a VAMP-Complexin fusion protein is 
expressed in mammalian neurones to raise Complexin concentration at 
the fusion machinery specifically (Ono et al., 1998; Tang et al., 2006). 
Similarly, in vitro, the addition of recombinant Complexin to liposome 
fusion assays, or cell-based fusion assays, is also inhibitory (Giraudo et 
al., 2006; Schaub et al., 2006). Together, these data indicate that 
Complexin may function as a ‘fusion clamp’, limiting the capacity of the 
SNARE complex to drive membrane fusion.
Figure 1.5. Crystal structure of a truncated form of the assembled neuronal SNARE complex bound 
a Complexin fragment. Complexin (pink) binds in a ‘groove’ formed between VAMP2 (red) and 
SyntaxInIA (blue). SNAP-25 Is shown in green. Molecular coordinates taken from Chen et al., 
2002 (RCSB PDB Structure ID 1KIL).
Given that both Synaptotagmin I and Complexin are required for 
synchronous neurotransmitter release, it was possible that they function as 
components of the same triggering machinery, and so a number of studies
38
were carried out to test this hypothesis. In vitro, and therefore in the 
absence of other factors, Complexin-blocked SNARE-driven liposome 
fusion was restored by the addition of calcium and Synaptotagmin I, and in 
fact proceeded faster than under conditions where both Complexin and 
Synaptotagmin were absent (Schaub et a/., 2006). In other experiments, 
addition of calcium to a cell based fusion assay containing Complexin and 
Synaptotagmin I was shown to trigger fusion, while in vitro binding of 
Complexin and Synaptotagmin I to SNARE complexes was found to be 
competitive (Giraudo et al., 2006; Tang et at., 2006). Therefore, it appears 
that calcium binding to Synaptotagmin I triggers rapid secretory responses 
by lifting a block imposed on the exocytosis of ‘docked’ synaptic vesicles 
by the binding of Complexin to trans-SNAREs. An interesting feature of the 
in vitro liposome fusion data, was that the binding of Complexin to trans- 
SNAREs appeared to promote hemifusion between the outer leaflets of 
liposomal membranes (Schaub et al., 2006). This seems to suggest that 
the protein can hold the rest of the exocytotic machinery at the brink of 
producing fusion, until calcium acts at Synaptotagmin I to trigger it.
1.2.7 Fusion
As already discussed, it has long been suggested that SNARE proteins, 
and more specifically trans-SNAREs, are responsible for driving the fusion 
of phospholipid bilayers in the exocytotic fusion event (Hanson et al., 
1997a; Burgoyne and Morgan, 2003). Strong evidence for this suggestion 
includes findings that some combinations of SNARE proteins can 
reconstitute liposomal fusion in vitro, and that exocytosis can be blocked
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where particular SNARE proteins are absent, or cleaved by highly specific 
clostridial neurotoxins (McNew et al., 2000; Parlati et al., 2000; Burgoyne 
and Morgan, 2003). Membrane fusion requires energy in order to 
overcome the powerful repulsion between the headgroups of apposed 
bilayers (Kozlovsky and Kozlov, 2002). It has been proposed that this 
energy is provided by the energetically favourable formation of trans- 
SNARE complexes, which might locally bring bilayers into close 
apposition. This proposal was formalised as the 'SNARE Zipper 
hypothesis’ (Hanson et al., 1997a).
It is widely accepted that there is a requirement for SNARE proteins in 
bringing vesicle/granule and plasma membranes into close apposition 
(Burgoyne and Morgan, 2003; Jahn and Scheller, 2006). However, in 
recent years, a number of researchers have questioned the assertion that 
SNARE complex assembly mediates their final fusion. It is suggested, for 
example, that Complexin binds to fully assembled trans-SNARE 
complexes prior to triggering (Giraudo et al., 2006; Schaub et al., 2006; 
Tang et al., 2006). While it is highly plausible that other factors might 
mediate, or facilitate the final fusion event, it is, difficult to reconcile notion 
of complete, metastable, SNARE complex assembly, with the degree of 
reversibility likely in tethering and docking, as discussed (Xu et al., 1999a; 
Pobbati et al., 2006; Sorensen et al., 2006; Toonen et al., 2006). Also as 
discussed, several lines of evidence point to stepwise SNARE assembly, 
with the final step producing a fusion pore (Pobbati et al., 2006; Sorensen 
et al., 2006). Most importantly, it is found that mutation of residues in
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SNAP-25 likely to affect its interactions with the other SNARE proteins in 
the final step of trans-SNARE assembly specifically slow down the fast 
component of the exocytotic response (Sorensen et at., 2006). It is 
probable, therefore, that the forces driving the transition from ‘intermediate’ 
to ‘fully-assembled’ trans-SNARE also determine the likelihood of fusion.
If trans-SNAREs exist in a partially assembled ‘intermediate’ state prior to 
full assembly and membrane fusion as argued above, the nature of this 
state should be discussed. Further, if Complexin binds to ‘intermediate’ 
trans-SNAREs prior to fusion, the finding that its addition to an in vitro 
fusion assay promotes hemifusion between the outer leaflets of liposomes 
must also be explained in these terms. To address these points, it may be 
useful to explore the process of membrane fusion more deeply. The 
principal paradigm for phospholipid bilayer fusion is known as the ‘stalk 
hypothesis’ (Kozlovsky and Kozlov, 2002; Blumenthal et at., 2003). Within 
this paradigm, the local approach of bilayers, where they are ‘pulled 
together’ can lead to transient, extreme membrane deformation and lipid 
distortion that results in hemifusion and continuity between a contacting 
monolayer, the ‘stalk’ (Blumenthal et at., 2003). Constrained, hemifused 
membranes must adopt the most energetically stable conformation 
possible, a characteristic ‘x’ shape in cross section, while phospholipids 
are still subject to distortion at this intermediate stage (Kozlovsky and 
Kozlov, 2002). For progression from a hemifused to a fully fused state, it is 
thought that the contacting ‘stalk’ must be expanded or ‘pulled apart’, while 
it is not known whether this leads to immediate bilayer fusion, or whether
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that follows formation of a ‘fusion diaphragm’ (Kozlovsky et al., 2002; 
Kozlovsky and Kozlov, 2002).
Figure 1.6. Likely structure of the ‘stalk’ as proposed in the stalk hypothesis of membrane fusion. 
Diagram shows hemifusion between apposed monolayers of two phospholipid bilayers -  the 
hemifused state is suggested to precede full fusion. Diagram modified from Kozlovsy and Kozlov, 
2002
It was argued here earlier that secretory granules tethered at the plasma 
membrane can become ‘docked’, reversibly, as a result of ‘intermediate’ 
trans-SNARE engagement. Further, it was suggested on the basis of TIRF 
data that this engagement was reflected in a greater responsiveness of 
granules to movement of the plasma membrane - a closer association with 
it (Toonen et al., 2006). According to the paradigm described above, 
progressively closer membrane association might lead to progressive 
membrane instability until a relatively stable hemifused state is reached. 
Therefore, it may be suggested that ‘intermediate’ trans-SNARE assembly 
drives membranes towards hemifusion, and complete trans-SNARE
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assembly drives full fusion. This seems intuitively likely, since there is 
evidence for two-step SNARE complex assembly, while the paradigm for 
membrane fusion suggests that to promote fusion, force may first draw 
phospholipid bilayers together, and then may draw a phospholipid bilayer 
apart: two mechanically distinct operations (Kozlovsky et al., 2002; 
Kozlovsky and Kozlov, 2002). Further there is evidence from a cell-based 
fusion assay that the minimal SNARE machinery of VAMP, Syntaxin and 
SNAP-25 can produce stable hemifusion between biological membranes 
(Giraudo et al., 2005). More subjectively, EM images of the active zone of 
the frog neuromuscular junction appear to show that the active zone 
tethering machinery promotes membrane deformation consistent with 
stable hemifusion between synaptic vesicles and the plasma membrane 
(Harlow et al., 2001).
To integrate the above model into one in which ‘tethering’ is the major 
determinant of membrane-association, and in which ‘docking’ is reversible, 
it may be suggested that membrane-associated vesicles or granules are 
continually at equilibrium between tethered/unfused and docked/hemifused 
states. In this context, it might be suggested that the finding that 
Complexin promotes hemifusion between liposomes in vitro reflects its 
stabilisation of ‘intermediate’ trans-SNAREs, and its consequent extension 
of the average hemifusion ‘lifetime’. In other words, Complexin might push 
the equilibrium between tethered/unfused and docked/hemifused states 
towards the latter.
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If it is essential that hemifusion precedes fusion, as suggested in the ‘stalk 
hypothesis’, an interesting consequence of the above suggestion would be 
that the Complexin-bound fusion machinery might promote more rapid 
exocytosis, though this would of course depend on calcium and 
Synaptotagmin. Within this model, the Complexin-Synaptotagmin 
triggering mechanism would define the fast component of exocytotic 
responses. The sustained component of release would be slower as a 
result its dependence on the relatively unstable formation of ‘intermediate’ 
trans-SNAREs in the absence of Complexin. Consistent with this model, it 
is found that the sustained phase of exocytotic responses is relatively 
unaffected in characterised Complexin and Synaptotagmin knockout 
animals (Geppert etal., 1994b; Reim etal., 2001; Voets eta!., 2001a; Xue 
et al., 2007).
When membranes fuse, a fusion pore is created. The nature of the fusion 
pore is debated, at one extreme it is proposed to be a channel-like 
assembly lined by the transmembrane domains of trans-SNAREs, and at 
the other, to result from the increasing instability of a hypothetical ‘fusion 
diaphragm’ with its increasing radius (Kozlovsky et al., 2002; Han et al., 
2004; Szule and Coorssen, 2004). It is thought, however, that fusion pores 
share some of the characteristics of large ion channels or gap junctions 
(Burgoyne and Morgan, 2003). That is, initial current flow through the 
pores can be of a defined magnitude, some pores may remain stably open 
for extended periods, and pore ‘flickering’ -  suggestive of rapid opening 
and re-closure -  has been observed (Fernandez et al., 1984; Wang et al.,
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2003). Experiments utilising carbon-fibre amperometry have suggested 
that proteins affecting the kinetics of fusion pore opening and expansion 
include Munc18 and Synaptotagmin (Fisher et al., 2001; Wang et a!., 
2003; Wang et al., 2006).
A direct role for Munc18 in fusion is suggested by evidence that it can 
interact with assembled SNARE complexes (Rickman et al., 2007; Shen et 
al., 2007). Further, it is found that expression of a Munc18 mutant with 
reduced affinity for Syntaxin alters kinetics of release from chromaffin 
granules in a manner consistent with faster opening and closing of the 
fusion pore (Fisher et al., 2001). Significantly, physiological 
phosphorylation of Munc18 may have the same effects on its interactions 
with Syntaxin, and on fusion pore kinetics (Barclay et al., 2003). Like 
Munc18, Synaptotagmin I can interact with assembled SNARE complexes, 
and is found to accelerate liposome fusion in vitro (Schaub et al., 2006; 
Stein et al., 2007). A direct role for the protein in fusion is suggested by 
evidence that it may be involved in the stabilisation of minimally conductive 
fusion pores, and their subsequent expansion (Wang et al., 2003; Wang et 
al., 2006). In this case, these effects may be physiologically significant 
because they vary with calcium concentration, and Synaptotagmin isoform 
(Wang etal., 2003; Wang eta!., 2006).
If it is accepted that the full assembly of trans-SNAREs drives fusion, it is 
possible that Munc18 and Synaptotagmin affect this assembly in some 
way, while it is also possible that they contribute to the fusion process
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directly. As their role remains unclear, these possibilities will not be 
discussed here. However, their possible roles in regulating quantal release 
and fusion pore kinetics may be physiologically important, and relevant to 
the discussion of membrane retrieval below.
1.2.8 Retrieval
Full exocytotic fusion may proceed with expansion of the fusion pore 
leading to incorporation of granular or vesicular membrane into the plasma 
membrane. In order to maintain the surface area of the plasma membrane, 
and for the retrieval of some of the granular/vesicular exocytotic 
machinery, membrane may be recycled through Clathrin-based and/or bulk 
endocytosis (Royle and Lagnado, 2003). The molecular mechanisms by 
which these forms of recycling occur are largely distinct from those directly 
involved in exocytosis, and so their discussion is beyond the scope of this 
introduction. However, another form of membrane recycling termed ‘kiss- 
and-run’ should be discussed (Fesce et a/., 1994). In ‘kiss-and-run’ 
exo/endocytosis, granular/vesicular membrane is not fully incorporated into 
the plasma membrane. Instead, granules or vesicles are recycled following 
the release of their contents or a portion of their contents (An and Zenisek, 
2004; Rutter and Tsuboi, 2004).
Evidence for the existence of ‘kiss-and-run’ comes from a number of 
sources. Experiments in which amperometry was combined with 
capacitance recordings showed that catecholamine release from single 
chromaffin cell granules could coincide with transient increases in
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membrane capacitance (Albillos et at., 1997; Ales et a i, 1999). This 
suggests that fusion between granular and plasma membranes can be 
closely followed by their fission (Burgoyne and Morgan, 2003). In 
neurones, quantal release is smaller, and so not amenable to this kind of 
direct approach. However, particularly at low levels of stimulation, 
fluorescent FM- dyes with different affinities for lipid may be released from 
vesicles at different rates (Cousin and Robinson, 2000; Stevens and 
Williams, 2000). This may suggest that kiss-and-run occurs in these cells 
because parallel destaining could be expected in the absence of transient 
fusion events. This is however, controversial, and has been disputed in a 
recent study (Granseth etal., 2006).
Various physiological roles for kiss-and-run might be proposed. One 
suggestion is that retrieval of granule or vesicle membrane via ‘kiss-and- 
run’ might be more energy-efficient than its retrieval via a Clathrin- 
dependent mechanism. In neurones, ‘kiss-and-run’ recycling of synaptic 
vesicles followed by their rapid refilling might also increase the rate at 
which they are replenished following their depletion (Rizzoli and Jahn, 
2007). Another possibility is that ‘kiss-and-run’ is regulated in order to alter 
the quantal size of release events, and possibly their character. For 
example, secretory granules might release only a fraction of their peptide 
contents through a transient fusion pore, but a greater proportion of any 
small molecule neurotransmitter content (Burgoyne and Barclay, 2002). It 
is possible that this might serve to modulate distinct responses at the cells’ 
targets (Burgoyne and Barclay, 2002). In neurones, it has been suggested
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that very limited neurotransmitter release through fusion pores with low 
conductance may be involved in sensitisation of post-synaptic receptors 
(Choi et al., 2000). Thus, release of the same neurotransmitter from the 
same cell, but at different levels and under different circumstances, might 
regulate different post-synaptic processes.
The mechanisms underlying transient fusion are unknown, and indeed it is 
likely that distinct forms of ‘kiss-and-run’ exist. It has been shown that 
expression of specific Munc18 mutants in chromaffin cells, or treatment of 
these cells with the phorbol ester PM A, can reduce the quantal size of 
release events, and alter release kinetics (Fisher et al., 2001; Graham et 
al., 2002; Barclay et al., 2003). These changes in release kinetics have 
been suggested to correspond to faster opening and closure of fusion 
pores, and one form of ‘kiss-and-run’. Further, they are partially reversed 
by treatments likely to inhibit the function of the Dynamin fission 
machinery, suggesting that this machinery may act to ‘pinch-off partially 
fused granules following a proportion of transient fusion events (Graham et 
al., 2002). In other studies, it has been suggested that overexpression of 
particular Synaptotagmin isoforms, or mutation of this protein in PC12 
cells, can produce changes in the numbers and duration of amperometric 
events suggested to correspond to neurotransmitter release through poorly 
conductive fusion pores (Wang et al., 2003; Wang et al., 2006). The 
molecular basis for opening and closure of these pores, and that for their 
expansion, is poorly understood, but it is unlikely to be the same as that for 
the opening and closure of more conductive pores already described.
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1.3 Regulation of regulated exocvtosis
In the above discussion of the regulated exocytotic pathway, emphasis has 
been placed on the past characterisation of the molecular machinery 
central to each step, and on the dynamic behaviour of this machinery. 
Given this focus, it should be noted that no attempt has been made to 
present a complete picture. For instance, no mention has been made of 
the role of key proteins such as Munc13, which is essential for 
neurotransmitter release, or the membrane modifications and makeup 
associated with exocytotic sites and events (Osborne et al., 2006; Wojcik 
and Brose, 2007). More importantly, however, the regulation and 
modulation of the exocytotic pathway as a whole has not yet been 
discussed directly. Multiple factors cooperatively regulate various aspects 
of each step in the pathway, and so a brief discussion here will explore, in 
general terms, how exocytotic systems are structured so that secretory 
responses are maintained and adaptively amenable to regulation.
One important observation is that the granules or vesicles of a given cell 
are often functionally segregated into ‘readily-releasable’ and ‘reserve’ 
pools. That is, one pool that undergoes exocytosis readily in response to a 
trigger, and another that is mobilised to replenish this pool as it is depleted. 
The ‘readily-releasable’ pool is primarily responsible for defining the size of 
exocytotic responses, while the ‘reserve’ pool determines the regenerative 
capacity of the system. Interestingly, it has been shown in both secretory 
cells and in neurones that these pools may not be distinguished
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morphologically (Han, 1999; Rizzoli and Betz, 2005). Of course, the 
synaptic vesicles exocytosed within microseconds of calcium influx are 
those present within a population associated with the active zone, but 
typically, a morphologically similar population of granules or vesicles will 
have a range of fusion competencies. It may be inferred from this that 
granules/vesicles exposed to the same regulatory systems may 
irrespectively be subject to differential regulation. Further, it may be 
inferred that granules/vesicles exposed to differing regulatory systems may 
contribute to the same process.
Another important observation is that longer maturation does not 
necessarily increase the capacity of secretory granules to fuse with the 
plasma membrane. In fact it is likely more recently synthesised granules 
are released preferentially. Indeed, it has been reported that even 
immature granules are fusogenic (Tooze et at., 1991). When a fluorescent 
‘timer’ was expressed in adrenal chromaffin cells, targeted to secretory 
granules, granules of different ages could be distinguished through 
progressive changes in the emission spectra of this protein (Duncan et a!., 
2003). When these cells were stimulated, it was reported that -99% of the 
granules synthesised up to 2 hours previously were exocytosed compared 
to 0% of the granules older than -16 hours, and -69% of granules of an 
intermediate age (Duncan et at., 2003). It may be inferred from this that 
granules do not ‘queue’ for fusion. Instead, it is likely that mechanisms 
promoting granule biosynthesis, trafficking, tethering and docking are 
temporally regulated, and accompanied by mechanisms promoting
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continual turnover in the makeup of ‘readily-releasable’ and ‘reserve’ 
pools. Consequently, regulatory changes at any step in the secretory 
pathway may produce a more rapid effect. Further, if granules are subject 
to differential regulation according to their temporal, as well as their spatial 
localisation, the capacity of the system for precision is increased, and 
regulatory mechanisms may be combined and choreographed more easily.
1.4 Rab protein structure
Small GTPases of the Ras superfamily are present in eukaryotic but not 
prokaryotic cells (Leipe et a i, 2002). Because they are present throughout 
the eukaryotic lineage, it is thought that expansion and diversification 
within the superfamily occurred early in eukaryote evolution (Leipe et al., 
2002; Jekely, 2003). It has been found that different subfamilies within the 
superfamily can fulfil very different cellular functions, while the members of 
each subfamily may have distinct, but more related roles (Jekely, 2003). 
Major subfamilies include the Ras/Ral/Rap, Rho/Rac/Cdc42, Arf/Arl/Sar1, 
Rit/Rin, Ran, Rheb and Rab proteins. The Rab proteins (see table 1.1) 
comprise the largest of these subfamilies, and are largely found to function 
in membrane trafficking, while some may also function in signal 
transduction (Takai etal., 2001; Schwartz etal., 2007).
Despite differences in their cellular activities, the members of the Ras 
superfamily show a high degree of sequence homology, and are thought to
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Isoform(s) Localisation(s) Function(s) References
R a b1 A -B ER E R  to  G o lg i tra ffic k in g (T is d a le  e t at., 1992; A lla n  e t at., 2 0 0 0 )
R a b2 A -B ER E R  to  G o lg i tra ffic k in g (T is d a le  e t al., 1992)
R a b3 A -D S y n a p tic  v e s ic le s  and  
s e c re to ry  g ra n u le s
R e g u la te d  exocy to s is (S c h lu te r e t al., 2 00 2 ; T su b o i a n d  Fukuda, 
2 0 0 6 a ; R u pn ik  e ta l. ,  2 0 0 7 )
R a b4 A -C E arly  and  re cyc lin g  
e n d oso m e s
R a p id  re cyc lin g  to  p lasm a  m e m b ra n e (van  d e rS lu ijs  e t  al., 1992; B o ttg e r e ta l. ,  
1996; M ruk  e ta l. ,  2 0 0 7 )
R a b5 A -C C la th r in -c o a te d  ve s ic le s , 
ca vo so m e s  and  e a rly  
e n d oso m e s
E n d o cy to s is  and  e a r ly  e n d o so m e  
fu s io n , ca v e o la r ve s ic le  ta rg e tin g  to 
e a rly  e n d o so m e s
(B u cc i e ta l. ,  1995; B a rb ie ri e ta l. ,  2000; 
A rn e tt e t a l., 2004; P e lkm a n s  e t a l., 2 0 0 4 )
R ab6A G o lg i G o lg i-E R  and  in tra -G o lg i tra ffic k in g (M a rtin e z  e t  a l., 1994; J ia n g  a n d  S to rr ie , 
2 00 5 ; D e l N e ry  e ta l . ,  2 00 6 )
R a b6 A ' G o lg i E n d o s o m e  to  G o lg i tra ffic k in g (M a rtin e z  e t a l., 1994; J ia n g  a n d  S to rr ie , 
2 00 5 ; D e l N e ry  e ta l. ,  2 00 6 )
R ab6B G o lg i G o lg i-E R  and  in tra -G o lg i tra ffic k in g (M a rtin e z  e t a l., 1994; O p d a m  e t a l., 2 0 0 0 ; 
J ia n g  a n d  S to rr ie , 2 00 5 )
R ab6C E R G IC -53  p o s itive  v e s ic le s m u lti-d ru g  re s is ta n ce  re g u la tio n (M a rtin e z  e t a l., 1994; S h a n  e t a l., 2000; 
J ia n g  a nd  S to rr ie , 2 00 5 )
R a b7 L a te  e nd oso m e s, 
lyso som es
T ra ff ic k in g  to  la te  e n d o s o m e s  fro m  
e a r ly  e nd o s o m e s ; lyso som e  
b io q e n e s is
(B u cc i e t  a l., 2 00 0 ; F e ng  e t a l., 2 0 0 1 )
R ab7B L a te  end oso m e s, 
lyso so m e s
T ra ff ic  to  lyso som es , T L R 4  s ig n a lin g (B u cc i e t a l., 2 000; F eng  e t  a l., 2 0 0 1 ; W a n g  
e ta l. ,  2 0 0 7 )
R a b8 A -B P os t-G o lg i ve s ic le s ; G o lg i; 
e nd oso m e s; p lasm a  
m e m b ra ne
T ra ffic k in g  b e tw e e n  G o lg i a n d  p lasm a  
m e m b ra n e
(P e ra n e n  e t a l., 1996; C h e n  e t  a l., 2 001; 
C h e n  a n d  W a n d in g e r-N e s s , 2 00 1 ; H a ttu la  
e t a l., 2 00 6 ; L in d e r e t al., 2 00 7 ; N a chu ry  e t 
al., 2 00 7 )
R a b9 A /B /C L a te  e nd oso m e s T ra ffic k in g  to  tra ns -G o lg i; t ra ff ic k in g  o f 
ly s o s o m a l e n zym e s  a n d  c h o le s te ro l
(L o m b a rd i e t a l., 1993; G a n le y  e t  al., 2 004; 
N a rita  e t a l. , 2 00 5 )
R ab10 G o lg i P o la rise d  m e m b ra n e  tra ffic k in g (C he n  e t a l., 1993; B a b b e y  e t a l., 2 006; 
S c h u c k  e ta l. ,  2 0 0 7 )
R a b1 1 A G o lg i and  re cyc lin g  
e nd oso m e s
T ra ff ic  fro m  G o lg i to  a p ica l recyc lin g  
e n d o so m e s ; p ha go cy tos is
(U llr ic h  e ta l. ,  1996; W ilc k e  e t al., 2 00 0 )
R a b1 1 B G o lg i and  re cyc lin g  
e nd oso m e s
c a lc i u rn -d e p e n d e n t se c re tion (U llr ic h  e ta l. ,  1996; W ilc k e  e ta l. ,  2000; 
K h v o tc h e v  e t a l., 2 00 3 )
R ab12 C e n tro so m e s T ra ff ic k in g  from  ce ll p e r ip h e ry  to  
p e r in u c le a r c e n tro s o m e s
(lid a  e t a l., 2 00 5 )
R ab13 T ig h t ju n c tio n s ; e n d o so m e s T ig h t ju n c tio n  b iog e ne s is (M a rze sco  e t a l., 2 002)
R ab14 R o ug h  ER; G o g i/tra n s - 
G o lg i; e a rly  e n d o s o m e s
P h a g o s o m e  a n d  e a rly  e nd o s o m e  
fu s io n ; tra ffic k in g  b e tw e e n  early  
e n d o s o m e s  a n d  G lqi
(J u n u tu la  e ta l. ,  2004; K ye i e ta l. ,  2 006; 
P ro ik a s -C e z a n n e  e t a l., 2 00 6 )
R a b1 5 E arly /so rtin g /re cyc lin g
e nd oso m e s
T ra ffic k in g  th ro u g h  re cyc lin g  
e n d o so m e s
(Z u k  a n d  E lfe rink , 2 000; E lfe r in k  and  S tr ick , 
2 00 5 )
R ab17 A p ica l re cyc lin g  e n d o so m e s  
in  e p ith e lia
T ra n d p o rt th ro u g h  re cyc lin g  
e n d o so m e s ; p o la rise d  s o rtin g
(Z a cch i e t a l. , 1998)
R ab18 K id ne y  d en se  ap ica l 
tub u le s ; In te s tine  
b aso la te ra l m e m b ra n e ; ER  
lip id  d ro p le ts ; s e c re to ry  
g ra nu le s
F o rm a tio n  o f  lip id  d ro p le ts ; n eg a tive  
re g u la to r o f  se cre tion
(L u tc k e  e t a l., 1994; O zek i e t a l., 2 005; 
V a zq u e z -M a rtin e z  e t a l., 2 0 0 7 )
R a b2 0 K id n e y  d en se  a p ic a l tub u les V -A T P a s e  tra ffic k in g (C u rtis  a n d  G lu ck , 2 0 0 5 )
Rab21 E arly  e n d oso m e s In te g rin  e n d o cy to s is ; c e ll-m a trix  
in te ra c tio n s
(P e llin e n  e ta l. ,  2 00 6 )
R a b2 2 A E arly  e n d o so m e s  a n d  tra n s - 
G o lg i
E n d o s o m e  to  G o lg i tra ffic k in g  a nd  
p h a g o s o m e  tra n sp o rt
(M e sa  e ta l. ,  2 001; K au p p i e ta l. ,  2002; 
R o b e rts  e t a l., 2 0 0 6 )
R ab22B E arly  e n d o so m e s  a n d  tra n s - 
G o lg i
T ra n s -G o lg i to  e n d o so m e  tra ffic k in g (M e sa  e t a l., 2 001; R o d r ig u e z -G a b in  e t a l., 
2 00 1 ; K au p p i e t a l., 2 0 0 2 ; R o b e rts  e t al., 
2 00 6 )
R ab23 P la sm a  m e m b ra ne , 
e n d oso m e s
e m b ryo g e n e s is ; c ilia ryy  tra ffic k in g , 
s o n ic  h e d g e h o g  tra ffic k in g
(E va ns  e t  a l., 2 0 0 3 )
R ab24 A u to p h a g o so m e s , n u c le a r 
in c lu s io n s
In d u c tio n  o f  a u to p h a g y (M u n a fo  a n d  C o lo m b o , 2 00 2 ; O ve rm e ye r 
a n d  M a lte se , 2 0 0 5 )
R a b2 5 A p ica l re cyc lin g  e n d o so m e s  
in  e p ith e lia
A p ic a l re c y c lin g  e n d o so m e  tra ffic (C a sa n o va  e t  a l., 1999; W a n g  e t a l., 2 000)
R a b2 6 S e c re to ry  g ra n u le s R e g u la te d  exocy to s is (Y o sh ie  e t  a l., 2000)
R a b2 7 A -B S e c re to ry  g ra n u le s R e g u la te d  exocy to s is (B a rra l e t a l., 2 002; Fu tte r, 2 00 6 ; Tsu bo i 
a n d  F ukuda , 2 006a ; T o lm a ch o va  e t  al., 
2 00 7 )
R ab32 P e rin u c lu a r ves ic les , 
m ito ch on d ria
P o s t-G o lg i tra ffic ; m ito ch on d ria l 
d y n a m ic s
(A lto  e t  al., 2 00 2 , W a s m e ie r e t  a l., 2 0 0 6 )
R a b3 3 A -B M e d ia l G olg i G o lg i-E R  and  tra ffic k in g (V a ls d o tt ir  e t a l., 2 00 1 )
R ab34 M e m b ra n e  ru ffles ; 
ly so som es
M a cro p in o s o m e  fo rm a tio n  and  
re g u la tio n  o f  ly s o s o m e  lo ca tio n
(S u n  e t a l., 2003; C o lu cc i e t a l., 2 0 0 5 ; S un  
a nd  E nd o , 2005; W u  e t a l., 2 0 0 5 )
R ab37 S e c re to ry  g ra n u le s M a s t ce ll d eg ra n u la tio n (M a su d a  e t a l., 2 00 0 ; B ru n n e r e t a l., 2007)
R a b3 8 T y ro s in a se -p o s itive  v e s ic le s M e la n o s o m e  b iog e ne s is (W a s m e ie r e t a l., 2006)
Table 1.1. Rab protein functions. Modified from Shwartz et al., 2007.
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be structurally similar (Stenmark and Olkkonen, 2001). Each protein is 
thought to consist of a six-stranded (3-sheet containing five parallel strands 
and one antiparallel strand, and surrounded by five a-helices (Pai et al., 
1989; Dumas et al., 1999; Stenmark and Olkkonen, 2001; Pfeffer, 2005c). 
Loops connecting the a-helices and (3-strands contain elements 
responsible for GTP/GDP binding, GTPase activity and Mg2+-binding, and 
the ‘active site’ of each protein contains conserved residues that interact 
with nucleotide phosphate groups, Mg2+, and the guanine base (Pai et al., 
1989; Dumas et al., 1999; Stenmark and Olkkonen, 2001). Regions 
denoted ‘Switch I’ and ‘Switch II’ are found to surround the y-phosphate of 
GTP where this nucleotide is bound, while GTP-hydrolysis produces 
dramatic conformational change (Milburn et al., 1990; Stroupe and 
Brunger, 2000).
Figure 1.7. Crystal structures of Rab protein Sec4 bound to GTP-analogue GppNHp (left) and GDP 
(right). Structures demonstrate dramatic conformational differences. Molecular coordinates taken 
from Stroupe and Brunger, 2000 (RCSB PDB Structure IDs 1G16 and 1G17)
The divergent functions of small GTPase subfamilies are often reflected by 
divergent subcellular localisations. These localisations may be partly 
dependent on differential post-translational modification. For example, Arf
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proteins are myristoylated at an amphipathic N-terminal helix (Takai et al., 
2001). This myristoylated domain mediates membrane association, while 
conformational changes induced by GTP-binding enhance this association 
(Kahn et al., 1991; Takai et al., 2001). Nascent Rab proteins undergo 
geranylgeranylation at two Cys residues within a C-terminal cysteine-rich 
hypervariable region, and the terminal Cys of this region may undergo 
carboxymethylation (Takai et al., 2001; Goody et al., 2005). A Rab escort 
protein (REP) is required to present each Rab protein to the 
geranylgeranyl transferase (GGTase) enzyme for modification, while the 
targeting of the modified protein to specific membranes may require 
additional factors (see below). It was originally thought that the 
hypervariable region conferred additional specificity to Rab-membrane 
targeting (Chavrier et at, 1991). More recently, it has been reported that 
multiple regions contribute to this specificity, while it has been suggested 
that the hypervariable regions are relatively unstructured and may have a 
‘tethering’ function (Ali et al., 2004; Pfeffer, 2005b). That is, their 
prénylation may lead to Rab membrane-association, while they may also 
provide a flexible ‘link’ allowing the structured portion of the Rab protein to 
operate at some distance from the membrane (Pfeffer, 2005b).
1.5 Rab protein function
The first work showing the importance of Rab proteins in membrane 
trafficking came from studies in Saccharomyces cerevisiae (yeast). It was
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shown that mutations in Sec4 could cause accumulation of post-Golgi 
vesicles and a block in their delivery to the plasma membrane, while 
mutations in the homologous Ypt1 could produce a similar block in traffic 
from the ER to the Golgi (Salminen and Novick, 1987; Segev et al., 1988). 
It has since been shown that deletion of genes encoding any of the yeast 
Rab proteins functioning in the biosynthetic pathway is lethal (Lazar et a i, 
1997). In mammals, deletion of a particular Rab isoform can produce 
variable and less dramatic effects, with deletion of Rab3A in the mouse, for 
example, producing no effects on viability, and only minimal effects on 
neurotransmitter release (Geppert et a i, 1994a). It is possible that this may 
reflect increasing overlap or specialisation in the roles of specific isoforms, 
and that this corresponds to increasing complexity in membrane trafficking 
in these organisms (Zerial and McBride, 2001; Gurkan et a i, 2005). In the 
course of mammalian evolution, there has been a dramatic expansion in 
the Rab protein family, with over 60 Rabs identified in mammals compared 
to only 11 in yeast (Grosshans et a i, 2006). This may indicate that some 
mammalian Rab proteins may sometimes serve redundant and/or non- 
essential cellular roles.
Expression profiling has been used to correlate the expression of specific 
Rab isoforms, and that of other proteins, also linked with the function of 
particular membrane compartments or with the mediation of particular 
steps in membrane trafficking (Gurkan et a i, 2005). Further, the 
association of a specific Rab(s) with particular membrane
compartments/trafficking steps is consistent with their localisation in cells,
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which is usually correspondingly restricted (Zerial and McBride, 2001; Ali 
et al., 2004). They are found to direct varied processes through a wide 
range of effector proteins, and are usually involved in the recruitment of 
these effectors to membranes.
The functional specialisation of different membrane compartments can be 
maintained by their continual maturation, and/or through the continual 
trafficking of transport vesicles between them (Pfeffer, 2003). A key role of 
Rabs and their effectors is thought to be in conferring specificity on these 
processes. For example, a particular vesicle-associated Rab protein may 
bind to effectors regulating multiple events in vesicle targeting to a specific 
target compartment conferring ‘compartmental specificity’ on vesicle 
trafficking (Grosshans et al., 2006). Other factors with a restricted 
compartmental localisation, such as the SNARE proteins, may also 
mediate ‘compartmental specificity’ (McNew et al., 2000). However, the 
cyclical manner by which Rab proteins are recruited and activated on 
membranes may be critical for establishment and maintenance of the 
necessary asymmetry in trafficking. Where other proteins require trafficking 
to their target compartments, they may be less likely to adopt these roles 
(Munro, 2002).
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1.6 The Rab GTPase cycle
As described above, small GTPases adopt distinct conformations 
according to whether they are GDP-, or GTP-bound (Milburn et a!., 1990). 
As distinct GTPase conformations can participate in distinct protein-protein 
interactions, this characteristic allows these proteins to function as 
molecular ‘switches’ or ‘timers’. That is, regulation of their nucleotide- 
bound states can reversibly limit or alter specific cellular activities. For this 
reason, small GTPases often act in signalling cascades. For example, 
mitogenic signalling can lead to association between Ras and GTP, and 
GTP-Ras, through recruitment of a kinase, Raf, can promote 
phosphorylation within the MAPK/ERK pathway (Stokoe et al., 1994; Takai 
et al., 2001).
Ras GTP-association is important in promoting many downstream 
processes including proliferation and migration (Takai et al., 2001). 
Mutations that directly or indirectly favour inappropriate Ras GTP- 
association are often linked to excessive proliferation and migration, and 
often found in cancers, indicating that cyclical GDP/GTP association may 
be dispensable for the function of Ras in signal transduction and 
amplification (Takai et al., 2001). However, cyclical GDP/GTP association 
are important for the functions of other small GTPases. For example, 
nuclear GTP-Ran is involved in the export of cargo molecules from the 
nucleus, while cytosolic Ran GTP-hydrolysis is required for its dissociation 
from the cargo and import back into the nucleus. In this case, mutations
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favouring Ran GTP-association inhibit the nuclear export process 
(Schlenstedt etal., 1995; Carey eta!., 1996).
Like Ras, it is found that Rab proteins typically interact with their effector 
proteins when in a membrane-associated, GTP-bound state. However, it is 
most likely that they are efficiently targeted to specific membrane 
compartments in a GDP-bound state. Rab protein targeting, nucleotide 
exchange and GTP hydrolysis are presented in Fig.1.8, and discussed in 
more detail below.
Figure 1.8. Conventional model for Rab protein function. Within the cytosol, Rab proteins are 
sequestered in a GDP-bound state by GDP dissociation inhibitor proteins (GDIs) which are involved 
in their extraction from membranes and also in the targeting of specific Rab proteins to specific 
membrane compartments through a mechanism also thought to require a GDI dissociation factor 
(GDF). Once membrane associated, GDP-bound Rab proteins may become GTP-bound through 
the action of a GDP to GTP exchange factor (GEF), and it is typically the GTP-bound Rab protein 
that interacts with effector proteins. A GTP-bound Rab protein may become GDP-bound though 
interaction with a GTPase-activating protein (GAP) that stimulates its intrinsic GTPase activity.
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Rab proteins can show highly specific subcellular localisation to particular 
membrane compartments (Ali et al., 2004). It is found that their isoform- 
specific targeting can depend on distinct domains, while it is also found 
that alone, prenylated Rab proteins can associate with isolated cellular 
membranes indiscriminately, demonstrating a requirement for an additional 
cellular factor(s) in the targeting process (Dirac-Svejstrup et al., 1994; Ali 
et al., 2004). In a GDP-bound state, Rabs and some other small GTPases 
may be sequestered in the cytosol by GDP dissociation-inhibitor (GDI) 
proteins (Ullrich et at., 1993; Takai et a i, 2001; Goody et at, 2005). While 
limiting their activity, these proteins can be involved in the appropriate 
targeting of GTPases to specific subcellular localisations. For example, 
RhoGDI may be displaced from Rho proteins by the ezrin/radixin/moesin 
(ERM) complex, and its subsequent activation can lead to ERM 
translocation to the plasma membrane (Takahashi et a i, 1997).
RabGDIs have a structure unlike that of RhoGDIs, but similar to REP 
proteins (Schalk et a i, 1996; Keep et a i, 1997; Goody et at, 2005). They 
are able to form soluble complexes with GDP-bound Rab proteins through 
sequestration of their hydrophobic prenyl groups, and so may prevent their 
inappropriate membrane-association, and mediate their membrane- 
extraction (Schalk et at, 1996; Goody et at, 2005). They may also be 
indirectly or directly involved in selective targeting of Rab proteins, 
because Rab5- and Rab9-GDI complexes are correctly targeted in vitro 
(Dirac-Svejstrup et at, 1994; Soldati et a i, 1994; Ullrich et at, 1994).
1.6.1 Targeting
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However, only three Rab-GDI isoforms are identified in mammals, GDIa, 
GDip and GDIy, and it has been suggested that these proteins act as 
general regulators of Rab protein function (Ullrich et al., 1993). Therefore, 
the specific targeting of Rab proteins is likely to involve their isoform- 
specific interactions with other factors.
It has been suggested that some additional selectivity in Rab targeting 
may be conferred by transiently-acting membrane-associated GDI- 
displacement factors (GDFs), which are required to mediate Rab- 
membrane association (Pfeffer and Aivazian, 2004). In yeast, Y ip lp may 
act as a GDF for a subset of Rab proteins targeted to the Golgi (Chen et 
al., 2004). In mammals, PRA1/Yip3 is shown to displace GDI from Rab 
proteins of the endosomal pathway including Rab9 and Rab5, and is 
required for their recruitment to membranes (Dirac-Svejstrup et al., 1997; 
Sivars et al., 2003). However, since these Rabs are targeted to distinct 
endosomal compartments it is unclear how their localisation is further 
restricted (Pfeffer and Aivazian, 2004; Behnia and Munro, 2005). One 
possibility is that Rab proteins are trafficked to the appropriate 
compartment after associating with membranes in a specific trafficking 
pathway (Pfeffer and Aivazian, 2004). Alternatively, it has been suggested 
that the sustained association of Rab proteins with their target 
compartment might be dependent on nucleotide exchange (Behnia and 
Munro, 2005).
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Following GDI displacement, GDP-bound Rab proteins associated with 
membranes may be subject to GDP->GTP exchange catalysed by guanine 
nucleotide exchange factors (GEFs)(Takai et al., 2001). When in a GDP- 
bound state, membrane-associated Rabs may be susceptible to GDI- 
mediated membrane extraction, but they do not interact with GDIs when 
GTP-bound. Any association of an isoform-specific RabGEF and a 
particular membrane compartment might therefore serve to selectively 
concentrate a particular Rab protein on this compartment, if its GDI- 
dependent extraction from other compartments is rapid. Further, Rab 
protein effectors, through which Rabs mediate their cellular functions, 
almost always interact with only the GTP-bound form of a given Rab 
protein, and so nucleotide exchange may couple selective targeting of Rab 
isoforms with their selective ‘activation’ (Carney et at., 2006).
GEFs for all of the Rab protein isoforms present in yeast have been 
identified, while the GEFs acting on specific mammalian Rab isoforms are 
largely unknown (Carney et al., 2006). The RabGEFs identified in yeast 
are found to share no sequence homology, while they are often found to 
function as components of large multi-subunit complexes (Jones et al., 
2000; Carney et al., 2006). Each GEF usually has Rab isoform-specific 
GEF activity, although the transport protein particle (TRAPP) complex is 
reported to act on Ypt1, Ypt31 and Ypt32 (Jones et al., 2000). The seven- 
subunit TRAPPI complex is thought to act preferentially on Ypt1, and to be 
involved in regulating the entry of cargo vesicles into the Golgi (Morozova
1.6.2 Nucleotide exchange
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et al., 2006). The maturation of the TRAPPI to the TRAPPII complex, 
through its association with three additional subunits, changes its 
specificity and is required for its regulation of Ypt31/32, and cargo exit from 
the Golgi (Morozova et al., 2006). Thus, the TRAPP complex appears to 
link sequential steps in membrane trafficking.
Several other RabGEFs also appear to link sequential steps in membrane 
trafficking, though they do so by linking sequential Rab protein functions 
more directly. In yeast, the Ypt31/32 effector Sec2 has been identified as a 
GEF for the Rab protein Sec4, which functions in the transport and fusion 
of post-Golgi vesicles with the plasma membrane (Walch-Solimena et al., 
1997; Ortiz et al., 2002). Similarly, mammalian Rab5 is found to interact 
with one subunit of the class C VPS/HOPS complex, another subunit of 
which acts as a GEF for Rab7 (Rink et al., 2005). In the transition from 
Rab5-positive early endosomes to Rab7-positive late endosomes, it is 
thought that Rab5 mediates the membrane-recruitment of Rab7 through 
the activity of this complex, and is subsequently replaced by it (Rink et al., 
2005).
If the systems described above represent typical examples, it might be 
suggested that Rab protein recruitment and/or activation initiates and 
directs discrete membrane trafficking processes. Consistent with this 
suggestion, it was found that the delivery of vesicles into the same 
trafficking pathway can be modulated through activation of a particular Rab 
isoform by multiple RabGEFs, according to cellular requirements (Carney
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et al., 2006). For example, several proteins with GEF activity on Rab5 
have been characterised, and have distinct roles. It is likely that Rabex5 is 
general regulator of Rab5-directed fusion of endocytic vesicles with early 
endosomes, and homotypic fusion between early endosomes (Carney et 
al., 2006). RME-6 localises to Clathrin-coated pits and may be required 
earlier in the endocytotic pathway (Sato et al., 2005). In contrast, Rin1 
more selectively binds to EGFRs and H-Ras, and its Rab5GEF activity, 
and thereby Rab5-directed EGFR internalisation, is potentiated where Ras 
is active (Tall et a!., 2001). Alsin and ALS2CL are thought to be involved in 
selective Rab5-directed endocytosis of receptors in the nervous system, 
while Alsin may coordinate nucleotide exchange at Rab5 and Rac 
(Hadano et a!., 2004; Topp et al., 2004).
1.6.3 GTP hydrolysis
Rab proteins possess constitutive GTPase activity, and so may in principle 
hydrolyse bound GTP to GDP autonomously (Takai et al., 2001). In fact, 
however, their GTP hydrolysis is usually low and is regulated 
physiologically by GTPase activating proteins, GAPs, which accelerate the 
reaction (Takai eta!., 2001). Unlike RabGEFs, RabGAPs with differing Rab 
isoform-specificity typically share conserved Tre-2, Bub-2, Cdc16 (TBC) 
domains which are responsible for their activity, and this has allowed the 
identification of many putative mammalian RabGAPs through sequence 
and functional analysis (Flaas et a i, 2005; Itoh et a i, 2006). However, the 
in vivo specificity of the majority of these proteins has not yet been fully 
characterised.
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Rab GTP-hydrolysis is classically associated with the termination of 
discrete membrane trafficking steps, since reduction in the levels of a 
GTP-bound Rab protein on a given membrane attenuates the activity of its 
effectors, while GDP-bound Rab protein may be extracted from 
membranes in a GDI-dependent manner (Goody et al., 2005). In order to 
regulate this process, a specific RabGAP may be localised to the last 
membrane compartment to which a given Rab isoform directs traffic, or the 
Rab protein may be relatively shielded from GAP activity prior to reaching 
this compartment. It has often been suggested that the association 
between GTP-bound Rab proteins and their effectors might generally 
shield them in this manner (Zerial and McBride, 2001; Grosshans et al., 
2006).
The continued characterisation of Rab protein function has shown that 
some Rab proteins can control multiple sequential events in a particular 
trafficking step through interaction with distinct effectors or groups of 
effectors (Zerial and McBride, 2001; Schwartz et al., 2007). In these cases, 
it may be that RabGAP activity and GTP-hydrolysis are associated with 
completion of each event. For example, GAP activity might underlie the 
observation that when levels of a GFP-tagged Rab5 fusion protein were 
tracked on single early endosomes, increases in individual endosomal 
levels of this protein that resulted from endosome-endosome fusion often 
declined rapidly following the fusion event, in the apparent absence of 
associated fission events (Rink et al., 2005). Since fusion between
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endosomes is controlled by Rab5, this suggestion is consistent with 
findings showing that depletion of RabGAP-5, or expression of mutated 
Rab5 deficient in GTPase activity, leads to endosome enlargement and 
accumulation (Stenmark et al., 1994; Roberts et al., 1999; Haas et al., 
2005). It is found that many rounds of endosome-endosome fusion may 
occur prior to the eventual loss of Rab5 when early endosomes mature 
into late endosomes (Rink et al., 2005). Thus, it is likely that GEFs and 
GAPs function in concert to dynamically maintain Rab5 levels appropriate 
for early endosome function, rather than functioning separately to promote 
its association with early endosomes, and its exclusion from late 
endosomes, respectively.
Convergence of opposed GEF and GAP activity on the same membrane 
compartment implies the possibility of a further level of complexity in the 
regulation of Rab protein nucleotide-binding and membrane-association. 
Upon association with their target membranes, GDP-bound Rab proteins 
may be subject to either GEF-mediated nucleotide exchange or GDI- 
mediated membrane-extraction. GTP-bound Rab proteins may hydrolyse 
GTP through interaction with a GAP, or may be stabilised to a variable 
degree through interactions with different effectors. Thus, ‘basal’ Rab- 
membrane association and dissociation may occur. In these 
circumstances, GEF and GAP activities would be determinants of ‘basal’ 
Rab association and dissociation rates, in addition to controlling the net 
extent of Rab dissociation following specific Rab-controlled events.
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The dynamics of Rab proteins functioning in secretory granule exocytosis 
is a major subject in this thesis, and will be discussed later with reference 
to experimental data presented here. However, there is support for 
dynamic Rab-membrane association and dissociation under ‘resting’ 
conditions from a number of studies focusing on other Rab isoforms. In a 
relatively early study, it was found that a GTP-analogue bound to Rab5 
underwent hydrolysis even in the absence of endosome-endosome fusion 
(Rybin et al., 1996). This suggests that a fraction of endosomal Rab5 may 
continually become susceptible to GDI-mediated extraction, and indeed, 
overexpression of RabGAP-5 or GDI can ‘strip’ Rab5 from endosomal 
membranes (Ullrich eta!., 1993; Ullrich et al., 1994; Haas et al., 2005).
More recently, a model has been proposed by which the regulation of 
RabGAP activity, and Rab dynamics, might control GLUT4 translocation in 
adipocytes. It is suggested that the RabGAP TBC1D4, and possibly also 
TBC1D1, limit the GTP-binding and/or membrane-association of Rab(s) 
targeted to GLUT4 carrier vesicles (Kane et al., 2002; Roach et al., 2007). 
TBC1D4 is found to be associated with, and essential for the intracellular 
retention of these vesicles in unstimulated cells, while stimulation of cells 
with insulin may lead to activation of the protein kinase Akt, and TBC1D4 
phosphorylation (Sano et al., 2003; Eguez et al., 2005; Larance et al., 
2005). Akt phosphorylation of TBC1D4 reduces its GAP activity in a 14-3- 
3-dependent manner, and it is suggested that this could lead to increased 
Rab10 recruitment or activation on these vesicles, initiating vesicle delivery 
to the plasma membrane (Ramm eta!., 2006; Sano et al., 2007).
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1.7 Effector interactions and Rab domains
Rab proteins can function through various effectors in the initiation and 
progression of discrete steps in membrane traffic. It is found through 
sequence analysis of the Rab family that there is a high degree of 
conservation in amino acid residues likely to surround the switch regions, 
while surface residues peripheral to this area show more divergence 
(Pereira-Leal and Seabra, 2000). On the basis of this analysis, it has been 
suggested that while effectors might interact with Rab proteins at the 
switch regions, and typically interact stably only where GTP is bound, the 
binding specificity of a given effector for a particular Rab isoform(s), may 
be conferred by a distinct protein-protein interaction (Pereira-Leal and 
Seabra, 2000). Consistent with this suggestion, published crystal 
structures of Rab proteins interacting with specific effectors show alternate 
modes of interaction (Ostermeier and Brunger, 1999; Zhu et al., 2004; 
Jagoe et al., 2006). Further, comparison of identified Rab effectors shows 
that those binding to divergent Rab proteins may have very different 
structures. Indeed, even effectors binding to the same Rab isoform do not 
necessarily show any sequence similarity (Gonzalez and Scheller, 1999; 
Pereira-Leal and Seabra, 2000). However, it is shown that some effector 
families can share homologous sequence motifs essential for their binding 
to a particular Rab protein isoform, or several closely related isoforms 
(Izumi et a!., 2003; Fukuda, 2005).
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Figure 1.9. Structural differences define the specificity in binding of Rabs to effectors, while 
nucleotide-binding regions show greater conservation. Crystal structures of Rab3A in a complex 
with a fragment of Rabphilin (left), Rab5 in a complex with a fragment of Ranaptin5 (centre), and 
Rab11 in a complex with a fragment of FIP2 (right). Molecular coordinates were taken from 
Ostermeier and Brunger, 1999; Zhu et al., 2004 and Jagoe et al., 2006. (RCSB PDB Structure IDs 
1ZDB, 1TU3 and 2GZD)
It is usually found that effectors are recruited from the cytosol by activated 
Rabs, and that their Rab binding specificity is important in their recruitment 
to appropriate membrane compartment(s). Typically, the in vitro binding 
specificity of a Rab effector mirrors that identified in vivo, and it is also 
found that the deletion of a particular Rab isoform can affect effector 
stability (Kuroda et al., 2002; Fukuda, 2003a). Where Rab3A is absent 
from neurones, for example, levels of its effector Rabphilin are reduced by 
-50% (Li et a i, 1994). Conversely, effector deletion can sometimes affect 
Rab stability. For example, there was a 4-fold decrease in Rab9 half-life 
where TIP47 levels were reduced with siRNA, and this may support the 
suggestion that Rabs and effectors promote reciprocal target-interactions 
(Ganley et al., 2004; Aivazian et at, 2006). This would be consistent with 
the prior suggestion that Rab-effector interactions, as well as the activities 
of specific GEF and GAP proteins, might be determinants of the activity 
and membrane-association of particular Rab isoforms.
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Effector-target interactions may also be contingent on other factors. TIP47 
binds to membrane-associated mannose-6-phosphate receptors (MPRs), 
for example, in order to direct cargo selection, and its affinity for these 
receptors is higher when it is simultaneously bound to Rab9 (Carroll et al.,
2001) . Rab9 and TIP47 may therefore be preferentially recruited to MPR- 
containing membrane subcompartments, the site of their combined 
function. Furthermore, this kind of ‘multi component requirement’ for 
recruitment may serve to restrict the activity of effectors to a greater extent 
than that of their target Rab. Thus, it may be one mechanism by which the 
activity of effectors involved in separated or sequential events coordinated 
by the same Rab isoform is regulated.
It has been shown that the localisation of membrane-associated Rab9 and 
TIP47 is not only restricted to a particular membrane subcompartment, but 
also to tightly packed ‘Rab domains’ on the surface of membranes 
(Barbero et al., 2002). In the case of these proteins, this characteristic may 
relate to their role in concentrating proteins in cargo selection at the late 
endosome, while many other Rabs are also characterised as components 
of such ‘domains’. On early endosomes and on recycling endosomes, 
Rabs 4 5 and 11 form distinct subdomains, on early/sorting endosomes, 
Rabs 4 and 5 form distinct domains, and on late endosomes, Rabs 9 and 7 
form distinct domains, for example (Sonnichsen e ta i, 2000; Barbero et al.,
2002) . Perhaps the best characterised Rab protein known to form ‘Rab 
domains’ is Rab5 (Zerial and McBride, 2001; Grosshans et al., 2006).
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Rab5 is recruited to clathrin-coated endocytotic vesicles and early 
endosomes, and is involved in tethering and fusion of endocytotic vesicles 
and early endosomes, and homotypic fusion between endosomes (Ullrich 
eta!., 1994; Horiuchi eta!., 1995; Christoforidis et a i, 1999; Nielsen et a i, 
2000). It is thought that Rab5 ‘domain’ formation is initiated as the result of 
a signalling cascade downstream of its binding to GTP. GTP-Rab5 can 
recruit the effector protein Rabaptin-5, which can in turn recruit the Rab5 
GEF Rabex5, thereby locally stabilising GTP-Rab5 through positive 
feedback (Stenmark et a i, 1995; Lippe et a i, 2001; Grosshans et a i, 
2006). The positive effect of Rabaptin-5 on Rab5 activation is supported by 
the finding that its overexpression leads to enlargement of endosomes; the 
same phenotype as seen where a consitutively active Rab5 is expressed, 
or where RabGAP-5 is subjected to siRNA knockdown (Stenmark et a i, 
1994; Stenmark et a i, 1995; Haas et a i, 2005). It has been found that 
constitutively active Rab5 domains localise to the interface between fusing 
endosomes, and these domains can persist as a localised spot following 
endosome-endosome fusion (Roberts et a i, 1999).
On early endosomes, GTP-Rab5 may recruit p150 phosphatidylinositol (PI) 
3-OH kinase/hVps34 and/or PI3K, leading to generation of PI(3)P on 
endosomal membranes (Simonsen et a i, 1998; Zerial and McBride, 2001). 
Since PI(3)P is required for the stable membrane association of Rab5 
effectors EEA1 and Rabenosyn5, and is not present on Clathrin-coated 
endocytotic vesicles, their stable recruitment by GTP-Rab5 is limited to 
early endosomes (Nielsen et al., 2000). The fusion of endocytotic vesicles
70
with early endosomes is dependent on EEA1, and this effector can 
substitute for cytosol in early endosome fusion assays (Christoforidis et al., 
1999; Rubino et al., 2000). EEA1 is a tethering protein, and forms a 
homodimer on which two binding sites each for PI(3)P and Rab5 are 
located at one end of a large coiled-coil region (Callaghan et al., 1999). As 
a component of ‘Rab5 domains’, it has been suggested to associate with 
the SNARE protein Syntaxin13, and transiently with NSF, and these 
interactions are thought to be essential for early endosomal fusion 
(McBride et al., 1999). It has been suggested that while stable EEA1- 
containing domains on early endosomes might promote homotypic fusion, 
distinct Rab5 domains on Clathrin-coated endocytotic vesicles may 
represent low affinity EEA1 binding sites, and this may confer specificity on 
their tethering to these organelles (Rubino etal., 2000).
In a number of cases, as noted above, distinct Rab isoforms may form 
‘domains’ at the same membrane compartment. Thus, in addition to 
serving as organisational platforms for effectors coordinating specific 
events, Rab domains may also serve to separate the independent 
functions of distinct Rab effectors. However, several Rab effectors have 
been shown to interact with multiple Rab isoforms. For example, 
Rabaptin5 and Rabenosyn each bind both rab4 and rab5, while RCP binds 
both Rab4 and Rab11 (Vitale et al., 1998; de Renzis et al., 2002; Lindsay 
et al., 2002). It has been suggested that such effectors link different Rab 
domains, and may in this way function in the retention of multiple Rabs on 
one membrane (de Renzis et al., 2002; Pfeffer, 2003). Different Rab
71
isoforms on a given membrane compartment may appear to have 
independent functions, functioning in the entry and exit of distinct transport 
vesicles, for example. However, in this example, their role in maintenance 
of the composition and function of the compartment is interdependent, 
since loss of either Rab would lead to formation of a terminal compartment 
(Pfeffer, 2003).
1.8 Summary
It is evident from the above discussion that considerable progress has 
been made in the characterisation of the function and regulation of specific 
Rab proteins. Nevertheless, there is still a significant amount to be learnt 
about the dynamics and effector interactions of each Rab protein isoform, 
and each of their functional roles in membrane trafficking. In general, Rab 
proteins appear to confer directionality in intra- and intercompartmental 
membrane trafficking, and to act as versatile platforms for the organisation 
of compartment-specific sorting, trafficking and fusion machinery. From the 
earlier discussion of regulated exocytosis, it is clear that diverse events 
can exquisitely control the biogenesis of secretory granules and synaptic 
vesicles, their approach to the plasma membrane, their fusion potential, 
and multiple aspects of the fusion process itself. While several Rab protein 
isoforms are suggested to function in exocytosis, and a number of their 
effectors have been identified and functionally characterised, a fully 
integrated picture of Rab protein function in the process is yet to emerge.
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1.9 Aims and objectives
The broad aim of this study was to explore the function, regulation and 
dynamics of Rab3A, Rab27A, and a number of their effectors. More 
specific aims were as follows:
1. To characterise the localisation of fluorescently-tagged Rab3A and 
Rab27A, their recruitment onto secretory granules, their effects on 
exocytosis, and their dynamics in resting and stimulated cells.
2. To characterise the localisation and fluorescently-tagged versions of the 
Rab effectors Rabphilin, Granuphilin, Slp5 and Noc2, and to analyse their 
dynamics in live cells. To characterise the functional effects of a novel 
Rab3A interactor Munc18-1.
3. To characterise proteins reported to act as GAPs for Rab3A and 
Rab27A, and to screen multiple TBC domain-containing proteins in order 
to identify additional candidate GAPs.
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Chapter 2:
Materials and Methods
2.1 Molecular Biology
2.1.1 cDNA preparation
Total PC12 cell RNA was prepared from ~106 PC 12 cells. Cells were 
sedimented by cetrifugation at 800 x g for 5 minutes, and then 
resuspended and lysed in 1ml TRIzol Reagent (Invitrogen, Paisley, UK). 
Following incubation at room temperature for 5 minutes, 200pl of 
chloroform was added, and the mixture was incubated for a further 2 
minutes. The mixture was then centrifuged at 12000 x g for 15 minutes at 
4°C, causing it to separate into organic and aqueous phases. The RNA- 
containing aqueous phase was removed to 500pl isopropanol to 
precipitate the RNA. Following incubation at room temperature for 10 
minutes, RNA was sedimented by centrifugation at 12000 x g for 10 
minutes, and the pellet was washed with 1ml 75% EtOFI. The purified RNA 
was sedimented by centrifugation at 7500 x g for 5 minutes, then partially 
air-dryed and finally dissolved in deionised, RNAse-free water.
cDNA was prepared using 1pg of the above RNA preparation in each 
reaction. The RNA, and 200pmol oligo dT(15) primers (Promega, 
Southampton, UK) were mixed in 5pl distilled water, on ice, and the 
template was prepared by incubating the mixture at 70°C for 5 minutes, 
and then rapidly cooling on ice. 15jul of a buffer solution was then added to 
give a reaction mixture containing 4pl ImPromll 5x buffer (Promega), 3mM 
MgCb, 0.5mM dNTPs and 1pl (1 reaction) ImProm-ll Reverse 
Transcriptase (Promega). This reaction mixture was incubated at room
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temperature for 5 minutes and then at 42°C for 1 hour. The resulting cDNA 
preparation was then incubated at 70°C for 15 minutes in order to 
inactivate the reverse transcriptase, and then used as a template for PCR.
2.1.2 PCR
For cloning from cDNA prepared as above, or subcloning from existing 
plasmids, KOD polymerase (Novagen, Nottingham, UK) was used in the 
PCR-mediated amplification of specific sequences. Each 50pl reaction 
mixture contained 5pl 10x PCR buffer (Novagen), 0.2mM dNTPs, 1mM 
MgS04, 0.3pM forward and reverse primers and 1U KOD polymerase in 
distilled water. 1pl PC12 cell cDNA, or 50ng plasmid DNA were used as 
template. The PCR conditions used were as follows:
1 cycle: 98°C 2 minutes
35 cycles: 98°C 15 seconds
55°C 30 seconds
68°C 20 seconds per kb product
1 cycle 72°C 5 minutes
30°C 1 minute
2.1.3 Restriction Endonuclease Digestion
For digestion of PCR products and vectors prior to ligation, or for restriction 
analysis of recombinant plasmids, the following conditions were used. 
Digestion mixtures containing 4pl of the appropriate 10x buffer (Promega, 
Southampton, UK), 1pl (10U) of each enzyme used (Promega), and up to
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1 ng DNA, in 40|nl distilled water, were made up on ice and then incubated 
at 37°C for 2 hours. Products of digestion were separated by agarose gel 
electrophoresis, and purified by gel extraction where required.
2.1.4 Agarose gel electrophoresis and gel extraction
For separation of DNA fragments, for purification or analysis, agarose gel 
electrophoresis was used. Gels were made with 1% (v/w) agarose in TAE 
buffer (40mM Tris base pH 8, 20mM acetic acid, 1mM EDTA). To label 
DNA, gels contained 0.5pg/ml ethidium bromide. DNA samples of up to 
50pl were combined with 2-1 Opl sucrose prior to running, and run against 
the Hyperladder I molecular weight marker (Bioline, Sheffield, UK) at 70- 
120V. For purification of DNA fragments from gels, QIAquick gel extraction 
kits (Qiagen, Crawley, UK) were used. ‘Bands’ cut from gels were initially 
dissolved to release DNAs, then the DNAs were bound to an anion 
exchange column, washed, and eluted in 30pl distilled water.
2.1.5 Ligation
Ligation reactions were used to generate circular DNAs from linear DNA 
fragment(s), typically for cloning or subcloning through insertion of a 
coding insert into a given vector. Reactions were carried out using 100ng 
vector DNA, with a 1:3 molar ratio of vector:insert DNA. The reactions 
were carried out by addition of a mixture of 5pl 2x Rapid Ligation buffer 
(Promega, Southampton, UK), 1pl (1-3U) T4 DNA Ligase (Promega) and 
distilled water to a final volume of 10jul, and incubation at room
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temperature for 30-60 minutes. The entire reaction mixture was then used 
to transform chemically competent E.coli.
2.1.6 Transformation of chemically competent E. coli
Where the products of a ligation reaction were used for transformation, XL- 
1 blue cells (Stratagene, Cambridge, UK) were used. For each 
transformation, 100pl of cells were thawed on ice and then added to 1.7pl 
of the provided (3-mercaptoethanol (Stratagene). Following 10-15 minutes 
incubation on ice, ligation products were added, and the suspension was 
incubated on ice for a further 30 minutes. Cells were then subjected to a 
42°C heat-shock for 45 minutes, retuned to ice briefly, and then added to 
900pl prewarmed SOC medium (20g/l tryptone, 5g/l yeast extract and 
500mg/l NaCI in distilled water). This suspension was then incubated at 
37°C for 1 hour, with shaking at 250RPM. Various volumes were then 
spread on LB-Agar plates (20g/l Agar, 10g/I tryptone, 10g/I NaCI and 5g/l 
yeast extract in distilled water) containing an appropriate antibiotic for 
selection (100pg/ml ampicillin or 25pg/ml kanamycin). Transformant clones 
were picked following overnight incubation at 37°C.
For routine transformation using plasmid DNA, TurboCells (Gene Therapy 
Systems Inc., San Diego, USA) were used. For each transformation, 50pl 
of cells were thawed on ice, and ~50ng vector DNA added. Following heat- 
shock at 37°C for 1 minute, 200pl TurboCells transformation buffer (Gene 
Therapy Systems) was added, and cells were spread on LB-Agar plates as 
above.
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In order to produce small plasmid preparations from transformant clones 
(see above), single clones were used to inoculate 4ml LB medium (1 Og/I 
tryptone, 10g/I NaCI and 5g/l yeast extract in distilled water) containing an 
appropriate antibiotic (100pg/ml ampicillin or 25pg/ml kanamycin), and 
these cultures were then grown overnight at 37°C with shaking at 
250RPM. 3ml of each stationary culture was sedimented by centrifugation 
(12000 x g, 10 minutes), and then plasmid DNA was prepared using a 
QIAprep Spin Miniprep (Qiagen, Crawley, UK) according to manufacturer’s 
instructions. Cells were lysed in alkaline sodium dodecyl sulphate (SDS) 
solution, and then unwanted material was precipitated through addition of 
acid solution. This material was sedimented by centrifugation (12000 x g, 
10 minutes), and the plasmid DNA in the supernatant was then bound to 
an anion exchange column, washed, and eluted in 30pl distilled water. 
Plasmid DNAs were analysed through restriction digestion and agarose 
gel electrophoresis (see above).
For preparation of larger plasmid preparations for transfection of PC12 
cells, single clones or 1ml cultures (left over from cultures used for 
minipreps above) were used to inoculate 150ml LB medium containing an 
appropriate antibiotic, and these cultures were then grown overnight at 
37°C with shaking at 250RPM. Plasmid DNA was purified from the 
resulting stationary cultures using QIAfilter Plasmid Maxi kits (Qiagen) 
according to manufacturer’s instructions. DNA concentration in the 
preparations produced was quantified through spectrophotometry.
2.1.7 Purification of plasmid DNA
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2.1.8 Gateway LR reaction
In order to facilitate rapid subcloning of a given coding sequence into 
multiple vectors, several sequences were initially inserted into the 
pENTR2A ‘entry’ vector by the conventional techniques described above. 
Within this vector, sequences are flanked by affl_1 and attL2 attachment 
sites, and can be subcloned into pDEST ‘destination’ vectors carrying 
affR1 and attR2 attachment sites by enzyme-mediated transposition 
(Landy, 1989). Such transposition reactions are the basis for the Gateway 
system (Invitrogen, Paisley, UK). In LR transposition reactions, 300ng of 
each pENTR2A clone and pDEST destination vector were mixed with 2pl 
LR Clonase II (lnvitrogen)(a propriatory mixture of integrase, excisionase 
and host integration factor) with distilled water to a total volume of 10pl. 
Reactions were incubated at room temperature for 3 hours and then 
incubated with 1pl proteinase K (2mg/ml) at 37°C for 15 minutes in order to 
inactivate the enzymes. 5pl of each reaction was used to transform 
chemically competent E. coli (see above). Since the pENTR2A vector 
confers ampicillin resistance, while the pDEST vectors used here confer 
kanamycin resistance, it was possible to select transformant clones on this 
basis. pDEST vector not undergoing transposition carries the ccdB gene, 
which prevents its propagation in most strains of E. coli, by lethally 
targeting DNAgyrase (Bernard and Couturier, 1992; Bernard etal., 1993).
2.1.9 Site directed mutagenesis
Site directed mutagenesis was carried out using either the Quickchange 
system (Stratagene, Cambridge, UK), or the GeneTailor system
79
(Invitrogen, Paisley, UK) according to manufacturers’ instructions. In the 
Quickchange system, template vector was amplified by PCR using 
complimentary primers carrying the desired mutation(s). The template was 
then digested using the restriction endonuclease DpnI, and the ‘nicked’ 
linear PCR products were used to transform XL-1 Blue E. coli (see above). 
In the GeneTailor system, DNA was methylated prior to PCR amplification 
using overlapping primers, one of which contained the desired mutation(s). 
The PCR products were then used to transform E. coli carrying wild-type 
mcrBC. The methylated template was destroyed by these cells, and so 
only the mutated plasmid is propagated.
PfuTurbo polymerase (Stratagene) was used in the PCR-mediated 
amplification of mutated vector DNA. Each 50pl reaction mixture contained 
5pl 10x PCR buffer (Stratagene), 0.2mM dNTPs, 62.5ng each of the 
forward and reverse primers, and 1pl (2.5U) PfuTurbo polymerase in 
distilled water. 50ng plasmid DNA was used as template. The PCR 
conditions used were as follows:-
1 cycle: 95°C 30 seconds
16 cycles: 95°C 30 seconds
55°C 1 minute
68°C 2 minutes per kb product
1 cycle 30°C 1 minute
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2.2 Plasmids
2.2.1 pEGFP-Rab3A
The rat Rab3A sequence was amplified from an existing vector (Haynes et 
al., 2001) by PCR, and inserted, in frame, into the pEGFP-C1 vector 
(Clontech, Basingstoke, UK) to generate a mammalian expression 
construct for Rab3A, N-terminally tagged with EGFP. Primers contained 
restriction endonuclease sites (underlined) to facilitate subcloning. The 
sense primer used was 5’-AGCAGAAGCTTTAAATATGGCATCTGCCACA 
GACGCT-3’-myc; Hind\\\, and the antisense primer was 5’-CAAGTA 
TGGATCCGCTCAGCAGGCGCAGTCCT GATGCGG-3’-myc; SamHI. The 
amplified sequence and the vector were digested with HindWUBambU, and 
the resulting fragments were ligated using standard methods.
2.2.2 pmRFP-Rab3A
The Rab3A sequence was cut from the pEGFP-Rab3A vector and 
inserted, in frame, into the pmRFP-C1 vector (kind gift of R. Y. Tsien, 
Department of Pharmacology, University of California, San Diego, CA) to 
generate a mammalian expression construct for Rab3A, N-terminally 
tagged with mRFP. The fragment encoding Rab3A, and the cut pmRFP-C1 
vector, were each generated through digestion with Hind\\\IBamb\, and 
these fragments were then ligated using standard methods.
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2.2.3 pECFP-Rab27A
The rat Rab27A sequence was amplified from PC12 cell cDNA by PCR, 
and inserted in frame into the pECFP-C1 vector (Clontech, Basingstoke, 
UK) to generate a mammalian expression construct for Rab27A, N- 
terminally tagged with EGFP. Primers contained restriction endonuclease 
sites (underlined) to facilitate subcloning. The sense primer used was 5’- 
AGCAGAAGCTTTAAATA TGTCGGATGGAGATTATGAC-3’-myc; Hind\\\, 
and the antisense primer was 5’-CAAGTATGGATCCGCTCAACAGC 
CGCATAACCCCTTCTC-3’-myc; BamHI. The amplified sequence and the 
vector were digested with /-//ndlll/BamHI, and the resulting fragments were 
ligated using standard methods.
2.2.4 pECFP-Rab27A(Q78L)
The ECFP-tagged Rab27A(Q78L) mutant was made through substitution 
of Leu for Gin at residue 78 using pECFP-Rab27A as a template and the 
primer pair 5’-GTTATGGGACACGGCGGGGCTGGAGAGGTTTCGTAG 
CCTG-3’ (sense) and 5’-CAGGCTACGAAACCTCTCCAGCCCCGCCG 
TGTCCCATAAC-3’ (antisense). Mutants were generated using the 
Quickchange system (Stratagene, Cambridge, UK) according to 
manufacturer’s instructions.
2.2.5 pECFPRab27A(N133I)
The ECFP-tagged Rab27A(N133l) mutant was made through substitution 
of lie for Asn at residue 133 using pECFP-Rab27A as a template and the 
primer pair 5’-GAT AT AGT GCT CT GCGGAATT AAG AGT G ACCT AG AA
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GAC-3’ (sense) and 5’-GTCTTCTAGGTCACTCTTAATTCCGCAGAGCAC 
TATATC-3’ (antisense). Mutants were generated using the Quickchange 
system (Stratagene, Cambridge, UK) according to manufacturer’s 
instructions.
2.2.6 pEGFP-Rab27A
The Rab27A sequence was cut from the pECFP-Rab27A vector and 
inserted, in frame, into the pEGFP-C1 vector (Clontech, Basingstoke, UK) 
to generate a mammalian expression construct for Rab27A, N-terminally 
tagged with EGFP. The fragment encoding Rab27A, and the cut pEGFP- 
C1 vector, were each generated through digestion with Hind\\\/BamH\, and 
these fragments were then ligated using standard methods.
2.2.7 pmRFP-Rab27A
The Rab27A sequence was cut from the pECFP-Rab27A vector and 
inserted, in frame, into the pmRFP-C1 vector to generate a mammalian 
expression construct for Rab27A, N-terminally tagged with mRFP. The 
fragment encoding Rab27A, and the cut pmRFP-C1 vector, were each 
generated through digestion with /-//ndlll/BamHI, and these fragments were 
then ligated using standard methods.
2.2.8 pRabphilinSTOP pENTR2A
The rat Rabphilin sequence was amplified from PC12 cell cDNA by PCR, 
and inserted into the pENTR2A (kind gift of J Johnson, Department of 
Physiology, University of Liverpool, UK) vector to generate a Gateway
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‘entry vector’ construct for Rabphilin, carrying a stop codon at the 3’ end of 
the insert. Primers contained restriction endonuclease sites (underlined) to 
facilitate subcloning. The sense primer used was 5’-AGCCTGTCGAC 
ATGACTGACACTGTGGTGAACCGTTG-3’-myc; Sail, and the antisense 
primer was 5’-AGGGCGCGGCCGCCTAGTCGCTCGACACGTGGTTCT 
CGT-3’-myc; Noti. The amplified sequence and the vector were digested 
with Sall/Notl, and the resulting fragments were ligated using standard 
methods.
2.2.9 pRabphilin pENTR2A
The rat Rabphil'm sequence was amplified from PC12 cell cDNA by PCR, 
and inserted into the pENTR2A vector to generate a Gateway ‘entry 
vector’. Primers contained restriction endonuclease sites (underlined) to 
facilitate subcloning. The sense primer used was 5’- AGCCTGTCGA 
CATGACTGACACTGTGGTGAACCGTTG-3’-myc; Sail, and the antisense 
primer was 5’- GCGCCGCGGCCGCCTAGTCGCTCGACACGTGGTTCT 
CGTTCT-3’-myc; Noti. The amplified sequence and the vector were 
digested with Sall/Notl, and the resulting fragments were ligated using 
standard methods.
2.2.10 pEGFP-Rabphilin
The rat Rabphilin sequence was transposed from pRabphilinSTOP 
pENTR2A, to pDEST-EGFP-C1 (kind gift of J. Johnson, Department of 
Physiology, University of Liverpool, UK) through the Gateway LR reaction.
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2.2.11 pRabphilin-EGFP
The rat Rabphilin sequence was transposed from pRabphilin pENTR2A, to 
pDEST-EGFP-N1 (kind gift of J. Johnson, Department of Physiology, 
University of Liverpool, UK) through the Gateway LR reaction.
2.2.12 pRabphilin pcDNA3.1(+)
The rat Rabphilin sequence was transposed from pRabphilinSTOP 
pENTR2A, to pDEST-cDNA3.1(+) (kind gift of J. Johnson, Department of 
Physiology, University of Liverpool, UK) through the Gateway LR reaction.
2.2.13 pEGFP-Rabphilin(1 -206)
The EGFP-tagged Rabphilin(1-206) mutant was made through substitution 
of the 207th codon, AGG, for a TGA stop codon using pEGFP-Rabphilin as 
a template and the primer pair 5’-GACATGGAGGACAGGTGAG 
CCCCAGGAC-3’ (sense) and 5’-CCTGTCCTCCATGTCACCTCGAGCT-3’ 
(antisense). Mutants were generated using the GeneTailor system 
(Invitrogen, Paisley, UK) according to manufacturer’s instructions.
2.2.14 pEGFP-Rabphilin(AAA)
The EGFP-tagged Rabphilin(AAA) mutant was made through substitution 
of condons for Trp-Phe-Phe, for codons for Ala-Ala-Ala, at residues 153- 
155 using pEGFP-Rabphilin as a template and the primer pair 5’- 
AAGCGCTCGGGAGCAGCGGCTGCTAAGGGT TTCC-3’ (sense) and 5’- 
TGCTCCCGAGCGCTTCCAGACCTCT-3’ (antisense). Underscoring 
reflects point mutations in the template sequence. Mutants were generated
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using the GeneTailor system (Invitrogen, Paisley, UK) according to 
manufacturer's instructions.
2.2.15 pGranuphilinSTOP pENTR2A
The rat Granuphilin sequence was amplified from PC12 cell cDNA by 
PCR, and inserted into the pENTR2A vector to generate a Gateway ‘entry 
vector’ construct for Granuphilin, carrying a stop codon at the 3’ end of the 
insert. Primers contained restriction endonuclease sites (underlined) to 
facilitate subcloning. The sense primer used was 5’- 
T ACAT GT CGAC AT GTCGGAG AT ACT AGACCT CT CTTT-3’-mvc; Sail, and 
the antisense primer was 5’-TACATGCGGCCGCTCATACACCCAGC 
TTCTGCTTGACCA-3’-myc; Notl. The amplified sequence and the vector 
were digested with Sall/Notl, and the resulting fragments were ligated 
using standard methods.
2.2.16 pGranuphilin pENTR2A
The rat Granuphilin sequence was amplified from PC12 cell cDNA by 
PCR, and inserted into the pENTR2A vector to generate a Gateway ‘entry 
vector’ construct. Primers contained restriction endonuclease sites 
(underlined) to facilitate subcloning. The sense primer used was 5’- 
T ACAT GTCGACAT GT CGGAG AT ACT AGACCT CT CTTT-3'-mvc: Sail, and 
the antisense primer was 5’- TACATGCGGCCGCTACACCCA 
GCTTCTGCTTGACCATTG-3’-myc; Notl. The amplified sequence and the 
vector were digested with Sall/Notl, and the resulting fragments were 
ligated using standard methods.
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2.2.17 pEGFP-Granuphilin
The rat Granuphilin sequence was transposed from pGranuphilinSTOP 
pENTR2A, to pDEST-EGFP-C1 through the Gateway LR reaction.
2.2.18 pGranuphilin-EGFP
The rat Granuphilin sequence was transposed from pGranuphilin 
pENTR2A, to pDEST-EGFP-N1 through the Gateway LR reaction.
2.2.19 pGranuphilin pcDNA3.1(+)
The rat Granuphilin sequence was transposed from pGranuphilinSTOP 
pENTR2A, to pDEST-cDNA3.1(+) through the Gateway LR reaction.
2.2.20 pSlp5STOP pENTR2A
The rat Slp5 sequence was amplified from PC12 cell cDNA by PCR, and 
inserted into the pENTR2A vector to generate a Gateway ‘entry vector’ 
construct for Slp5, carrying a stop codon at the 3’ end of the insert. Primers 
contained restriction endonuclease sites (underlined) to facilitate 
subcloning. The sense primer used was 5’-TACATGTCGACATG 
TCTAAGAACTCGGAGTTCATCAA-3’-myc; Sail, and the antisense primer 
was 5’-T AC AT GCGGCCGCT C AGAGCCT AC ATTTCGCC AT GCT AG-3’-
myc; Notl. The amplified sequence and the vector were digested with 
Sall/Notl, and the resulting fragments were ligated using standard 
methods.
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The rat Slp5 sequence was amplified from PC12 cell cDNA by PCR, and 
inserted into the pENTR2A vector to generate a Gateway ‘entry vector’ 
construct. Primers contained restriction endonuclease sites (underlined) to 
facilitate subcloning. The sense primer used was 5’- TACATGTCGAC 
ATGTCTAAGAACTCGGAGTTCATCAA-3’-myc; Sail, and the antisense 
primer was 5’-T ACAT GCGGCCGCG AGCCT AC ATTT CGCCAT GCT AG A 
AC-3’-myc; Notl. The amplified sequence and the vector were digested 
with Sall/Notl, and the resulting fragments were ligated using standard 
methods.
2.2.21 pSlp5 pENTR2A
2.2.22 pEGFP-Slp5
The rat Slp5 sequence was transposed from pSlp5STOP pENTR2A, to 
pDEST-EGFP-C1 through the Gateway LR reaction.
2.2.23 pSlp5-EGFP
The rat Slp5 sequence was transposed from pSlp5 pENTR2A, to pDEST- 
EGFP-N1 through the Gateway LR reaction.
2.2.24 pSlp5 pcDNA3.1(+)
The rat Slp5 sequence was transposed from pSlp5STOP pENTR2A, to 
pDEST-cDNA3.1(+) through the Gateway LR reaction.
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2.2.25 pNoc2-EYFP
The Noc2 sequence was amplified from pNoc2 (Haynes et al., 2001) and 
inserted in frame into the pEYFP-N1 vector (Clontech, Basingstoke, UK) to 
generate a mammalian expression construct for Noc2, C-terminally tagged 
with EYFP. Primers contained restriction endonuclease sites (underlined) 
to facilitate subcloning. The sense primer used was 5’-TGACAAGCTT 
ATGGCTGACACCATCTTCAGCAG-3’-myc; Hind\\\, and the antisense 
primer was 5’-T GACÇÇGÇGGGT AATGGGT AGTT GCCCAG-3’-myc;
Sacll. The amplified sequence and the vector were digested with 
/-//nc/lll/Sacll, and the resulting fragments were ligated using standard 
methods.
2.2.26 pNoc2(V58A)-EYFP
A Noc2 sequence carrying a point mutation leading to substitution of Ala 
for Val at residue 58 was amplified from pNoc2(V58A) (Haynes et al., 
2001). This was then inserted in frame into the pEYFP-N1 vector 
(Clontech, Basingstoke, UK) to generate a mammalian expression 
construct for Noc2(V58A), C-terminally tagged with EYFP. Primers 
contained restriction endonuclease sites (underlined) to facilitate 
subcloning. The sense primer used was 5’-TACTAGGCTAGCA 
ATGGCTGACACCATCTTCAGCAG-3’-myc; Nhe\, and the antisense 
primer was 5’-CAG TTGÇÇÇGGGCGTAATGGGTAGTTGCCCAG-3’-myc; 
Xma\. The amplified sequence and the vector were digested with 
Nhe\IXma\, and the resulting fragments were ligated using standard 
methods.
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2.2.27 pNoc2(AAA)-EYFP
A Noc2 sequence carrying point mutations leading to substitution of Ala 
residues for Trp, Phe and Tyr at residues 154-156 was amplified from 
pNoc2(AAA) (Haynes et al., 2001). This was then inserted in frame into the 
pEYFP-N1 vector (Clontech, Basingstoke, UK) to generate a mammalian 
expression construct for Noc2(AAA), C-terminally tagged with EYFP. 
Primers contained restriction endonuclease sites (underlined) to facilitate 
subcloning. The sense primer used was 5’-TACTAGGCTAGCAAT 
GGCTGACACCATCTTCAGCAG-3’-myc; Nhe\, and the antisense primer 
was 5’-CAGTTGCCCGGGCGTAATGGGTAGTTGCCCAG-3’-myc; Xma\. 
The amplified sequence and the vector were digested with Nhe\/Xma\, and 
the resulting fragments were ligated using standard methods.
2.2.28 pNoc2-EGFP
The Noc2 sequence was cut from the pNoc2-EYFP vector and inserted, in 
frame, into the pEGFP-N1 vector (Clontech, Basingstoke, UK) to generate 
a mammalian expression construct for Noc2, C-terminally tagged with 
EGFP. The fragment encoding Noc2, and the cut pEGFP-C1 vector, were 
each generated through digestion with HindWUSacW, and these fragments 
were then ligated using standard methods.
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Sequences contained in plasmids generated through cloning or site- 
directed mutagenesis were verified by automatic sequencing carried out by 
DBS Genomics (Durham, UK) or The Sequencing Service’ (Dundee, UK).
2.2.29 Sequencing
2.2.30 Other Plasmids
The plasmids tabulated below were constructed elsewhere as described:-
Plasmid Reference
pArf1-EGFP As Arf-1-ECFP in (Haynes et a/., 2005)
pECFP-C1 Clontech, Basingstoke, UK
pEGFP-C1 Clontech, Basingstoke, UK
pEGFP-NI Clontech, Basingstoke, UK
pEYFP-N1 Clontech, Basingstoke, UK
pGCR-EGFP J Johnson, Liverpool, UK
pMunc18-1 (Ciufo et at., 2005)
pM und 8-1 (E466K) (Ciufo et at., 2005)
pM und 8-1 (E466K/R39C) (Ciufo et at., 2005)
pNoc2 (Haynes et at., 2001)
pppANF-EGFP (Burke et at., 1997)
pXGH5 Nichols Institute Diagnostics, (Selden etal., 1986)
Plasmids encoding putative RabGAPs carrying myc-tags were the kind gift
of Professor F Barr (Liverpool, UK). These were as follows:-
pRabGAP-5-myc; pParis1-myc; pRab3GAP-myc; pRUPTBC2-myc; 
pGAPCenA-myc; pGyp6-myc; pUSP6-myc; pTBC1 D22B-myc; pTBC1D1- 
myc; pTBC1D16-myc; pEVI5-myc; pRN-tre-myc; pRUPTBC1-myc; 
pTBC1D3-myc; pTBC1D7-myc; pTBC1D10A-myc; pTBC1 D10B-myc; 
pTBC1D10C-myc; pTBC1 D12-myc; pTBC1 D13-myc; pTBC1 D14-myc; 
pTBC1D15-myc; pTBC1 D17-myc; pTBC1 D18-myc; pTBC1 D19-myc; 
pTBC1D20-myc; pTBC1D21-myc; pGyp1-myc; pAK074305-myc; 
pAAH_33712-myc; pKIAA0882-myc; pNM_018309-myc; pEvi5-like-myc; 
pXM_037557-myc; pXM_370928-myc; pNM_198868-myc; pTBC1D4-myc.
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2.3 Cell culture and transfection
PC12 cells were grown in suspension in 75cm2 culture flasks at 37°C, 5% 
C 02 in RPMI 1640 medium (Gibco, Paisley, UK) supplemented with 10% 
horse serum, 5% foetal calf serum, 100U/ml penicillin and 0.1mg/ml 
streptomycin. Cells were passaged once weekly.
Transfection of PC12 cells was carried out as follows. Coverslips in live­
cell dishes, 6 or 24-well plates, were seeded with ~3 x 105 cells/lml 
supplemented media (as above). To facilitate cells’ adherence, cover slips 
were coated with collagen VII, or poly-D-lysine (Sigma Aldrich, Dorset, 
UK). In some cases, commercial BD Biocoat™ poly-D-lysine-coated 
coverslips were used (VWR, Dorset, UK). For hGH cotransfection assays, 
~3 x 105 cells were seeded onto commercial BD Biocoat™ poly-D-lysine- 
coated plates (VWR). In each case, cells became adherent following 
incubation overnight at 37°C, 5% C 02. Before transfection, media was 
removed, and replaced with 400-1400pl/well Optimem 1 media (Gibco, 
Paisley, UK). Transfection mixes were made up with 3pl of the 
Lipofectamine 2000 reagent (Invitrogen, Paisley, UK) per pg plasmid in 
100pl Optimem 1 according to manufacturer’s instructions. Mixes were 
incubated at room temperature for 30 minutes in order for the lipid and the 
DNA to associate and then added dropwise to the cells. 5 hours following 
their addition, the transfection mixes were removed from cells and 
replaced with supplemented media. Cells were incubated for a further 18- 
54 hours prior to experiments.
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The following table indicates the levels of each plasmid used in the 
experiments shown in the figures presented in this study:-
F ig u r e P la s m id ( s ) n g  p e r  t r a n s f e c t io n
3.1 A -C p E G F P -R a b 3 A 5 0 0
3.1 D-F p E G F P -R a b 3 A 5 0 0
p E C F P -R a b 2 7 A 500
3 .2 A -C p E C F P -R a b 2 7 A 5 0 0
3 .3 A -C , J-L p p p A N F -E G F P 500
3 .3 D -F , M -0 p E G F P -R a b 3 A 500
3 .3 G -I, P -R p E G F P -R a b 2 7 A 500
3 .3 T -V p E C F P -R a b 2 7 A 5 0 0
p E G F P -R a b 3 A 5 0 0
3 .4 A , D p p p A N F -E G F P 500
3 .4 B , E p E G F P -R a b 3 A 500
3 .4 C , F p E G F P -R a b 2 7 A 5 0 0
3 .4 G  (top) p m R F P -R a b 3 A 5 0 0
p p p A N F -E G F P 500
3 .4 G  (b o tto m ) p m R F P -R a b 2 7 A 500
p p p A N F -E G F P 500
3 .5 A p X G H 5 100 0
p E G F P -C I A s  in d ica te d
p E G F P -R a b 3 A A s  in d ica te d
3 .5 B p E C F P -C I A s  in d ica te d
p E C F P -R a b 2 7 A A s  in d ica te d
3 .6 A , D p E C F P -R a b 2 7 A 500
3 .6 B , E p E C F P -R a b 2 7 A (Q 7 8 L ) 500
3 .6 C , F p E C F P -R a b 2 7 A (N 1 3 3 l) 500
3 .6 G p X G H 5 100 0
pE C F P -C 1 A s  in d ica te d
p E C F P -R a b 2 7 A A s  in d ica te d
p E C F P -R a b 2 7 A (Q 7 8 L ) A s  in d ica te d
p E C F P -R a b 2 7 A (N 1 331) A s  in d ica te d
3 .7 A -D p A rf-1 -E G F P 500
3 .7 E -H p p p A N F -E G F P 500
3 .7 I-L p E G F P -R a b 3 A 500
3 .7 M -P p E G F P -R a b 2 7 A 500
3 .7 S p p p A N F -E G F P 500
3.8 p E G F P -R a b 3 A 500
3 .9 B p X G H 5 100 0
3 .9 C -D p G C R -E G F P 5 0 0
3 .1 0 A p p p A N F -E G F P 100
3 .1 0 B -C  (to p ) p p p A N F -E G F P 100
3 .1 0 B -C  (m id d le ) p E G F P -R a b 3 A 100
3 .1 0 B -C  (b o tto m ) p E G F P -R a b 2 7 A 100
4.1 A p R a b p h ilin -E G F P 100 0
4.1 B p E G F P -R a b ph ilin 100 0
4 .1 C p G ra n u p h ilin -E G F P 100 0
4.1 D p E G F P -G ra n u p h ilin 1 0 0 0
4.1 E p S lp 5 -E G F P 100 0
4.1 F p E G F P -S lp 5 1 0 0 0
4 .1 G p N o c2 -E G F P 1 0 0 0
4 .2  A -C p E G F P -R a b p h ilin 5 0 0
p m R F P -R a b 3 A 500
4 .2 D -F p G ra n u p h ilin -E G F P 500
p m R F P -R a b 3 A 500
4 .2 G -I p N o c2 -E G F P 500
p m R F P -R a b 3 A 500
4 .2 J -L p E G F P -R a b p h ilin 500
p m R F P -R a b 2 7 A 500
4 .2 M -0 p G ra n u p h ilin -E G F P 500
p m R F P -R a b 2 7 A 500
4 .2 P -R p N o c2 -E G F P 500
p m R F P -R a b 2 7 A 500
4 .3 A p X G H 5 5 0 0
p E G F P -C I A s  in d ica te d
p R ab p h ilin  p cD N A 3 .1 (+ ) A s  in d ica te d
p G ra n u p h ilin  p cD N A 3 .1 (+ ) A s  in d ica te d
p S lp 5  p cD N A 3 .1 (+ ) A s  in d ica te d
4 .3 B p X G H 5 100 0
pE G F P -N 1 A s  in d ica te d
p N oc2 A s  in d ica te d
4 .4  A -C p E C F P -R a b 2 7 A 5 00
p N oc2 -E Y F P 5 00
4 .4 D -F p E C F P -R a b 2 7 A 5 00
p N o c2 (V 5 8 A )-E Y F P 5 0 0
4 .4 G -I p E C F P -R a b 2 7 A 5 0 0
p N o c2 (A A A )-E Y F P 5 0 0
4 .4 J p N o c2 (A A A )-E Y F P 500
4 .4 K p X G H 5 100 0
pE Y FP -N 1 A s  in d ica te d
p N oc2 -E Y F P A s  in d ica te d
F ig u r e P la s m id ( s ) n g  p e r  t r a n s f e c t io n
p N o c 2 (V 5 8 A )-E Y F P A s  in d ica te d
p N o c 2 (A A A )-E Y F P A s  in d ica te d
4 .5 A -D p E G F P -R a b p h ilin 5 0 0
4 .5 E -H p G ra n u p h ilin -E G F P 5 0 0
4 .5 I-L p N o c2 -E G F P 5 0 0
4 .6 A p E G F P -R a b p h ilin 5 0 0
4 .6 B p E G F P -R a b p h ilin (1  -2 0 6 ) 5 0 0
4 .6 C p E G F P -R a b p h ilin (A A A ) 5 0 0
4 .7 A p E G F P -R a b 3 A 2 0 0
[+ /-] p M u n c 1 8 -1 (E 4 6 6 K ) 8 0 0
4 .7 B -C pM u nc1 8 -1 9 0 0
p E G F P -R a b 3 A 100
4 .7 D -E p E G F P -R a b 3 A 100
4 .7 F p E G F P -R a b 3 A 2 0 0
4 .7 G pM u nc1 8-1 8 0 0
p E G F P -R a b 3 A 2 0 0
4 .7 H pM u nc1 8-1  (E 4 6 6 K ) 8 0 0
p E G F P -R a b 3 A 2 0 0
4 .7 I pM u nc1 8 -1  (E 4 6 6 K /R 3 9 C ) 8 0 0
p E G F P -R a b 3 A 2 0 0
4 .8 A p E G F P -R a b 2 7 A 2 0 0
4 .8 B pM u nc1 8 -1 8 0 0
p E G F P -R a b 2 7 A 2 0 0
4 .8 C p M u n c 1 8 -1 (E 4 6 6 K ) 8 0 0
p E G F P -R a b 2 7 A 2 0 0
4 .8 D p M u n d  8-1 (E 4 6 6 K /R 3 9 C ) 8 0 0
p E G F P -R a b 2 7 A 2 0 0
4 .8 F -G  (r igh t) p M u n c 1 8 -1 (E 4 6 6 K ) 8 0 0
4 .9 A  (b o tto m ) p M u n c 1 8 -1 (E 4 6 6 K ) 8 0 0
5.1 A -C p E G F P -R a b 3 A 2 5 0
p R a b 3 G A P -m y c 7 5 0
5.1 D -F p E G F P -R a b 2 7 A 2 5 0
p R a b 3 G A P -m y c 7 5 0
5 .1 G p X G H 5 1 0 0 0
p E G F P -N I A s  in d ica te d
p R a b 3 G A P -m y c A s  in d ica te d
5 .2 A -F p E G F P -R a b 2 7 A 2 5 0
p T B C 1 D 1 0 A -m y c 7 5 0
5 .2 G -L p E G F P -R a b 3 A 2 5 0
p T B C 1 D 1 0 A -m y c 7 5 0
5 .2 M p X G H 5 1 0 0 0
p E G F P -N I A s  in d ic a te d
p T B C 1 D 1 0 A -m y c A s  in d ica te d
5 .3 A -F p E G F P -R a b 2 7 A 2 5 0
p T B C 1 D 1 0 B -m y c 7 5 0
5 .3 G -L p E G F P -R a b 3 A 2 5 0
p T B C 1 D 1 0 B -m y c 7 5 0
5 .3 M p X G H 5 1 0 0 0
p E G F P -N I A s  in d ica te d
p T B C 1 D 1 0 B -m y c A s  in d ica te d
5 .4 A p T B C 1 D 7 -m y c 7 5 0
5 .4 B p T B C 1 D 1 0 C -m y c 7 5 0
5 .4 C p T B C 1 D 1 4 -m y c 7 5 0
5 .4 D p T B C 1 D 1 9 -m y c 7 5 0
5 .4 E p N M _ 0 1 8 3 0 9 -m y c 7 5 0
5 .4 F p X M _ 0 3 7 5 5 7 -m y c 7 5 0
5 .4 G p T B C 1 D 3 -m yc 7 5 0
5 .4H p R N -tre -m yc 7 5 0
5 .5  A -C p E G F P -R a b 3 A 2 5 0
p R U T B C 1 -m y c 7 5 0
5 .5 D -F p E G F P -R a b 2 7 A 2 5 0
p R U T B C 1 -m y c 7 5 0
5 .5 G p X G H 5 1 0 0 0
pE G F P -N 1 A s  in d ica te d
p E G F P -R a b 3 A A s  in d ica te d
p R U T B C 1 -m y c A s  in d ica te d
5 .5 H p X G H 5 1 0 0 0
p E G F P -N I A s  in d ica te d
p E G F P -R a b 2 7 A A s  in d ica te d
p R U T B C 1 -m y c A s  in d ica te d
5 .6 A -F p E G F P -R a b 2 7 A 2 5 0
p R U T B C 2 -m y c 7 5 0
5 .6 G -I p E G F P -R a b 3 A 2 5 0
p R U T B C 2 -m y c 7 5 0
5 .6 J p X G H 5 1 0 0 0
p E G F P -N I A s  in d ica te d
p E G F P -R a b 2 7 A A s  in d ica te d
p R U T B C 2 -m y c A s  in d ica te d
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2.4 Cell preparation and immunocvtochemistrv
2.4.1 Fixation and immunocytochemistry
Coverslips were washed in phosphate-buffered saline (PBS) and then 
fixed in 0.5ml 4% paraformaldehyde for 30 minutes at room temperature. 
Following this fixation step, the coverslips were again washed twice with 
PBS. Where cells were not to be immunostained, coverslips were then 
airdried and mounted onto slides. Where cells were to be immunostained, 
they were incubated in PBT (PBS containing 0.3% BSA and 0.1% Triton- 
X-100) for 1 hour, at room temperature, prior to the addition of primary 
antibody. Cells were immunostained by exposure to primary antibody in 
PBT for 1 hour at room temperature, or overnight at 4°C. Unbound 
antibody was removed by washing three times with PBT, and coverslips 
were then exposed to appropriate secondary antibodies. Coverslips 
exposed to an Alexa Fluor 488-conjugated, or an Alexa Fluor 594- 
conjugated secondary (Molecular Probes, Paisley, UK), were incubated for 
1 hour with a 1:100 dilution of this antibody in PBT, washed twice in PBS, 
airdried, and mounted onto slides. Coverslips exposed to a biotinylated 
secondary (Amersham Biosciences, Buckinghamshire, UK) were 
incubated for 1 hour with a 1:100 dilution of this antibody in PBT, washed 
twice in PBT. They were then exposed to a 1:50 dilution of streptavidin- 
conjugated Texas red (Amersham Biosciences) in PBT for 30 minutes, 
washed and mounted as above. The following table shows the specific 
primary and secondary antibodies used in the experiments shown in the 
figures presented in this study:-
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Figure Primary Antibody Dilution Secondary Antibody
3.1A-C anti-Rab3A 1:400 Biotin-anti-Mouse
anti-Secretogranin II 1:100 Biotin-anti-Rabbit
3.2A-C anti-CSP 1:400 Biotin-anti-Rabbit
3.3A-R anti-Secretogranin II 1:100 Alexa 594-anti-Rabbit
4.7B anti-Munc18 1:400 Alexa 594-anti-Rabbit
4.8F anti-Rab3A 1:400 Alexa 488-anti-Mouse
4.9A anti-Munc18 1:400 Alexa 594-anti-Rabbit
5.1-5.6 anti-myc 1:200 Alexa 594-anti-Rabbit
Primary antibodies were sourced as follows:-
Species Antibody
Rabbit anti-CSP
Rabbit anti-Munc18
Rabbit anti-myc
Mouse anti-Rab3A
Rabbit anti-Secretogranin II
Source______________________
(Chamberlain e t a l., 1996) 
Calbiochem, CA, USA 
Sigma, Dorset, UK 
Transduction Labs, Cowley, UK 
Abeam, Cambridge, UK
2.4.2 Temperature-block experiments
Incubation of PC12 cells at 20°C prevents vesicle formation at the trans- 
Golgi network (TGN)(Rudolf et al., 2001). This phenomenon was exploited 
in experiments used to examine association of proteins with newly 
synthesised and immature secretory granules. PC12 cells were transfected 
as normal (see above), but following 2 hours incubation at 37°C, 5% C 0 2, 
they were incubated for a further 16 hours at 20°C. They were then 
incubated at 37°C, 5% C 02, for a measured time of between 0-30 minutes, 
after which they were immediately fixed as described above.
2.4.3 Digitonin permeablisation
Digitonin permeablisation was used to remove cytosolic protein from cells 
prior to fixation. Coverslips were washed three times in Krebs-Ringer
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solution (145mM NaCI, 5mM KCI, 1.3mM MgCI2, 1.2mM NaH2P04, 10mM 
Glucose, 20mM HEPES; pH7.4) and then incubated for 15minutes with 
20(j M digitonin in a permeablisation buffer containing 139mM potassium 
glutamate, 20mM PIPES, 5mM EGTA, 2mM MgCI2 and 2mM ATP (pH6.5). 
Cells were then immediately fixed and mounted as described above.
2.4.4 Phalloidin staining
After fixation cells were incubated with anti-Munc18-1 and actin filaments 
were stained with 25nM TRITC-conjugated Phalloidin (Molecular Probes, 
Paisley, UK) which was visualised with a 543nm laser and light collected 
between 500-535nm.
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2.5 Confocal microscopy
2.5.1 Fixed-cell imaging
Fixed-cell imaging was carried out on a Leica TCS-SP microscope (Leica 
Microsystems, Heidelberg, Germany). A 63x oil immersion objective with a
1.4 numerical aperture was used, and the pinhole was set to airyl. ECFP- 
containing constructs were excited using a 405nm laser, and emitted light 
was collected at 450-500nm. EGFP-containing constructs and Alexa Fluor- 
488 were excited using a 488nm laser, and light was collected at 500- 
550nm. EYFP-containing constructs were excited using a 514nm laser, 
and light was collected at 525-575nm. mRFP-containing constructs, Texas 
Red, and Alexa Fluor 594 were excited using a 593nm laser, and light was 
collected at 625-675nm.
2.5.2 Quantification of fluorescence distribution
In order to quantify the effects of cooverexpression of one protein, on the 
peripheral distribution of another within fixed cells, the following means of 
quantification was developed. Regions of interest were drawn around the 
outside of each cell, immediately beneath the cell periphery, and around 
the nucleus. Peripheral fluorescence was calculated by subtraction of 
cytoplasmic and nuclear fluorescence from the outer region of interest. 
Cytosolic fluorescence was calculated by subtraction of nuclear 
fluorescence. Ratios of peripheral to cytosolic fluorescence were 
calculated on the basis of the mean fluorescence per pixel in respective
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regions rather than total fluorescence to avoid problems arising from 
variations in the size of the selected regions of interest.
2.5.3 Quantification of glucocorticoid receptor translocation
In order to quantify the effects of the heat-shock protein 90 (HSP90) 
inhibitor geldanamycin (GA) on the dexamethasone-induced translocation 
of glucocorticoid receptor (GCR)-EGFP to PC12 cell nuclei, the following 
protocol was taken from a previous study (Galigniana et at., 1998). 18 
hours following transfection with GCR-EGFP, control cells were chilled on 
ice, and exposed to OpM or 1pM dexamethasone for 1 hour, while treated 
cells were exposed to 1pM dexamethasone for 30 minutes, and then a 
combination of 1pM dexamethasone and 10pM GA for 30 minutes. 
Solutions were made in Krebs Ringer buffer (NaCI 145mM, FIEPES 20mM, 
Glucose 10mM, KCI 5mM, MgCI2 1.3mM, NaFl2P04 1.2Mm). Cells were 
fixed following 20 minutes incubation at 37°C, 5% C 02, and 100 cells per 
condition were imaged. GCR-EGFP localisation in each cell was blindly 
scored as either predominantly nuclear or cytoplasmic, and this data was 
then used to calculate cytoplasmic:nuclear ratios for each condition.
2.5.4 Live-cell imaging
Live-cell imaging was carried out on a Leica TCS-SP-MP microscope 
(Leica Microsystems, Heidelberg, Germany). A 63x water immersion 
objective with a 1.2 numerical aperture was used, and images were 
captured every 1.64 seconds. Cells were maintained at room temperature. 
EGFP-containing constructs were excited using a 488nm laser, and light
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was collected at 500-550nm. X-Rhod was excited using a 593nm laser, 
and light was collected at 600-650nm.
2.5.5 Fluorescence recovery after photobleaching
In order to investigate the dynamics of EGFP-containing constructs in live 
cells, fluorescence recovery after photobleaching (FRAP) was used. PC12 
cells, imaged as above, were imaged at a 3x zoom, and the confocal 
pinhole was set to airy 2.06. Bleaching was carried out using the FRAP 
macro and ‘zoom-in’ functions available on the Leica confocal software. 
Circular regions of interest, of diameter 2.5pm, were bleached using 75% 
of maximal laser power. To determine the rate of fluorescence recovery, 
fluorescence in these regions was measured over time, and then 
normalised with respect to corresponding total cellular fluorescence at 
each individual time point, to correct for bleaching during low level 
imaging. 10 pre-bleach and 100 post-bleach frames were recorded per 
cell. Cells were maintained in Krebs Ringer buffer (NaCI 145mM, HEPES 
20mM, Glucose 10mM, KCI 5mM, MgCI2 1.3mM, NaH2P04 1.2Mm). 
Where the effects of geldanamycin (GA) were analysed, control cells were 
incubated in Krebs, and treated cells were incubated in Krebs containing 
10pM GA, for 1 hour prior to bleaching.
2.5.6 ATP stimulation of live-cells
For characterisation of the effects of ATP stimulation on numbers of 
secretory granules labeled with EGFP-containing constructs in live cells, a 
perfusion system was used. Cells were imaged as in ‘Live-cell imaging’
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above, at a 6x zoom, and the confocal pinhole was set to airy 3. 
Transmitted light images were taken during experiments to ensure that 
changes in fluorescence were not the result of drift in the focal plane. Cells 
were maintained in Krebs Ringer buffer, containing 3mM CaCI2, and were 
stimulated through perfusion with 300pM ATP, also in Ca2+-Krebs. 10 pre­
stimulation and 90 post-stimulation frames were recorded per cell. Where 
cells were loaded with the calcium indicator X-Rhod (Molecular Probes, 
Paisley, UK), they were incubated in a solution of 5pM X-Rhod in 3mM 
Ca2+-Krebs for 20 minutes, and then in 3mM Ca2+-Krebs for a further 20 
minutes prior to imaging.
In order to identify any change in the numbers of granules labeled with a 
given EGFP-tagged construct, before and after ATP-stimulation, ‘before’ 
and ‘after’ frames for each cell were blindly scored for granule numbers, 
and mean change in granule numbers was later calculated. Frames 
recorded 32 seconds and 127 seconds into the stimulation protocol were 
used for this quantitative analysis, as these timepoints correspond to a 
point before the start of ATP-stimulated calcium-influx, and a point of peak 
intracellular calcium, in the majority of cells, as identified in terms of X- 
Rhod fluorescence.
100
2.6 hGH cotransfection assays
In order to determine the effects of coexpressed protein, or drug treatment, 
on secretion of exogenous human growth hormone (hGH) from PC12 cells, 
the following previously described protocol was used (Graham et al., 
2000). 48 hours following transfection (described in Section 2.3, above), 
cells were washed once in Krebs Ringer buffer (NaCI 145mM, HEPES 
20mM, Glucose 10mM, KCI 5mM, MgCI2 1.3mM, NaH2P04 1.2mM), 
containing 3mM CaCI2, in order to remove hGH secreted prior to 
stimulation. Each well was then exposed to 200pl 3mM Ca2+-Krebs 
(unstimulated) or 200pl 3mM Ca2+-Krebs, 300pM ATP, (stimulated) for 15 
minutes at room temperature. The hGH released in this period was 
quantified using an enzyme-linked immunosorbent assay (ELISA) kit 
(Roche, East Sussex, UK) according to manufacturer’s instructions. 
Remaining cellular hGH was determined following lysis of cells in 200pl 
0.5% Triton-X-100. hGH secretion in each well was calculated as 
percentage of total hGH, and presented as mean ± s.e.m. for each 
condition. Where the effects of geldanamycin (GA) on secretion were 
analysed, control cells were incubated with Ca2+-Krebs, and treated cells 
were incubated with Ca2+-Krebs containing 10pM GA, for 1 hour prior to 
stimulation, at room temperature.
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Chapter 3:
Rab proteins in neuroendocrine 
exocytosis
3.1 Introduction
A broad range of cell types including neuronal, exocrine, endocrine and 
immune cells are specialised for regulated exocytosis, and there are 
sometimes dramatic differences in the regulation of the process and in the 
morphology of the organelles involved (Burgoyne and Morgan, 2003). It is 
thought that the core machinery of exocytosis, and indeed that of 
membrane fusion in general, is conserved in the form of the soluble N- 
ethyl maleimide-sensitive attachment protein receptor (SNARE) proteins, 
while many other proteins, including the Rabs and their effectors, are 
involved in adapting the process according to its discrete cellular or 
physiological roles. Indeed, the expansion of the Rab gene family in the 
higher eukaryotes (from 11 in yeast to over 60 in mammals) is likely to 
reflect the increased complexity and regulation of membrane trafficking in 
these organisms, and particularly that associated with specialisation (Bock 
et al., 2001).
As previously described, Rabs are ‘molecular switches’, present in either 
GDP- or GTP-bound forms. When membrane-associated, they may 
become GTP-bound through interaction with specific guanine nucleotide 
exchange factors (GEFs). It is generally the GTP-bound form of the Rab 
that is considered active and that interacts with effectors. Rabs hydrolyse 
bound GTP to GDP following interaction with specific GTPase-activating 
proteins (GAPs). In the GDP-bound form, Rabs may be vulnerable to 
extraction to the cytosol, a process likely to involve guanine nucleotide
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dissociation inhibitor (GDIs) since all cytosolic Rab protein is GDI-bound 
(Luan et at., 1999). GDIs are also thought to be important for correct 
targeting of Rabs back onto specific target membranes, a process also 
hypothesised to require a GDI displacement-factor (GDF) (Pfeffer, 2005b). 
Standard models suggest that Rabs follow continuous cycles of organelle 
association and disassociation (Grosshans et al., 2006). Thus, the 
dynamics underlying recruitment of these proteins to those target 
membranes are likely to be functionally important.
Recent work has established that Rab3A and Rab27A are likely to be the 
only two Rabs that contribute in a non-redundant manner to secretory 
granule exocytosis in PC12 cells (Pereira-Leal et at., 2001; Fukuda, 
2003a; Tsuboi and Fukuda, 2006a). This would suggest that these cells 
are an ideal system in which to investigate the discrete functions of these 
Rabs. Since little was known about the dynamic behaviour of these 
proteins in this cell type, this study was initially directed towards 
characterising that behaviour.
103
3.2 Results
3.2.1 Recruitment of exocytotic Rab proteins to secretory granules
In order to pursue a study focusing on the involvement of Rab proteins in 
exocytosis, it was initially necessary to identify a model system suited to 
this study. PC12 cells are derived from rat phaeochromocytoma, a tumour 
of adrenal chromaffin cells (Greene and Tischler, 1976). They are a very 
widely used cell-line in the exocytosis field since they retain the capacity 
for secretion and are readily-transfectable. Of relevance to this study, is 
that the molecular machinery of exocytosis identified in PC12 cells shares 
a number of characteristics with that identified in neuronal cells as well as 
with that identified in endocrine and exocrine cells (Burgoyne and Morgan, 
2003). Of particular relevance, is that PC12 cells have been found to 
endogenously express Rab3A, which has been widely studied in the 
context of neuronal exocytosis of synaptic vesicles, and Rab27A, which 
has been widely studied in the context of endocrine and exocrine secretion 
of secretory granules (Izumi etal., 2003; Sudhof, 2004). The choice of this 
cell-line as a model system therefore enabled simultaneous and 
physiologically meaningful study of both of these important proteins.
Endogenous Rab3A and Rab27A are reported to associate with secretory 
granules in PC12 cells (Darchen et al., 1995; Tsuboi and Fukuda, 2006a). 
To confirm the localisation of Rab3A in the PC12 cells used in this 
laboratory, fixed cells were probed with antibodies against Rab3A, and the 
secretory granule marker protein secretogranin II (SGII) (Fig.3.1, A-C)
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Figure 3.1. Endogenous Rab3A and secretogranin II (SGII), and exogenous ECFP-Rab27A and 
EGFP-Rab3A, colocalise strongly in PC12 cells. (A-C) Fixed cells co-immunostained with anti- 
Rab3A and anti-SGII. (D-F) Cells fixed 18 hours after cotransfection with plasmids encoding ECFP- 
Rab27A and EGFP-Rab3A. Each overlay image on the right of the figure is a composite of green 
from the left image and red from the centre image. Areas of overlap appear in yellow. Bars, 4^m.
(Steiner et al., 1989). As expected, these proteins colocalised strongly at 
punctae within the cytosol and at the periphery of cells, consistent with 
their granular localisation. Unfortunately, it was not possible to carry out a 
similar experiment to determine the localisation of endogenous Rab27A 
because a suitable antibody was not available.
As tools to study the localisation and dynamics of Rab3A and Rab27A in 
live cells, expression vectors for N-terminally fluorescently tagged versions 
of these proteins were generated. N-terminal modification does not appear 
to affect Rab protein function, because chimeric Rab27A N-terminally 
tagged with GFP has the capacity to functionally replace the wild-type 
protein in a mouse ‘knock-in’ model (Tolmachova eta!., 2004).
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Since it had not been possible to determine the localisation of endogenous 
Rab27A in PC12 cells in this study through immunocytochemistry, the 
localisation of ECFP-Rab27A with respect to that of EGFP-Rab3A was 
explored. When ECFP-Rab27A and EGFP-Rab3A were coexpressed, their 
localisation was punctate, closely resembled that of endogenous Rab3A, 
and the two tagged Rab proteins showed very strong colocalisation 
(Fig.3.1, D-F). These data were consistent with the suggestion that both 
constructs localise to secretory granules. In order to test this suggestion 
directly, the localisation of the exogenous Rabs was compared to that of 
secretory granule marker proteins in single cells. Examples of these 
experiments include comparison of ECFP-Rab27A fluorescence with 
staining for the granule marker cysteine string protein (CSP) (Chamberlain 
et a/., 1996) (Fig.3.2), and comparison of EGFP-Rab3A and EGFP- 
Rab27A fluorescence with staining for SGII (Fig.3.3, D-F and G-l 
respectively). Surprisingly, the localisation of the exogenous Rabs only 
partially matched that of the markers. By inference, this suggests that the 
localisation of tagged-Rab3A and that of tagged-Rab27A does not entirely 
match that of their endogenous counterparts.
The above might suggest that the exogenously expressed Rab proteins 
were mislocalised. However, in a previously presented model (Fischer von 
Mollard eta/., 1991; Sudhof, 1997), neuronal Rab3A is recruited to, and 
remains associated with, synaptic vesicles, until an exocytotic signal leads 
to fusion between the vesicular and plasma membranes; an event 
associated with the dispersal of the Rab (Fischer von Mollard et al., 1991;
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Figure 3.2. ECFP-Rab27A partially colocalises with the secretory granule marker cysteine-string 
protein (CSP) in PC12 cells. (A-C) Cells fixed 18 hours after transfection with a plasmid encoding 
ECFP-Rab27A were Immunostained with antl-CSP. The overlay image on the right of the figure Is a 
composite of green from the left image and red from the centre Image. Areas of overlap appear In 
yellow. Bar, 4p.m.
Star et al., 2005). Coupled to the suggestion that Rab3A recruitment is 
saturable, and dependent on a proteinaceous receptor (Chou and Jahn, 
2000), another possibility arises. It is possible that the newly synthesised 
Rabs are preferentially recruited to newly made secretory granules, not 
already saturated with the protein, and therefore that the tagged Rab 
proteins localised with only part of the cellular compliment of granules 
because the protein synthesised post-transfection was only recruited to 
secretory granules synthesised post-transfection.
To test this hypothesis, a transfectable granule content marker, prepro- 
atrial natriuretic factor-EGFP (ppANF-EGFP), was used. ppANF-EGFP is 
packaged within the granule core, and so the granules labeled by this 
construct are only those formed post-transfection (Burke et al., 1997). 
Therefore, its colocalisation with SGII, as a marker of the total cellular 
compliment of granules, should mirror that of the tagged Rab proteins if 
these preferentially label newly synthesised granules. Furthermore, 
colocalisation between each construct and SGII should improve over time,
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Figure 3.3. Improved colocalisation between ppANF-EGFP/EGFP-Rab3A/EGFP-Rab27A and 
secretory granules over time post transfection. PC12 cells were transfected with ppANF-EGFP (A- 
C, J-L), EGFP-Rab3A (D-F, M-O) or EGFP-Rab27A (G-l, P-R) and fixed 18 hours or 30 hours post 
transfection as indicated. After fixation, cells were immunostained with anti-secretogranin II (anti- 
SGII). (S) Quantification of the increased colocalisation of EGFP and SGII seen over this time. (T-V) 
PC12 cells cotransfected with ECFP-Rab27A and ppANF-EGFP, and fixed 18 hours after 
transfection. Each overlay image on the right of the figure is a composite of green from the left 
image and red from the centre image. Areas of overlap appear in yellow. Quantitative data shown 
for the correlation coefficient as mean ± s.e.m. (n=5) Bars, 4pm.
as granules synthesised post-transfection make up a greater proportion of 
the total. Cells were transfected with ppANF-EGFP, EGFP-Rab3A or 
EGFP-Rab27A, fixed at 18 hours and 30 hours post-transfection, probed 
with anti-SGII, and compared (Fig.3.3, A-R). Quantitative analysis showed 
that at each timepoint, colocalisation between each construct and SGII 
was strikingly similar, while it was partial 18 hours after transfection, and 
significantly more extensive after 30 hours (Fig 1.3, S). Since there was
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such similarity between ppANF-EGFP and tagged Rab protein 
fluorescence, the extent of their colocalisation was determined. When 
ppANF-EGFP was cotransfected with ECFP-Rab27A (Fig.3.3, T-V), the 
proteins were found to colocalise strongly.
The above data provide strong evidence that the tagged Rab proteins are 
preferentially recruited to relatively newly synthesised secretory granules, 
and so it was decided to more precisely determine the time course of their 
recruitment. To do this, a blockade of vesicle budding at the TGN 
produced when cells are incubated at 20°C was utilised. This technique 
has been used previously to follow immature granules in PC12 cells 
(Rudolf et al., 2001). Following culture for 18 hours at 20°C and fixation, 
cells expressing ppANF-EGFP showed accumulated fluorescence in a 
perinuclear region, as expected if it was trapped in the TGN (Fig.3.4, A). In 
contrast, EGFP-Rab3A and EGFP-Rab27A showed a more diffuse 
cytosolic distribution (Fig.3.4, B-C). Although punctate structures were 
visible in many cells, indicating that a proportion of the Rabs can associate 
with pre-existing granules, these results do indicate a deficit in the 
recruitment of Rabs to existing granules in the absence of normal granule 
biogenesis. Switching of cells to 37°C for 30 minutes prior to fixation 
altered the localisation of all three of the constructs (Fig.3.4, D-F). This 
relief of the blockade of vesicle budding led to the appearance of labeled 
punctate structures throughout the cells, indicating that ppANF-EGFP- 
containing granule biogenesis was initiated rapidly, and that the Rabs were 
able to interact with granules early in this process.
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Figure 3.4. Appearance of Rab3A and Rab27A on immature secretory granules during granule 
biogenesis and maturation. (A-F) PC12 cells were transfected with ppANF-EGFP, EGFP-Rab3A or 
EGFP-Rab27A and cultured for 18 hours at 20°C to block granule budding at the TGN and then 
fixed (time 0) or incubated for 30 minutes at 37°C to allow budding of immature granules. (G) PC12 
cells were co-transfected with ppANF-EGFP and mRFP-Rab3A or mRFP-Rab27A, cultured for 18 
hours at 20°C and then fixed at the indicated times after incubation at 37°C. The images show 
overlays of ppANF-EGFP fluorescence in green and mRFP fluorescence In red.
Other studies in PC12 cells have shown that immature secretory granules 
move within seconds to the cell periphery following their budding from the 
TGN, and after a further period of tens of minutes become immobilised in 
the cell cortex (Rudolf et at., 2001). During maturation secretory granules 
increase in size and specific components are removed from them with a 
half-time of around 45 minutes (Tooze et a!., 1991; Dittie et at., 1997).
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Since it was found that Rab recruitment was effected within 30 minutes
following the lifting of the 20°C temperature-block, it is likely that these 
proteins were recruited to immature secretory granules at some stage 
during their maturation.
To follow the time course of their association with immature granules, cells 
were transfected to coexpress ppANF-EGFP and Rab3A or Rab27A 
tagged with monomeric red fluorescent protein (Fig.3.4, G). Immature 
secretory granules labeled with ppANF-EGFP were visible throughout the 
cells after 5-10 minutes following incubation at 37°C. However, 
colocalisation between the ppANF-EGFP and mRFP-Rab3A or mRFP- 
Rab27A was not evident until the cells had been incubated at 37°C for 20 
minutes or more, indicating a lag period between release of immature 
secretory granules from the TGN and the association of the Rab proteins 
of up to 20 minutes.
3.2.2 Rab activity and exocytosis
Following the characterisation of Rab protein recruitment to secretory 
granules, the functional effects of this recruitment were explored. Rab3A 
overexpression is reported to be inhibitory (Holz et al., 1994; Regazzi et 
a/., 1996; Johannes et al., 1998), though it may enhance spontaneous 
exocytosis (Schluter et al., 2002; Sons and Plomp, 2006). Rab27A 
overexpression is variously reported to inhibit or enhance exocytosis (Yi et 
al., 2002; Desnos et al., 2003; Menasche et al., 2003; Johnson et al., 
2005). In PC12 cells, several groups have reported that overexpression of
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AFigure 3.5. Exogenous Rab proteins affect secretion of exogenous hGH. Secretion of exogenous 
human growth hormone (hGH) from cells cotransfected with varying levels of plasmids encoding 
EGFP-Rab3A (A) or ECFP-Rab27 (B) 48 hours before stimulation was assayed. Stimulated cells 
were exposed to 300 p.M ATP, hGH release over 15 minutes was assayed and expressed as a 
percentage of total hGH (shown to the right of the figure). Data are expressed as mean ± s.e.m. 
(n=6)
either Rab3A or Rab27A inhibits secretion (Schluter et al., 2002; Desnos 
et al., 2003). It was therefore necessary to determine whether the 
constructs already used in this study produced the same functional effects. 
It was possible to employ hGH cotransfection assays for this determination 
because of the very high cotransfection efficiency of PC12 cells (Graham 
et al., 2000). Cells were cotransfected with a range of concentrations of
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fluorescently tagged Rab expression vectors and an hGH expression 
vector. pEGFP-C1 or pECFP-C1 vector was added to transfection mixes 
where applicable so that each mix contained the same final DNA 
concentration. 48 hours post-transfection, cells were stimulated with 
300pM ATP, secreted hGH was assayed, normalised with respect to total 
hGH, and compared with hGH secreted from unstimulated cells. 
Transfection with as little as 50ng EGFP-Rab3A or ECFP-Rab27A vector 
DNA was found to significantly inhibit hGH secretion, while where higher 
levels of vector were used, a greater degree of inhibition was seen 
(Fig.3.5, A-B).
Following synthesis, Rab3A and Rab27A are subjected to C-terminal 
geranylgeranylation, a post-translational modification essential for their 
membrane-association and function (Zerial and McBride, 2001; Leung et 
al., 2006). The unprenylated Rab is bound by a Rab escort protein (REP) 
that mediates its presentation to the alpha and beta subunits of a 
geranylgeranyl transferase enzyme (GGTase). REP and GGTase proteins 
are thought to bind preferentially to GDP-bound Rab proteins (Seabra, 
1996). REPs are suggested to participate in multiple rounds of Rab 
geranylgeranylation, because upon completion of each round, these 
proteins can mediate initial delivery of prenylated Rabs to membranes 
(Alexandrov et al., 1994). On the surface of membranes, Rab proteins can 
become GTP-associated, which is a requirement for their interaction with 
the majority of Rab effectors (Takai et al., 2001). However, while GDP- 
bound, Rabs are susceptible to extraction back into the cytosol in a
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process involving GDP-dissociation inhibitors (GDIs). GDIs sequester 
GDP-bound Rab protein within the cytosol, while they are also suggested 
to participate in the correct targeting of specific Rab proteins to specific 
membrane compartments (Goody et al., 2005; Leung et al., 2006). Given 
that the above evidence suggests that the association between Rab 
proteins and secretory granules is intrinsically linked to their nucleotide­
binding, it was decided to explore the effects of mutations that affect that 
binding on the localisation and function of Rab27A.
ECFP-Rab27A point-mutants with reduced intrinsic GTPase activity 
(Q78L), and defective nucleotide-binding (N133I), were generated by site- 
directed mutagenesis (SDM). Because of its reduced GTPase activity, the 
Q78L mutant is thought to be predominantly in a GTP-bound state under 
physiological conditions (Desnos et al., 2003; Fukuda, 2003b). The N133I 
mutation is analogous to a mutant of Ras, N116I, in which defective 
nucleotide binding prevents or attenuates the protein's geranylgeranylation 
(Huang et al., 2001). When either mutant was expressed in PC12 cells, 
they showed a largely diffuse cytosolic localisation, markedly different from 
that of the unmutated ECFP-Rab27A control (Fig.3.6, A-C). Because it is 
difficult to determine by confocal microscopy whether a fraction of a 
fluorescent protein is not cytosolic where there is a strong signal from a 
cytosolic fraction, these data could not distinguish a complete arrest in the 
targeting of the mutant proteins to secretory granules from a partial 
reduction in this targeting. Therefore, another series of experiments were 
carried out in which cells transfected with the mutants were digitonin-
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Figure 3.6. Effects of Q78L and N133I mutations on ECFP-Rab27A localisation and function. (A-C) 
Cells fixed 18 hours after transfection with a plasmid encoding ECFP-Rab27, ECFP-Rab27A 
(Q78L) or EGFP-Rab27A (N133I) were imaged. (D-F) Cells as above were exposed to a 
permeablisation buffer containing 10pM digitonin for 15minutes for the removal of free cytosolic 
protein prior to fixation. Images show the association of each construct with puncta within cells. 
Bars, 4pm. (G) Secretion of exogenous human growth hormone (hGH) from cells cotransfected with 
the above plasmids 48 hours before stimulation was assayed. Stimulated cells were exposed to 300 
pM ATP, hGH release over 15 minutes was assayed and expressed as a percentage of total hGH 
(shown to the right of the figure). Data are expressed as mean ± s.e.m. (n=6)
permeablised prior to fixation in order to remove cytosolic protein. As 
shown in Fig.3.6, D-F, permeablisation revealed an association between 
the mutants and punctuate structures, likely to be secretory granules, 
within the cells, suggesting that some targeting to granules still occurred.
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Since the unmutated ECFP-Rab27A construct had been shown to reduce
secretion in the hGH cotransfection assay in PC12 cells, the effects of the 
mutant proteins were determined using the same system (Fig.3.6, G). 
While the N133I mutant was found to have no significant effect on hGH 
secretion compared to the control, the Q78L mutant reduced secretion to 
almost the same level as the unmutated Rab, despite its apparently 
significantly reduced secretory granule binding capability.
3.2.3 Rab3A but not Rab27A is dynamically associated with secretory 
granules in PC12 cells
Recruitment of Rab3A and Rab27A to immature secretory granules is 
consistent with the suggestion made for synaptic vesicles that once the 
proteins associate with these vesicles, they are only released during or 
following exocytosis (Fischer von Mollard etal., 1991; Star eta i ,  2005). To 
directly address this possibility, it was decided to use fluorescence 
recovery after photobleaching (FRAP) experiments. In a FRAP experiment, 
the fluorescent protein within a small region of interest (ROI) of a cell is 
bleached using a high-intensity laser, and the recovery of fluorescence 
within this area is subsequently monitored (Lippincott-Schwartz and 
Patterson, 2003). The recorded fluorescence recovery reflects the 
replacement of bleached protein in the ROI with unbleached protein from 
outside this region. To test whether the protocol that was to be used could 
successfully resolve exchange of fluorescent protein between cytosol and 
membrane in PC12 cells, bleaching experiments were carried out on
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ARF1-EGFP-transfected cells. ARF1 is a small GTPase shown to cycle 
rapidly between cytosolic and Golgi-associated states in other cell types 
(Vasudevan et a/., 1998; Presley et at., 2002). Expressed ARF-1-EGFP 
was partially cytosolic but also showed a clear localisation to a perinuclear 
region presumed to be the Golgi complex in PC12 cells (Fig.3.7, A). 
Following the bleaching of an area of the Golgi complex, fluorescence 
recovery of this ARF-1-EGFP occurred with a tV2 of 44 seconds and was 
almost complete (fractional recovery of 87.5%) within the recorded 
timeframe of the experiments (Fig.3.7, A-D, Q). This behaviour was similar 
to that described for ARF1 previously, and confirms the applicability of the 
FRAP protocol in PC12 cells.
Following bleaching of fluorescently tagged EGFP-Rab3A or EGFP- 
Rab27A, fluorescence recovery in the ROI could be attributed to three 
sources: the diffusion of unbleached cytosolic protein, exchange between 
bleached and unbleached protein on granule membranes, and the 
movement from other parts of the cell of granules carrying unbleached 
protein. Compared with the other components of recovery, diffusion of 
unbleached protein into the ROI was likely to be rapid (~1 second), 
whereas recovery as a result of granule movement was initially an 
unknown quantity. For the latter aspect, the recovery following bleaching of 
ppANF-EGFP was assessed (Fig.3.7, E-FI, Q). Since this protein is 
contained within granules, its recovery profile would be solely due to the 
effects of granule movement, and provides a reference for comparison 
with the other data. ppANF-EGFP showed only a slow and partial
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Figure 3.7. Dynamics of EGFP-Rab3A and EGFP-Rab27A on secretory granules in PC12 cells. 
(A-P) PC12 cells were transfected to express the indicated EGFP-tagged protein and imaged 18 
hours following transfection. Regions of interest (ROIs) in each cell were bleached with high 
intensity laser (arrows) and the fluorescence recovery in these areas was recorded over time. (Q) 
Plot of fluorescence recovery data corrected for general photobleaching and combined after initial 
fluorescence for each cell was normalised to 100. (R) Plot of fluorescence recovery as above but 
with first post-bleaching data point normalised to 0. (S) Three consecutive frames from imaging of a 
ppANF-EGFP-transfected cell. Data shown are mean ±s.e.m. of 14 ARF1-EGFP, 13 ppANF-EGFP, 
21 EGFP-Rab27A and 21 EGFP-Rab3A expressing cells. Bar, 4pm.
fluorescence recovery (fractional recovery of 23.7%) in the bleached 
region, with a tV2 of 58 seconds. These findings were consistent with 
limited secretory granule mobility under resting conditions (Burke et a i, 
1997), a suggestion confirmed here by direct imaging of live cells 
expressing the construct (Fig.3.7, S).
FRAP experiments were conducted on EGFP-Rab3A and EGFP-Rab27A- 
transfected PC12 cells 18 hours following their transfection. Only cells 
expressing relatively low levels of the exogenous protein were selected. 
For Rab27A (Fig.3.7, M-P, Q), as expected, it was found that proportionate 
fluorescence recovery at ~1.6 seconds post bleaching (i.e. the first post- 
bleaching data point) was greater than seen in the ppANF-EGFP- 
transfected cells, consistent with a greater cytosolic component of 
recovery. However, when the data were normalised with respect to this 
initial data point, the recovery profiles of these proteins were not 
significantly different, suggesting that the minimal EGFP-Rab27A recovery
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seen after photobleaching was largely or entirely due to granule movement 
rather than exchange of Rab27A on the granules (Fig.3.7, R). In the case 
of EGFP-Rab3A (fractional recovery 66.6%), the recovery profile (Fig.3.7, 
l-L, Q-R) was strikingly different to that of EGFP-Rab27A (fractional 
recovery 37.8%). In fact, the recovery of EGFP-Rab3A was more similar to 
that of the ARF1-EGFP, with extensive, although not complete recovery 
with a U/2 of 32 seconds. These data suggest that like ARF1 but unlike 
Rab27A, Rab3A cycles continuously between the cytosol and membranes, 
and that in PC12 cells at least, this recycling is not exclusively coupled to 
the exocytotic event and so may be important prior to fusion.
Earlier in this chapter, experiments were described in which exogenous 
EGFP-Rab3A was shown to associate with a greater proportion of 
secretory granules at 30 hours post-transfection than at 18 hours post­
transfection. In the light of the findings described above, which suggest 
that the Rab protein associates with granules in a dynamic manner, it is 
possible to rule out the suggestion that this was due to progressive 
saturation of Rab3A binding-sites on more recently synthesised granules. 
This leaves two explanations open. The first is that Rab3A on older 
granules is unable to cycle between the granules and cytosol. The second 
is that the capacity of old granules for recruitment of Rab3A is lower than 
that of newer granules. To test the possibility of a difference in cycling we 
carried out FRAP experiments on older EGFP-Rab3A-labeled granules in 
cells at 30 and 54 hours after transfection and compared these to granules 
in cells at 18 hours post transfection. EGFP-Rab3A recovered with similar
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Figure 3.8. Dynamics of EGFP-Rab3A with increasing time post-transfection. (A-H) PC12 cells 
were transfected to express EGFP-Rab3A and imaged 30 or 54 hours following transfection as 
indicated. Regions of interest (ROIs) in each cell were bleached with high intensity laser (arrows) 
and the fluorescence recovery in these areas was recorded over time. (I) Plot of fluorescence 
recovery data corrected for general photobleaching and combined after Initial fluorescence for each 
cell was normalised to 100. (J) Plot of fluorescence recovery as above but with first post-bleaching 
data point normalised to 0. Data shown are mean ±s.e.m. of 10 cells at 30 hours and 27 cells at 54 
hours.
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kinetics onto granules in cells at 18, 30 and 54 hours but with a 
progressively higher fractional recovery for the older granules (Fig.3.8, A- 
J). This data supports the second explanation since it indicates that Rab3A 
can cycle on and off both the newer and the older granules, but may cycle 
off older granules more rapidly.
Recent work has suggested that Rab protein extraction from membranes 
involves the heat-shock protein Hsp90 (Sakisaka et al., 2002; Chen and 
Balch, 2006). More specifically, it was found that extraction of Rab3A from 
synaptosome membranes was regulated by a chaperone complex 
containing GDIa, Hsp90, Hsc70 and CSP, and that inhibition of Hsp90 
inhibited Ca2+-triggered exocytosis in this system (Sakisaka et al., 2002). 
While the authors suggest that Hsp90-dependent Rab3A extraction is 
coupled to exocytosis, it was possible that the continuous cycling of EGFP- 
Rab3A between membrane and cytosol that we observed was also 
mediated via this complex. To investigate this possibility, parallel bleaching 
experiments were carried out on control EGFP-Rab3A-transfected cells 
and cells incubated with 10 pM geldanamycin for 1 hour before bleaching. 
Geldanamycin is a potent and specific inhibitor of Hsp90, and was used 
here at the concentration found to virtually abolish extraction of Rab3A 
from synaptosomal membranes following stimulation with Ca2+ (Sakisaka 
et al., 2002). The recovery profile for EGFP-Rab3A following 
photobleaching in control cells was closely similar to that in the earlier 
experiments (compare Fig.3.7, Q-R and Fig.3.9, A). It was found that 
recovery profiles for control and treated cells were virtually superimposable
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Figure 3.9. Inhibition of HSP90 does not affect EGFP-Rab3A dynamics or exocytosis in PC12 cells. 
(A) PC12 cells were transfected to express EGFP-Rab3A, and imaged 18 hours following 
transfection following a 1 hour treatment with vehicle or 10pM geldanamycln (GA). Regions of 
interest (ROIs) in each cell were bleached with high intensity laser and the fluorescence recovery in 
these areas was recorded over time, (left) Plot of fluorescence recovery data corrected for general 
photobleaching and combined after initial fluorescence for each cell was normalised to 100. (right) 
Plot of fluorescence recovery as above but with first post-bleaching data point normalised to 0. Data 
shown are mean ±s.e.m. of 11 EGFP-Rab3A expressing cells for each condition. (B) Secretion of 
exogenous human growth hormone (hGH) was assayed. 18 hours following transfection, cells were 
treated with GA for 1 hour, then exposed to 300 jj.M ATP. hGH release over 15 minutes was 
assayed and expressed as a percentage of total hGH (shown to the right of the figure). Data are 
expressed as mean ± s.e.m. (n=6). (C) Representative image showing cytosolic or nuclear 
glucocorticoid receptor (GCR-EGFP). (D) Effect of GA on GCR-EGFP translocation to the nucleus. 
Treated cells were exposed to 1pM dexamethasone on ice for 1 hour, or 1pM dexamethasone on 
ice for 1 hour, with the addition of 10pM GA for the final 30 minutes, [contd. on next page].
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Figure 3.9 contd. Following a 20-minute incubation at 37°C and fixation, 100 cells were scored for 
each condition according to the cytosolic or nuclear localisation of the GCR-EGFP. Data are 
expressed as cytoplasmic:nuclear ratios and are representative of two independent experiments. 
Bar, 2pm.
(Fig.3.9, A), with f1/2 of 29 and 28.6 seconds for control and geldanamycin- 
treated cells, respectively. This suggests that the resting EGFP-Rab3A 
cycling observed here occurs independently of Hsp90.
As it had been reported that geldanamycin blocks neurotransmitter release 
from synaptosomes, its effects on secretion from PC12 cells were assayed 
here. ATP-stimulated release of exogenously expressed human growth 
hormone (hGH) from PC12 cells pre-incubated for 1 hour prior to 
stimulation with varying concentrations of the inhibitor was measured 
(Fig.3.9, B). The release of hGH was assayed to allow examination of 
release from newly synthesised granules in transfected cells (i.e. those 
that exogenous Rabs become associated with). As shown, geldanamycin 
had no significant effect on hGH release within the range of concentrations 
used, suggesting that secretory granule exocytosis occurs in an Hsp90- 
independent manner in this cell type.
It was possible that the negative results described above were caused 
because the geldanamycin used was inactive, or because PC12 cells were 
in some way resistant to its effects. To rule out these possibilities, the 
effects of the inhibitor on the well-characterised Hsp90-dependent nuclear 
translocation of glucocorticoid receptor (GCR) were determined. It has 
been found that 10pM geldanamycin can block dexamethasone induced
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nuclear translocation of GCR-EGFP in NIH-3T3 cells (Galigniana et al., 
1998), and so this protocol was applied to PC12 cells. GCR-EGFP- 
transfected cells were serum starved, chilled on ice, exposed to 1 pM 
dexamethasone, and then either vehicle or 10pM geldanamycin. Following 
a brief period of incubation at 37°C and fixation, 100 cells per treatment 
expressing moderate amounts of this protein were scored according to its 
localisation. In individual cells in the cultures, the GCR-EGFP was either 
predominantly in the cytosol or nucleus (Fig. 1.9, C). As expected, the 
presence of geldanamycin increased the proportion of cells in which the 
GCR-EGFP was cytosolic, indicating that it was indeed active in PC12 
cells (Fig.3.9, D).
It has previously been reported that activation of exocytosis leads to 
Rab3A extraction from synaptic membranes (Fischer von Mollard et al., 
1991; Star et al., 2005). Indeed, Star et al. have directly imaged the 
reversible dispersal of EGFP-Rab3A away from presynaptic terminals and 
into neighbouring axonal regions during periods of synaptic activity. It was 
unknown, however, whether dissociation and dispersal occurs for Rabs 
located on dense core secretory granules. In addition, experiments on 
synaptic Rabs requires use of either biochemical approaches or imaging of 
whole synaptic terminals whereas study of PC12 cells allows imaging of 
events on single secretory granules in live cells. Therefore, it was decided 
to image EGFP-Rab3A and EGFP-Rab27A-transfected cells during 
stimulation with ATP to raise intracellular calcium and activate exocytosis 
in PC12 cells. As it had previously been shown in hGH cotransfection
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assays that the constructs used in this study are capable of inhibiting 
exocytosis (Fig.3.5), cells were transfected with only 0.1 pg of each 
construct; a level at which inhibition was in each case found to be less 
than half maximal. Further, imaging was carried out only 18 hours post­
transfection so that expression levels of the Rabs would be less than in the 
48-hour hGFI experiments, and only those cells expressing low levels of 
fluorescence were monitored.
Images were taken using settings to image within a thick confocal section 
to ensure that granules were not lost because of movement out of the 
confocal section and cells were rejected if any focus drift as a result of cell 
movement was detected. Initially, ppANF-EGFP-transfected cells were 
observed to see if the cells underwent exocytosis in response to 300 pM 
ATP. As noted previously, there is little movement or loss of granules from 
the imaged field under resting conditions. During stimulation, ppANF- 
labeled granules in the cell periphery but not those in the cell interior were 
seen to disappear abruptly often between successive images (Fig.3.10, A), 
indicating exocytosis of these granules. This can also be seen in the 
example shown in Fig.3.10, B in which images before (green) and after 
(red) stimulation have been overlaid so that granules that remained appear 
yellow. A green ‘corona’ of released granules can be seen in the ppANF- 
EGFP-transfected cell. The number of granules lost per cell was variable 
but on average close to 20% of labeled granules disappeared. By contrast, 
when EGFP-Rab3A or EGFP-Rab27A-transfected cells were imaged 
during ATP stimulation, although some short-range granule movement
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Figure 3.10. Effect of activation of exocytosis on secretory granules labelled with EGFP-ppANF, 
EGFP-Rab3A or EGFP-Rab27A In live cells. Cells were transfected to express EGFP-ppANF, 
EGFP-Rab3A or EGFP-Rab27A and imaged 18 hours after transfection. Cells showing low levels of 
fusion protein expression were selected for observation and stimulated by perfusion with 300 piM 
ATP. (A) Disappearance of a ppANP-EGFP-labelled granule during stimulation. The images shown 
are sequential frames in which the sudden disappearance of a granule (arrow) can be observed. (B) 
Effect of stimulation with 300 piM ATP on secretory granules labelled with EGFP-ppANF, EGFP- 
Rab3A or EGFP-Rab27A as indicated. Images were taken at 32 seconds and 127 seconds into the 
series, [contd. on next page]
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Figure 3.10 contd. Overlay images are shown with f=32 seconds in green and f=127 seconds in 
red so that granules that disappear between the images appear green. Granules that disappeared 
in the ppANF-EGFP cell are indicated with arrowheads. (C) The number of granules that 
disappeared between the before and after images was identified by the comparison of images at 19 
and 76 seconds, quantified and shown as mean ± s.e.m, for 8 cells expressing each construct. (D) 
Example of the time course of Ca2+ changes from monitoring of X-Rhod fluorescence following ATP 
stimulation (n=11 cells).
was noted, there was no overall loss of fluorescent granules at the cell 
periphery or in the cell interior (Fig.3.10, C). These results suggest that 
Rab3A and Rab27A do not immediately disperse from sites of exocytosis 
at the plasma membrane in PC12 cells.
As an additional control for the above experiments, cells were loaded with 
the intracellular Ca2+ indicator X-Rhod to confirm that they responded to 
ATP stimulation. An increase in Ca2+ concentration was found to occur in 
all cells analysed and the mean change in X-Rhod fluorescence over the 
time course of experiments is shown in Fig.3.10, D.
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3.3 Discussion
Much of the work described in this chapter was carried out on cells 
transfected with N-terminally tagged chimeras between fluorescent 
proteins and either Rab3A or Rab27A. It is therefore important to consider 
whether tagging and overexpression might have affected normal Rab 
protein distribution and function before discussing any findings in this 
context. Overexpression of fluorescently tagged protein can be associated 
with mislocalisation and aggregation (Shaner et at., 2005). However, 
several lines of evidence suggest that this did not occur in the experiments 
described. Both the increased colocalisation between EGFP-Rab3A or 
EGFP-Rab27A and SGII with time post-transfection (Fig.3.3, A-R), and the 
strong colocalisation between ECFP-Rab27A and ppANF-EGFP (Fig.3.3, 
T-V) point to the correct targeting of the chimeras to secretory granules. 
Severe disruption of this targeting in the ECFP-Rab27A Q78L and N133I 
point mutants (Fig.3.6, B-C), are almost certainly a result of their specific 
effects on nucleotide binding, and dynamic exchange of EGFP-Rab3A 
between granule membranes and cytosol revealed by FRAP (Fig.3.7) does 
not support the notion that the proteins aggregate. Finally, like their 
endogenous counterparts (Schluter et al., 2002; Desnos et at., 2003), both 
EGFP-Rab3A and EGFP-Rab27A were shown to inhibit secretion in hGH 
cotransfection assays (Fig.3.5), indicating that these proteins are unlikely 
to be functionally compromised, and EGFP-Rab27A has previously been 
shown to functionally replace wild-type Rab27A in a mouse ‘knock in’ 
model (Tolmachova eta!., 2004).
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If it can be concluded that the behaviour of the tagged Rab proteins is 
representative of that of the untagged proteins, it appears very likely that 
Rabs 3A and 27A are preferentially recruited to newly synthesised 
granules: the initially partial colocalisation of the exogenous Rabs with 
SGII (Fig.3.3, D-l); their stronger colocalisation over time post-transfection 
(Fig.3.3, M-R); the colocalisation between ECFP-Rab27A and EGFP- 
Rab3A and ppANF-EGFP (Fig.3.1, D-F, Fig.3.3, T-V); and the reduced 
recruitment of the mRFP-tagged Rabs to punctae in the absence of 
immature secretory granules under temperature-block (Fig.3.4, B-C) all 
suggest this. One explanation of this finding would be a model in which 
granules possess saturable binding sites for Rabs and in which 
endogenous Rab3A and Rab27A block the association between 
exogenous Rabs and these sites by occupying them. This would be 
consistent with reports that Rab3A-binding to synaptic vesicles is 
saturable, and dependent on a proteinaceous receptor (Chou and Jahn, 
2000). The overall picture must however, be more complex, as FRAP 
experiments in this study demonstrate a more dynamic interaction between 
EGFP-Rab3A and granules than could be supported in this model.
The data from FRAP analysis showed that Rab3A, but not Rab27A can 
cycle rapidly between the granule membrane and the cytosol (Fig.3.7, Q). 
The reproducibility of the FRAP technique is demonstrated by the virtual 
superimposability of recovery profiles from two independent series of 
experiments carried out in the presence or absence of geldanamycin
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(Fig.3.9, A). While previous studies on Rab3A have only identified 
neuronal Rab3A dispersal coupled to exocytosis (Fischer von Mollard et 
al., 1991; Sakisaka etal., 2002; Star et al., 2005), they have not addressed 
the possibility that cycles of granule/vesicle association and dissociation 
occur under resting conditions: because they compared membrane and 
cytosolic levels of Rab3A by Western blotting or changes in fusion protein 
distribution, it would be impossible to identify a system of exchange at the 
point of equilibrium. Further, it is possible that the biochemical procedures 
used could have led to the rapid loss of cycling Rab3A from vesicles, or a 
rapid loss of Rab3A cycling capability, due to the dilution of cytosol through 
suspension in a large volume of buffer (Fischer von Mollard et al., 1991), 
or digitonin-permeablisation (Sakisaka et al., 2002). Indeed, other small 
GTPases, including Rab5 and Rab7 can exchange between membrane 
and cytosol (Vasudevan etal., 1998; Mochizuki et al., 2001; Presley et al., 
?002). FRAP experiments on EGFP-Rab5 exogenously expressed in CHO 
cells showed that the bleached protein on phagosomes is rapidly replaced 
with a ty2 of ~5 seconds (Vieira et al., 2003). EGFP-Rab7 expressed in 
Mel JuSo cells is replaced on endosomes and lysosomes with a fi/2 of ~52 
seconds, while 31% of the protein was found to be in an immobile fraction 
(Jordens et al., 2001). In this context, it may be the finding that Rab27A 
does not cycle once it becomes granule-associated that is surprising.
How can the preferential recruitment of Rab3A to newly synthesised 
granules be reconciled with its rapid cycling between granule membrane 
and cytosol? It may be targeted to saturable binding sites on newly
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synthesised granules and initially exchanged between the granule 
membrane and the cytosol, but over time become progressively more 
unexchangable, thus blocking any further binding of the cycling pool. 
Under this model, fluorescence recovery of EGFP-Rab3A would be 
expected to be incomplete. The EGFP-Rab3A fluorescence recovery 
profile presented here does not reach a point of maximal recovery, and so 
it is unclear whether eventual recovery is complete or incomplete. 
However, EGFP-Rab27A (Fig.3.7, Q-R) and other characterised Rab 
proteins (Jordens et al., 2001) do show such partial recovery. Furthermore, 
progressive unexchangability of Rab3A would be consistent with the 
suggested behaviour of Rab5 and Rab9 (Zerial and McBride, 2001; 
Ganley et al., 2004; Grosshans et al., 2006). It is suggested that these 
Rabs can become segregated to stable multimolecular ‘Rab domains’, and 
that these domains are resistant to disassembly because of positive 
feedback activation via RabGEF.
The above model could explain the observed difference between EGFP- 
Rab3A and EGFP-Rab27A dynamics in that it would suggest that Rab27A 
becomes unexchangable much more readily than Rab3A. However, the 
model would also predict that EGFP-Rab3A recovery after bleaching 
should become progressively more partial with time post-transfection, as 
older granules carrying more stably associated protein make up an 
increasingly greater component or the protein that is bleached. This effect 
was not seen in FRAP experiments conducted in this study. In fact, in 
experiments carried out 30 hours and 54 hours -  as opposed to 18 hours -
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post transfection, proportionate fluorescence recovery was unchanged or 
slightly increased (Fig.3.8, I), and the rate of recovery was slightly more 
rapid (Fig.3.8, J). These results should be treated with a degree of caution 
since multiple relevant factors could change with time. For example, the 
proportion of tightly granule-associated Rab might increase with time, but 
so might the proportion of cytosolic Rab. Nevertheless, they might lead to 
an alternative model in which the Rab3A binding capacity of older granules 
is lower than that of newer granules. Under this model, the observed 
change in EGFP-Rab3A dynamics with time could be explained if a small 
fraction of the total cellular Rab exchanging between cytosol and older 
granules is removed from them, and therefore replaced, more rapidly.
On consideration, the above two models are not mutually exclusive. As 
granules age, a fraction of the cycling Rab protein may become 
unexchangable, while the capacity of the granule to bind additional Rab for 
any length of time may be gradually lost. This ‘combined’ model would be 
consistent with data presented here, as well as findings showing that GDP- 
bound but not GTP-bound Rab proteins are susceptible to GDI-mediated 
extraction from membranes (Chou and Jahn, 2000), and those showing 
that RabGEFs required to catalyse exchange of GDP for GTP on 
membrane-bound Rabs and ‘activate’ them, may become incorporated into 
stable multimolecular ‘Rab domains’ (Zerial and McBride, 2001). Together, 
these data suggest a system in which, as secretory granules age, ‘Rab3A 
domains’ may form and sequester Rab3GEF, thus lowering the capacity of 
the remainder of the granule membrane to ‘activate’ additional Rab. This
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would increase that Rab’s susceptibility to GDI-extraction and thereby limit 
the amount of time for which this additional protein remains membrane- 
associated. See diagram below.
Figure 3.11. Model for accelerated Rab3A extraction from secretory granules with Increasing 
granule age. On new granules, GDP-bound Rab protein complexed with GDP dissociation inhibitor 
(GDI) Is displaced by a granular receptor (R), with GDI displacement factor (GDF) activity. The 
GDP-Rab may be activated through interaction with a GDP-GTP exchange factor (GEF), or 
extracted from the membrane by a GDI. GTP-bound Rab protein may bind effectors, or be 
inactivated through interaction with a GTPase activating protein (GAP). On older granules, GTP- 
bound Rab protein may sequester GEF protein in a stable ‘Rab domain’, so that additional GDP- 
Rab protein delivered to the granule membrane Is less likely to be activated, and more likely to 
undergo GDI-dependent extraction. Figs. 3.1-4 suggest preferential recruitment of Rab3A to newly 
synthesised granules, Figs. 3.7-8 suggest increasingly dynamically associated component to 
granular Rab3A, Fig. 3.10 suggests stably associated component to granular Rab3A.
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What is the mechanistic basis for the observed difference between
Rab27A and Rab3A dynamics? According to the above model, one 
suggestion would be that Rab27A could become more rapidly 
unexchangable as a result of its incorporation into ‘Rab domains’. More 
simply though, it might become unexchangable as a result of a larger 
proportion of the protein maintaining a prolonged GTP-bound state on 
secretory granules. In agreement with this suggestion, the membrane- 
associated protein is predominantly GTP-bound in unstimulated platelets 
(Kondo et al., 2006), while membrane-associated Rab3A in PC12 cells is 
only ~50% GTP-bound (Burstein et al., 1993). A factor in producing this 
difference may be the intrinsic GTP hydrolysis rate of Rab27A, which has 
been found to be much lower than that of Rab3A and Rab5A in vitro 
(0.0058min'1 compared to 0.082 min"1 and 0.164 min'1 
respectively)(Larijani et al., 2003). However, this low intrinsic GTPase 
activity cannot entirely account for the relative unexchangability of 
Rab27A, since Rab7, which has a comparable GTP hydrolysis rate of 
0.0023mm"1 (Shapiro et al., 1993), retains the capacity to cycle between 
membrane and cytosol (Jordens etal., 2001).
Other factors that might impact on the membrane-bound state of Rab27A 
include the relative accessibility and activity of regulatory GEF and GAP 
proteins on the granule membrane, the effects of any interaction between 
the Rab protein and its effectors, the susceptibility of the GDP-bound Rab 
to extraction from the membrane, and, as previously stated, the 
incorporation of the GTP-bound Rab into ‘Rab domains’. One recent
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finding that might speculatively provide a mechanism for the relative 
stability of Rab27A membrane-association comes from a structural study 
on the related protein Rab27B (Chavas et al., 2007). When crystallised in 
its GDP-bound form, this protein was found to form a ‘swapped dimer’ in 
which switch I and II regions are suggested to be stabilised (Chavas et al., 
2007). Although this dimer was not identified in vitro in solution, it is 
plausible that its formation on membranes in vivo might shield Rab27B 
from GDIs. Rab9A and Rab11A are also shown to dimerise when 
crystallised, and their dimérisation is suggested to confer protection from 
membrane-extraction (Pasqualato et al., 2004; Wittmann and Rudolph, 
2004). Consistent with the suggestion that Rab27A may be protected in a 
similar way, GDP-Rab27A is found to remain associated with secretory 
granule membranes following stimulation of platelets (Kondo et al., 2006).
In this study, the ‘constitutively active’ Q78L mutant of ECFP-Rab27A, 
which is likely to possess reduced GTPase activity, was found to be largely 
cytosolic (Fig.3.6, B). In a context in which GTP-bound Rab proteins are 
retained on membranes (see above), this finding is surprising. However, 
several explanations are possible. Nascent Rab27A is suggested to exist 
in a largely GTP-bound state, and this may contribute to its less efficient 
REP/GGTase-mediated geranylgeranylation when compared to other Rab 
proteins since both REPs and GGTases bind GDP-bound Rabs 
preferentially (Seabra et al., 1995; Seabra, 1996; Larijani et al., 2003). If 
the Q78L mutation increased the proportion of GTP-bound Rab27A still 
further, this might affect its post-translational modification and thereby its
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ability to associate with granule membranes. Another explanation of the 
mutant’s localisation might be that the mutation affects its regulation. The 
Rab3A Q81L mutant - which is analogous to the Rab27 Q78L mutant -  is 
present, in PC12 cells, in a GTP-bound form, only to a similar extent to the 
wild-type protein despite its reduced GTPase activity (Brondyk et al., 
1993). It was discovered that this was because the mutant was sensitive to 
Rab3GAP, while insensitive to Rab3GEF. Speculatively, if the Q78L 
mutation were to have a similar effect on Rab27A, the resulting change in 
the protein’s nucleotide-binding dynamics might reduce its activation on 
granules and/or enhance its extraction. Further, a reduction in its 
sensitivity to Rab27GEF might be expected to selectively disrupt any ‘Rab 
domains’, as a stable GEF-Rab association, and ‘positive activation loop’, 
is thought to underlie their formation (Grosshans et al., 2006). On the other 
hand, should wild-type GDP-Rab27A become resistant to GDI-mediated 
extraction from membranes in vivo through dimerisation, the Q78L mutant 
might be more readily extracted if the mutation prevents stable formation of 
the dimer.
Despite the presence on secretory granules of a proportionately smaller 
component of the expressed mutant (Fig.3.6, B), ECFP-Rab27A Q78L was 
found to inhibit secretion in an hGH cotransfection assay to a similar 
degree to the unmutated protein (Fig.3.6, G). Since that inhibition was 
found to be concentration dependent (Fig.3.5, B), it is possible that the 
mutant was simply more highly expressed, although this is unlikely since 
expression levels of analogous Q81L and wild-type Rab3A in PC12 cells is
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found to be indistinguishable by flow cytometry (Holz etal., 1994). It seems 
more likely that the mutant protein produced a more potent inhibitory effect 
than the wild type. In the light of possible explanations for the mutant’s 
cytosolic localisation (see above), this finding would be open to conflicting 
interpretations. If a smaller proportion of the mutant protein was recruited 
to granules as a result of reduced post-translational modification, then its 
inhibitory effect may relate to increased interaction of the minimal amount 
of successfully modified and ‘constitutively active’ protein on the granule 
membrane with its effectors. It might also relate to a ‘dominant-negative’ 
effect should unsuccessfully modified, ‘constitutively active’, protein in the 
cytosol bind and sequester effectors due to a reduced ability to bind GDIs. 
If a smaller proportion of the mutant protein was recruited to granules as a 
result of altered regulation of its nucleotide-binding on the granule 
membrane, then its inhibitory effect might reflect an increased transience 
in its interactions with its effectors, perhaps as a result of the disruption of 
‘Rab domains’ or dimers. This would be an interesting possibility, as it 
would imply that for Rab27A, these domains/dimers act to moderate the 
protein’s inhibitory function.
One identified mechanism of rab3A extraction, is that following stimulation 
of synaptosomes, and involving ATP hydrolysis via an Hsp90-containing 
complex (Sakisaka et a!., 2002). Hsp90 inhibition by geldanamycin in this 
system led to reduced Rab3A extraction, and reduced exocytosis. 
However, it was found here, that the maximal concentration of inhibitor 
used in that study had no effect on ‘resting’ Rab3A cycling in PC12 cells as
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identified by FRAP, nor did it affect secretion (Fig.3.9). While it is formally 
possible that a higher concentration of inhibitor may have revealed some 
involvement of HSP90, it was sufficiently high to inhibit dexamethasone- 
induced nuclear translocation of GCR-EGFP (Fig.3.9, C-D), and such a 
concentration may also have produced undesired non-specific effects such 
as inhibition of kinase-regulated cascades (Richter et al., 2001; Young et 
al., 2001).
One interpretation of the above data is that the mechanism for membrane- 
extraction of Rab3A differs between PC12 cells and neurons. However, 
Chen and Balch (Chen and Balch, 2006) reported that an Hsp90- 
dependent mechanism of Rab extraction operates on other Rab subtypes 
and in various cell types, making this interpretation unlikely. Another 
interpretation is that separate mechanisms exist for Rab extraction during 
‘resting’ cycling and for extraction following fusion between a donor 
membrane compartment and its target membrane. Under this 
interpretation the Hsp90-dependent mechanism would only control Rab3A 
extraction following exocytosis. This may be a plausible suggestion, if it is 
considered that removal of the Rab during ‘resting’ cycling may involve the 
removal of the Rab alone, whereas removal of the Rab at the target 
membrane may require the active disassembly of Rab-containing 
complexes. While the mechanism for the ‘resting’ cycling of Rab3A 
remains obscure, this suggestion would strengthen the argument that 
some proportion of granular Rab3A could form a component of a stable 
structure such as a ‘Rab domain’. By analogy, it might also offer some
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explanation for the retention of GDP-Rab27A on granules in stimulated 
platelets (Kondo et al., 2006): the disassembly of stable Rab27A- 
containing complexes might require more than GTP-hydrolysis .
The lack of a detectable effect of geldanamycin on secretion from PC12 
cells (Fig.3.9, B) suggests that HSP90-mediated dissociation of Rab3A 
and Rab27A from membranes is not an integral aspect of the exocytotic 
process in this cell type. What is the explanation of this finding given that 
the same compound potently inhibits exocytosis from synaptosomes 
(Sakisaka et al., 2002)? One characterised difference between neuronal 
and neuroendocrine exocytosis, is the rapid recycling and refilling of 
synaptic vesicles in presynaptic terminals (Fernandez-Alfonso and Ryan, 
2006). Is it possible that rapid HSP90-dependent recycling of Rab3A, and 
the resulting increase in cytosolic GDI-bound GDP-Rab3A enhances its 
recruitment to these newly recycled vesicles? Neuronal exocytosis has 
been long suggested to be coupled to rapid Rab3 dispersal (Fischer von 
Mollard et al., 1991; Sakisaka et al., 2002; Star et al., 2005), and it may be 
that the rapidity of the process reflects a functionally important 
specialisation of this cell type rather than a mechanism conserved in all 
cells. In PC12 cells, dispersal of Rab3A is unlikely to so dramatically affect 
its cytosolic concentration, and in this study, no evidence was found that 
granule-associated Rab3A and Rab27A disperse when these cells were 
stimulated (Fig.3.10). Further, evidence has been provided for very rapid 
retrieval of secretory granules following exocytosis (Graham et al., 2002; 
Flolroyd et al., 2002), and it is therefore possible that Rab3A and Rab27A
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remain in stable complexes in order to be retrieved as part of this divergent 
process.
It should be noted, that recent work by another group, utilizing total internal 
reflection microscopy (TIRFM), has identified some dispersal of EGFP- 
Rab3A following exocytosis of secretory granules from PC12 cells (Lin et 
al., 2007). In cells expressing the secretory granule content marker 
neuropeptide Y-EGFP (NPY-EGFP), -56% of NPY-EGFP-containing 
secretory granules visible within an evanescent field very close to the cells’ 
plasma membranes were seen to disappear within 20 seconds of 
stimulation. While a similar decrease in NPY-EGFP fluorescence was seen 
in control cells and cells cotransfected with Rab3A, dispersal of EGFP- 
Rab3A on stimulation of EGFP-Rab3A-transfected cells was associated 
with only ~4% of labeled granules. These data do not necessarily conflict 
with the data presented and discussed above, if it is concluded that the 
high resolution of the TIRFM-based assay identified EGFP-Rab3A 
dispersal from only a small proportion of exocytotic sites.
Recent work by Schluter et al. has improved understanding of the function 
of Rab3A in synaptic exocytosis and suggested that Rab3A boosts the 
release probability of a subset of the vesicles of the readily releasable pool 
(Schluter et al., 2004). This finding presents the question as to how 
Rab3A, which is present on all vesicles, can regulate the properties of only 
some. It may be relevant that in chromaffin cells, one factor regulating the 
release probability of secretory granules is granule age, with newly
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synthesised granules reportedly released in preference to older granules 
(Duncan et at., 2003). The molecular basis for this difference between 
populations of synaptic vesicles and between old and new granules is 
unknown. However, since we describe data suggesting that Rab3A 
dynamics in PC12 cells change as granules age, it is an intriguing 
possibility that a cycling pool of Rab3A in neurones and in neuroendocrine 
cells is a functionally important determinant of both phenomena. In the 
context of the whole cell then, cycles of Rab3A membrane association and 
dissociation may firstly ensure the correct targeting of the protein, and 
secondly, functionally segregate target organelles according to their age, 
expanding the range of exocytotic responses that they can mediate.
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Chapter 4:
Rab effectors in neuroendocrine 
exocytosis
4.1 Introduction
Rab proteins are thought to associate with specific membrane 
compartments and to regulate the functionally diverse, and functionally 
discrete, multimolecular systems that control various aspects of membrane 
trafficking (Zerial and McBride, 2001). A given Rab protein may regulate 
one or several processes that are important for a specific membrane 
trafficking step, while the basis for such regulation is thought to be 
interactions between Rabs proteins and effector proteins (Takai et al., 
2001; Fukuda, 2005). It is thought that the multiplicity of functions that 
some Rab proteins exhibit reflects their interaction with multiple effectors 
(Fukuda, 2005). For example, it is thought that interactions between 
Rab3A and Synapsins may be important for coordinating interactions 
between synaptic vesicles and the synaptic cytoskeleton, while its 
interactions with Rab-interacting molecule (RIM) proteins may be important 
for coordinating interactions between vesicles and presynaptic active 
zones (Giovedi et al., 2004a; Giovedi et al., 2004b; Kaeser and Sudhof, 
2005). As well as interacting with different effectors within the same cell, a 
given Rab protein may interact with different effectors in different cell types 
reflecting specialisation of a given trafficking step according to cellular 
needs. For example, in melanocytes, Rab27A links melanosomes to the 
motor protein Myosin Va via its effector Melanophilin (Wu et al., 2002), 
while in PC12 cells it links secretory granules to Myosin Vila via its effector 
MyRIP (Desnos et al., 2003).
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Rab proteins are often required for the recruitment of their effectors to a 
specific membrane compartment, and are likely to be involved in the 
spatio-temporal control of their activity. In support of this, it is found that 
most Rab-effector interactions are regulated by the nucleotide-bound state 
of the Rab, and that many, but not all effectors, bind exclusively to GTP- 
bound Rab protein (Fukuda, 2005). However, until now, few studies have 
focused on the dynamics of Rab effectors involved in regulated secretion. 
On the basis that experiments conducted earlier in this study had 
successfully characterised aspects of the recruitment and dynamics of 
Rab3A and Rab27A in PC12 cells, it was decided to widen the scope of 
the investigation to include selected effectors of these proteins.
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4.2 Results
4.2.1 Localisation of exocytotic Rab effectors
In order to study the recruitment and dynamics of Rab protein effectors 
that associate with secretory granules, it was decided to apply some of the 
same techniques previously used in the characterisation of Rab3A and 
Rab27A. To generate vectors for the exogenous expression of wild type or 
fluorescently tagged effector proteins in PC12 cells, coding sequences for 
Rabphilin, Granuphilin and Slp-5 were amplified from a PC12 cell cDNA 
library. Amplification of these sequences from a cDNA library produced 
from the PC12 cells used in this laboratory demonstrates the transcription 
of mRNAs encoding these effector proteins in these cells. The coding 
sequence for Noc2, another Rab effector, was available following previous 
work (Haynes et al., 2001), and was kindly provided by L. Haynes. 
Transcription of Noc2 in PC12 cells has been identified by another group 
through the use of Northern Blot analysis (Kotake et al., 1997).
Vectors encoding EGFP-tagged Rab effectors were transfected into PC12 
cells in order to determine the localisation of these proteins (Fig.4.1). 
Rabphilin-EGFP, EGFP-Rabphilin, and Noc2-EGFP (Fig.4.1, A-B and G 
respectively) were found to localise to punctate structures distributed 
throughout the cytosol and at the periphery of cells. This pattern was like 
that of EGFP-Rab3A and EGFP-Rab27A described in the previous chapter 
(Fig.3.3), and was consistent with the reported association of the effectors 
with secretory granules (Chung et al., 1999; Cheviet et al., 2004a; Fukuda
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Figure 4.1. Expression of EGFP-tagged exocytotic Rab effectors in PC12 cells. (A-G) Cells were 
fixed 18 hours following transfection with a plasmid encoding the indicated fusion protein. Bars, 
4 p.m.
et al., 2004). Granuphilin-EGFP was also found associated with punctate 
structures, although these structures were largely present at the periphery 
of cells (Fig.4.1, C). This is consistent with findings showing that 
Granuphilin promotes granule tethering/docking in PC12 cells as gauged 
by TIRFM (Tsuboi and Fukuda, 2006b), and those showing that
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overexpressed HA-tagged Granuphilin, in the pancreatic p-cell-derived 
Min6 cell line, associates with peripheral granules and promotes granule 
targeting to the plasma membrane (Torii et al., 2002; Torii et al., 2004; 
Gomi et al., 2005). While N-terminally tagged mRFP-Granuphilin 
expressed in PC12 cells in another study appears to be granule- 
associated (Tsuboi and Fukuda, 2006b), it was found here that N- 
terminally tagged EGFP-Granuphilin was largely cytosolic (Fig.4.1, D), 
presumably because the fluorescent tag disrupted the normal function of 
the protein. Both Slp-5-EGFP and EGFP-Slp-5 were found to show a 
peripheral localisation, while in this case no punctae were evident. As Slp- 
5 has previously been reported to bind strongly to Rab27A, and to 
colocalise with secretory granules (Tsuboi and Fukuda, 2006b), it is likely 
that the EGFP-tagging of the protein led to its mislocalisation.
To further characterise the localisation of the effector proteins, PC12 cells 
were cotransfected with EGFP-tagged effector, and either mRFP-Rab3A or 
mRFP-Rab27A (Fig.4.2). While Rabphilin-EGFP and EGFP-Rabphilin 
showed similar localisation, N-terminally tagged Rabphilin has been used 
in previous studies (McKiernan et al., 1996; Tsuboi and Fukuda, 2005; 
Tsuboi et al., 2007) and so EGFP-Rabphilin was used in these 
experiments. Granuphilin-EGFP was used in preference to EGFP- 
Granuphilin since the latter protein appeared to mislocalise. Fluorescently 
tagged Slp-5 was not used. Both EGFP-Rabphilin (Fig.4.2, A-C, J-L) and 
Noc2-EGFP (Fig.4.2, G-l, P-R) were each found to colocalise very strongly 
with both of the mRFP-tagged Rab proteins. This is consistent with the
148
-4|'t -■
:%T
EG FP-Rabphilin
f  M  »
1 ' T  
%
v . _
G ranuphilin -EG FP
m R FP-R ab3A Overlay
.* » .  * v .
t> : "v
V  S
N oc2-EG FP
EG FP-Rabphilin
m R FP-R ab3A
m R FP-R ab27A
Overlay
■ \
G ranuphilin -EG FP I  m R FP-R ab27A
& ic
■ M W  mt<*S
m R FP-R ab27A Overlay
149
Figure 4.2. Colocalisation between EGFP-tagged exocytotic Rab effectors and mRFP-tagged Rab 
proteins in PC12 cells. Cells were cotransfected with EGFP-Rabphllin (A-C, J-L), Granuphilin-EGFP 
(D-F, M-O) or Noc2-EGFP (G-l, P-R) and either mRFP-Rab3A (A-l), or mRFP-Rab27A (J-R), and 
fixed 18 hours following transfection. Each overlay Image on the right of the figure is a composite of 
green from the left image and red from the centre Image. Areas of overlap appear in yellow. Bars, 
4p.m.
suggestion that these effectors localise to secretory granules, while it may 
also indicate that they, like the tagged Rab proteins, are preferentially 
recruited to newly synthesised granules. However, it is also possible that 
since the Rab proteins were overexpressed, effector recruitment to newer 
granules resulted from an increase in the levels of the Rab proteins on 
these granules and thereby an increase in the number of effector 
recruitment sites. Granuphilin-EGFP showed more limited colocalisation 
with the tagged Rabs, largely confined to perinuclear regions, and to 
punctae at the periphery of cells (Fig.4.2, D-F, M-O). There was some 
indication that coexpression of the Granuphilin construct led to the partial 
redistribution of mRFP-Rab protein-labeled punctae towards a more 
peripheral localisation (compare Fig.4.2, E with B and H, and N with K and 
Q). There was also some indication that mRFP-Rab coexpression caused 
redistribution of some Granuphilin-EGFP to a perinuclear region (compare 
Fig.4.2, E and N, with Fig.4.1, C). Thus, it appears that Granuphilin-EGFP, 
and the mRFP-tagged Rab constructs, label overlapping populations of 
secretory granules, while the Granuphilin may promote targeting of 
granules to the plasma membrane in PC12 cells as previously reported 
(Tsuboi and Fukuda, 2006b). This behaviour may reflect the capacity of 
Granuphilin to bind to Syntaxin and Munc18 proteins (Coppola et al., 2002; 
Torii et al., 2002; Torii et al., 2004; Fukuda et al., 2005; Tsuboi and 
Fukuda, 2006b) and/or phosphatidylinositol (4,5)bisphosphate (PIP2)
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(Osborne et al., 2007), each of which are enriched at the plasma 
membrane.
4.2.2 Rab effector function
The overexpression of Rabphilin, Granuphilin, Slp5 or Noc2 has been 
previously linked to differing effects on regulated exocytosis. 
Overexpression of Rabphilin in adrenal chromaffin cells is found to 
enhance nicotinic AChR agonist-stimulated (DMPP-stimulated) secretion 
of cotransfected hGH (Chung et al., 1995). Its overexpression in PC12 
cells is reported to produce no effect on cotransfected hGH release in 
response to high-K+-stimulation (Komuro et al., 1996), although it is also 
reported to increase high-K+-stimulated release events associated with 
cotransfected neuropeptide-Y-Venus (NPY-Venus) (Tsuboi and Fukuda, 
2005). In contrast, overexpression of Granuphilin is found to inhibit high- 
K+-stimulated secretion of endogenous insulin from Min6 cells (Torii et al., 
2002) and high-K+-stimulated secretion of cotransfected NPY from PC12 
cells (Fukuda et al., 2002; Fukuda, 2003b). Slp5 or Noc2 overexpression 
in PC12 cells was reported to enhance high-K+-stimulated secretion of 
cotransfected NPY (Fukuda, 2003b; Fukuda et al., 2004), while Noc2 
overexpression was also found to inhibit cotransfected hGH release from 
permeablised PC12 cells in response to Ca2+ (Haynes et al., 2001), and 
from INS-1 E cells in response to multiple secretagogues (Cheviet et al., 
2004a).
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In the light of the above, sometimes conflicting, data, it was necessary to 
characterise the effects of effector overexpression on secretion as 
determined by the assay used in this laboratory. As for analysis of the 
effects of Rab overexpression (see Chapter 3), PC12 cells were 
cotransfected with test and hGH-expression vectors, and 48 hours after 
transfection, hGH secretion in response to 300pM ATP was assayed and 
compared to that from unstimulated cells. ATP-stimulation produces a 
secretory response because it activates purinergic receptors leading to 
calcium influx (Kim and Rabin, 1994). It was used here in preference to 
high-K+-stimulation, as it is a more effective secretogouge in PC12 cells. 
Stimulation through application of Ca2+ to permeablised cells was not used 
because cell permeablisation could lead to the loss of cytosolic Rabs, 
effectors, or other factors involved in their function.
pcDNA3.1 vectors encoding untagged effector protein were used in each 
cotransfection experiment in order that the effects of their overexpression 
could not be attributed to the presence of a fluorescent tag. 0.5jag of each 
vector was used per transfection, because transfection with this amount of 
the EGFP-effector-encoding constructs (see previous section) had been 
found to minimise the number of cells displaying aberrant morphology as a 
result of excessive expression of exogenous protein. Expression from 
these constructs, and from the pcDNA3.1 -derived constructs, is driven by 
an identical cytomegalovirus (CMV) promoter. Overexpression of wild type 
Rabphilin, Granuphilin or Slp5 in these experiments was found to produce 
little or no effect on ATP-stimulated hGH secretion, although there was
152
p E G F P -N 1  N oc2  p c D N A  N o c2  p c D N A  N o c2  p c D N A
(0.5|jg) (o.5|jg) (0.1 gg) (0.05Mg>
Xo
JO
3o
100
60
40
20
0
Figure 4.3. Exogenous Rab effectors affect secretion of exogenous hGH. Secretion of exogenous 
human growth hormone (hGH) from cells cotransfected with plasmids encoding Rabphilin, 
Granuphilin or Slp5 (A) or varying levels of a plasmid encoding Noc2 (B), 48 hours before 
stimulation was assayed. Stimulated cells were exposed to 300 piM ATP, hGH release over 15 
minutes was assayed and expressed as a percentage of total hGH (shown to the right of the figure). 
Data are expressed as mean ± s.e.m. (n=6)
some indication that Rabphilin enhanced basal secretion (Fig.4.3, A ). In 
contrast, overexpression of Noc2 (0.5pg/well) produced a marked 
inhibitory effect (Fig.4.3, B). While it was not demonstrated that each 
construct was equally well expressed, it appears from these data that 
Noc2 has a significant role in secretory granule exocytosis as an inhibitory 
Rab effector.
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Because Noc2 overexpression produced a consistent inhibitory effect on 
secretion, it was possible to determine the functional effects of mutations 
in the protein that reduce or abolish its interaction with Rab proteins. 
Previous work on the structure of a Rab3A-Rabphilin complex showed that 
two adjacent sites on Rabphilin were important for their interaction 
(Ostermeier and Brunger, 1999) and that a mutation in one of these sites, 
V61A, could attenuate this interaction in vitro (Joberty, 1999). Later work in 
this laboratory showed that an analogous, V58A, mutation in Noc2, which 
shares homology to Rabphilin in this region, could also attenuate an in 
vitro interaction with Rab3A, while mutation of residues in the area 
analogous to the second site, by which a SGAWFY structural element was 
changed to SGAAAA (W154A, F155A, Y156A), could abolish it (Haynes et 
a!., 2001). It was then found that while wild type Noc2 and the Noc2(V58A) 
mutant interacted comparably with Rab27A, the ‘Noc2(AAA)’ mutations 
abolished this interaction as well (Cheviet et al., 2004a).
Before determining the effects of the above mutations on the inhibitory 
action of Noc2 on secretion, Noc2, Noc2(V58A) and Noc2(AAA) cDNAs 
were subcloned into pEYFP-N1 expression vectors in order that 
fluorescence microscopy could be used to identify whether the mutations 
affected protein localisation. Cells were cotransfected with each of these 
constructs and ECFP-Rab27A, as a marker for secretory granules. It was 
found that Noc2-EYFP and Noc2(V58A)-EYFP colocalised strongly with 
ECFP-Rab27A, while Noc2(AAA)-EYFP adopted a more diffuse cytosolic 
localisation (Fig.4.4, A-l). However, as in previous experiments with the
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Figure 4.4. Effects of Noc2 V58A and SGAWFY->SGAAA mutation. (A-l) Cells were fixed 18 hours 
after cotransfection with plasmids encoding ECFP-Rab27, and Noc2-EYFP, Noc2(V58A)-EYFP or 
Noc2(AAA)-EYFP as indicated. Each overlay Image on the right of the figure is a composite of 
green from the left image and red from the centre image. Areas of overlap appear In yellow. (J) 
Cells transfected with Noc2(AAA)-EYFP were exposed to a permeabllsatlon buffer containing 10pxM 
digitonln for 15minutes for the removal of free cytosolic protein prior to fixation. (K) Secretion of 
exogenous human growth hormone (hGH) from cells cotransfected with the above plasmids 48 
hours before stimulation was assayed. Stimulated cells were exposed to 300 piM ATP, hGH release 
over 15 minutes was assayed and expressed as a percentage of total hGH (shown to the right of 
the figure). Data are expressed as mean ± s.e.m. (n=6). Bars, 4|am.
Rab27A mutants (see Fig.3.6, D-F), removal of cytosolic protein from cells 
through digitonin permeablisation prior to fixation, revealed a that small 
component of the Noc2(AAA)-EYFP was associated with punctae likely to 
be secretory granules (Fig.4.4, J). When the constructs were used in hGFI 
cotransfection experiments, it was found that Noc2-EYFP inhibited hGH 
secretion in a manner comparable to wild type Noc2 (compare Fig.4.3, B 
and Fig.4.4, K), indicating that its fluorescent tag was unlikely to have 
affected its physiological activity. Cotransfection of Noc2(V58A)-EYFP 
produced a more moderate inhibitory effect, while Noc2(AAA)-EYFP, 
produced a smaller effect still. Together, these data are consistent with 
previous work suggesting that interaction with Rab proteins is critical for 
Noc2 function, and may support the suggestion that Noc2 is recruited to 
secretory vesicles via Rab27A rather than by Rab3A (Haynes et a/., 2001; 
Cheviet et al., 2004a; Fukuda et a!., 2004).
4.2.3 Rab effector dynamics
As previously discussed, it is thought that many Rab effectors, including 
Rabphilin, Granuphilin and Noc2, are recruited to secretory granule 
membranes through their interaction with Rab proteins (Stahl et al., 1996; 
Fukuda, 2003b; Fukuda et al., 2004). In support of this suggestion, it is
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found that mutations in these effectors that abolish their capacity to bind to 
Rab proteins, also markedly reduce that recruitment (Cheviet et al., 2004a; 
Fukuda et al., 2004). It was found here previously using FRAP 
experiments that the Rab proteins Rab3A and Rab27A show respectively 
dynamic and sustained interaction with secretory granules (Flandley et al., 
2007). It was therefore decided to expand these experiments to include the 
Rab effectors, in order to identify any similar differences.
PC12 cells were transfected with vectors encoding the EGFP-tagged 
effectors. As before, 18 hours following transfection, cells expressing 
moderate levels of fluorescent protein were selected, regions of interest 
(ROIs) within these cells were bleached with high intensity laser, the 
recovery of fluorescence within these areas was recorded over time, and 
this data was then normalised with respect to total cell fluorescence to 
correct for general photobleaching. Example frames from these 
experiments are shown in Fig.4.5, A-L. Initial fluorescence in each 
experiment was normalised to 100 arbitrary fluorescence units in order that 
data from multiple bleaching experiments could be pooled. The pooled 
data for each construct is shown in Fig.4.5, M. In Fig.4.5, N, the same data 
has been normalised with respect to the first reading taken following 
bleaching. Fluorescence recovery due to diffusion of cytosolic fluorescent 
protein from unbleached regions of cells into the bleached region is likely 
to be largely complete at this point (~1.6 seconds post-bleach), and so the 
normalised data reflects recovery due to other sources. Recovery profiles 
of EGFP-Rab27A and EGFP-Rab3A are presented for comparison.
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Figure 4.5. Dynamics EGFP-tagged Rab effectors on secretory granules in PC12 cells. (A-L) PC12 
cells were transfected to express the Indicated EGFP-tagged protein and Imaged 18 hours following 
transfection. Regions of Interest (ROIs) in each cell were bleached with high intensity laser (arrows) 
and the fluorescence recovery in these areas was recorded over time, [contd. on next page]
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Figure 4.5 contd. (M) Plot of fluorescence recovery data corrected for general photobleaching and 
combined after initial fluorescence for each cell was normalised to 100. (N) Plot of fluorescence 
recovery as above but with first post-bleaching data point normalised to 0. Data shown are mean 
±s.e.m. of 18 EGFP-Rabphilin, 21 Granuphilin-EGFP and 11 Noc2-EGFP expressing cells. 
Recovery profiles of EGFP-Rab3A (red) and EGFP-Rab27A (green) are provided for comparison.
When EGFP-Rabphilin-expressing cells were bleached, fluorescence 
levels recorded in bleached regions were found to be initially reduced to a 
similar extent to those recorded where EGFP-Rab3A and EGFP-Rab27A- 
expressing cells were bleached in previous experiments. This suggests 
that similar proportions of these exogenously expressed proteins are 
present in cytosolic and granule-associated fractions within cells (Fig.4.5, 
N-M). Fluorescence recovery of EGFP-Rabphilin following bleaching was 
rapid, and was almost complete within the timeframe of experiments 
(Fig.4.5, M). Since a large component of this fluorescence recovery is 
likely to be the result of exchange between bleached, granule-associated 
protein, and unbleached protein, this data indicates that like Rab3A, 
Rabphilin associates with granules in a dynamic manner. Indeed, in gross 
terms, it appears that EGFP-Rabphilin is exchanged more rapidly between 
the cytosol and granule membranes than EGFP-Rab3A. Further, the 
extent of its recovery indicates that most, if not all of the protein, is 
continually exchanged in this way.
The large reduction in Granuphilin-EGFP fluorescence that was recorded 
following bleaching suggests that a high proportion of the expressed 
protein is granule-associated, while the slow recovery of this fluorescence 
indicates that Granuphilin can associate with granules in a relatively 
sustained manner (Fig.4.5, M). The same bleaching protocol was applied
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to Granuphilin-EGFP-transfected cells as was applied to cells transfected 
with other constructs. However, Granuphilin-EGFP bleaching data should 
not be directly compared to the other bleaching data presented here, 
because this construct labels a distinct population of peripheral secretory 
granules (Fig.4.2, D-F, J-L). Nevertheless, it may be possible to interpret 
the observed differences between the recovery profiles generated for 
Granuphilin-EGFP, and EGFP-Rab27A, which was previously suggested 
to show sustained interaction with granules (Handley et at., 2007). Where 
the first few fluorescence readings following bleaching are compared, 
there is a comparatively fast, albeit very limited, recovery of EGFP-Rab27A 
fluorescence. This may be explained, if that recovery is related to the 
movement of unbleached granules at the border of bleached regions: 
since EGFP-Rab27A-labeled granules are distributed throughout the 
cytosol, more will usually border on these regions than would Granuphilin- 
EGFP-labeled granules, which are more spatially restricted. Where later 
fluorescence recovery is compared, recovery of Granuphilin-EGFP 
fluorescence is slightly faster than that of EGFP-Rab27A. This may 
indicate that some small level of exchange of bleached Granuphilin-EGFP, 
for unbleached protein, does occur.
Where Noc2-EGFP-transfected cells were imaged prior to bleaching, it 
was noted that the protein appeared more cytosolic than in previous 
experiments (compare Fig.4.5, l-L and Fig.4.2, G, P). This may reflect the 
use of fixed cells in those previous experiments, and it might also reflect 
the use of a wider confocal plane in the bleaching experiments. In any
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case, the relatively small reduction in Noc2-EGFP fluorescence that was 
recorded following bleaching confirms the visual indication that a large 
proportion of the expressed protein is cytosolic in live cells (Fig.4.5, M). 
That fluorescence is reduced, almost certainly indicates that some of the 
protein associates with secretory granules. This protein is likely to do so in 
a sustained manner, since when fluorescence recovery not due to diffusion 
of cytosolic protein is compared, recovery profiles for Noc2-EGFP and 
EGFP-Rab27A are not significantly different (Fig.4.5, N).
Because the recovery profile of EGFP-Rabphilin indicated that the protein 
was subject to rapid exchange, it was decided to investigate the effects of 
a series of characterised Rabphilin mutations on this behavior. The 
generation of a series of mutants through site-directed mutagenesis of the 
existing EGFP-Rabphilin-encoding plasmid was attempted, and potential 
mutant plasmids were analysed by automated sequencing. A truncation 
mutant, Rabphilin(1 -206) and a SGAWFF->SGAAA mutant, 
Rabphilin(AAA) were successfully generated (Fig. 2.6, B-C). However, the 
sequencing data showed that each mutant plasmid, and the original 
EGFP-Rabphilin plasmid, carried a deletion in the region encoding the N- 
terminus so that the 20th residue, an asparagine, became a lysine, and 
residues 21-24 became absent (N20K, A21-24). While this region is not 
suggested to contribute to the protein’s interaction with Rab3A (Ostermeier 
and Brunger, 1999), future work may be required to determine whether the 
mutation affects Rabphilin dynamics. It should be noted that the 
localisation of the EGFP- Rabphilin(1 -206) mutant in initial experiments
161
A B
E G FP -R abphilin E G F P -R ab p h ilin 1206 E G F P -R ab p h ilin '
Figure 4.6. Effects of 1-206 truncation mutation and SGAWFF->SGAAAA Rabphilin mutation on 
EGFP-Rabphilin localisation in PC12 cells. (A-C) Cells were fixed 18 hours following transfection 
with a plasmid encoding the indicated fusion protein. Bars, 4p.m.
was indistinguishable from that of the full-length protein, consistent with 
the protein’s recruitment to secretory granules via the conserved N- 
terminal RBD (Fig.4.6, B)(Fukuda et al., 2004). The EGFP-Rabphilin(AAA) 
mutant was largely cytosolic, consistent with the suggested requirement for 
the SGAWFF motif in interactions with Rab proteins (Fig.4.6, C) (Fukuda et 
al., 2004).
4.2.4 Munc18-1 as a putative Rab3A effector
Effectors of Rab3A and Rab27A include members of the Synaptotagmin- 
jike protein (Sip), and Synaptotagmin-like jacking C2 domains (Slac2), 
protein families (Fukuda, 2003a, 2005). These effectors possess 
homologous Rab-interacting domains (RBDs)(Fukuda, 2005). However, 
other effectors of these Rabs are identified that do not carry such domains. 
These include the calcium-binding protein Calmodulin, which could act as 
a Rab3A effector (Park et al., 2002), and the ‘priming factor’ Munc13-4, 
which is suggested to act as a Rab27A effector (Shirakawa et al., 2004; 
Neeft et al., 2005). Recent work in this laboratory has suggested that the
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Sec1/Munc18-like (SM) protein Munc18-1 might act as a Rab3A effector, 
and could therefore be included in this group.
It is thought that there is an essential requirement for an SM protein in 
every vesicular trafficking step in cells (Jahn, 2000; Burgoyne and Morgan, 
2007). Further, it is thought that this requirement is related to the ability of 
these proteins to interact with the Syntaxin isoforms involved in each step 
(Burgoyne and Morgan, 2007). Munc18-1 is found to interact with 
Syntaxin 1A at the plasma membrane (Rickman et al., 2007). It is found to 
be essential for neurotransmission (Verhage et at., 2000), and is 
suggested to be involved in the tethering/docking of synaptic vesicles in 
neurones (Weimer et at., 2003), and that of secretory granules in 
neuroendocrine cells (Voets et at., 2001b). It is also suggested to be 
involved in the later stages of exocytosis (Fisher et at., 2001; Ciufo et at., 
2005).
A link between the function of Rab proteins and that of SM proteins was 
suggested by studies conducted in yeast, in which a point mutation in the 
SM protein S lylp was found to suppress the effects of deletion of Ypt1, a 
Rab protein involved in ER to Golgi membrane trafficking (Dascher et al., 
1991; Ossig et al., 1991). In later work in this laboratory, overexpression of 
a corresponding Munc18-1 mutant, E466K, in adrenal chromaffin cells, 
was found to increase the frequency of exocytotic events recorded 
following stimulation (Ciufo eta!., 2005).
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More recent work in this laboratory, conducted by Graham et al., 2008, has 
explored the basis for the above finding. Another mutation was introduced 
into the Munc18-1(E466K)-encoding sequence to generate a sequence 
encoding Munc18-1(E466K/R39C). In difference to the single mutant, it 
was found that overexpression of the double mutant did not enhance 
exocytotic responses in adrenal chromaffin or PC12 cells. Since the R39C 
mutation had been found to cause reduced interaction between Munc18-1 
and the ‘closed’ conformation of Syntaxin (Fisher et al., 2001; Ciufo et al., 
2005), that data suggested that this interaction was required for the 
enhancement produced by the single mutant. Pull-down experiments were 
conducted, but it was found that the binding of Syntaxin from bovine brain 
to GST-Munc18-1 (E466K), and to GST-Munc18-1 (E466K, R39C), was 
similar to that of unmutated GST-Munc18-1. On further analysis however, 
these experiments also showed that binding of Rab3A to these mutant 
proteins was increased. When direct binding assays were carried out, it 
was found that recombinant Rab3A interacted with both GST-Munc18-1, 
and GST-Munc18-1(E466K, R39C), either in the presence of GTPyS, or in 
the presence of GDP(5S (Graham etal., 2008).
Because Munc18-1(E466K) was found to interact with Rab3A from bovine 
brain lysate, it might also do so in PC12 cells. In order to examine whether 
such an interaction could affect the previously characterised dynamic 
association between Rab3A and secretory granules (Handley et al., 2007), 
a series of FRAP experiments were carried out. Cells were transfected to 
express EGFP-Rab3A alone, or to coexpress EFGP-Rab3A and Munc18-
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1(E466K). As previously, recovery of EGFP-Rab3A fluorescence in 
bleached regions was recorded over time. It was found that the recovery 
profile of EGFP-Rab3A was not significantly changed with coexpression of 
Munc18-1(E466K) (Fig.4.7, A). However, it was noted that the distribution 
of EGFP-Rab3A became more peripheral in a proportion of cells 
expressing this protein.
Previous work has implicated both Rab3A and Munc18-1 in 
tethering/docking of secretory granules to the plasma membrane (Voets et 
al., 2001b; Tsuboi and Fukuda, 2006a). The newly identified direct 
interaction between these proteins, and the genetic interaction between 
homologous proteins (Dascher et al., 1991; Ossig et al., 1991), might 
suggest that they are components of the same tethering/docking 
machinery. Indeed, it has very recently been found that enhanced 
tethering/docking seen where Rab3A is overexpressed is dependent on 
expression of Munc18-1 (van Weering et al., 2007). Given this data, the 
observations made during the imaging experiments might suggest that the 
enhancement in exocytotic responses, seen where Munc18-1(E466K) is 
overexpressed, is the result of some concomitant enhancement in the 
tethering/docking process.
In order to test the above suggestion, it was decided to assess the effects 
of overexpression of wild type and mutant Munc18s on the localisation of 
EGFP-Rab3A labeled granules in PC12 cells more quantitatively. Cells 
were transfected to coexpress a Munc18-1 protein, and EGFP-Rab3A,
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Figure 4.7. Effects of Munc18-1(E466K) coexpression on EGFP-Rab3A in PC12 cells. (A) PC12 
cells were transfected to express EGFP-Rab3A alone, or EGFP-Rab3A and Munc18-1(E466K), and 
imaged 18 hours following transfection. Regions of interest (ROIs) In each cell were bleached with 
high intensity laser and the fluorescence recovery in these areas was recorded over time. Plot 
shows fluorescence recovery data, corrected for general photobleaching, and combined after initial 
fluorescence for each cell was normalised to 100. Data shown are mean ±s.e.m. of 10 control cells 
and 7 Munc18-1(E466K)-expressing cells. (B-C) Cells were transfected to coexpress EGFP-Rab3A 
and Munc18-1 and immunostained with anti-Munc18. Cells expressing exogenous Munc18-1 are 
identifiable because of greater staining marks an untransfected cell. (D-E) For quantification of 
EGFP-Rab3A localisation, regions of interest were drawn around cell periphery and nucleus, [contd. 
on next page]
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Figure 4.7 contd. (F-l) Localisation of EGFP-Rab3A in control cells, and cells expressing high 
levels of the indicated Munc18-1 protein. (J) Quantification of the ratio of mean pixel intensity at the 
cell periphery compared to cytosol. Cells on each coversilp were selected for high or background 
levels of Munc18-1 expression. The data are mean ±s.e.m, derived from 10 cells for each condition.
fixed 18 hours following transfection, and immunostained with an antibody 
against Munc18. When these cells were visualised, immunostained cells 
overexpressing a Munc18-1 protein were clearly distinguishable from 
those expressing only endogenous Munc18, as a result of their higher 
fluorescence intensity (compare adjacent cells in Fig.4.7, B-C). Cells 
expressing low levels of EGFP-Rab3A (see Fig. 2.7, D), and either low or 
high levels of each Munc18-1, were imaged. In order to generate a 
numerical measure for the extent of peripheral localisation of EGFP-Rab3A 
in each cell, regions of interest were drawn defining peripheral, cytosolic 
and nuclear areas (see Fig.4.7, E). For each image, mean pixel intensities 
in the defined peripheral and cytosolic areas were determined, and these 
values were then expressed as a ratio. Fig.4.7, F-l, shows representative 
images of EGFP-Rab3A localisation in cells expressing high levels of the 
Munc18-1 protein indicated. Fig.4.7, J, shows the pooled data from these 
experiments. As shown, it was found that overexpression of Munc18- 
1(E466K) caused significant redistribution of EGFP-Rab3A-labeled 
granules to the periphery of cells, while the overexpression of wild type 
Munc18-1, or Munc18-1(E466K, R39C), had no effect.
In the experiments described above, it was possible that the apparent 
increase in peripheral granule numbers caused by Munc18-1(E466K) 
overexpression was dependent on the simultaneous overexpression of
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Figure 4.8. Effects of Muncl 8-1 (E466K) expression on EGFP-Rab27A, and endogenous Rab3A, in 
PC12 cells. (A-D) Localisation of EGFP-Rab27A in control cells, and cells expressing high levels of 
the Indicated Munc18-1 protein. (E) Quantification of the ratio of mean EGFP-Rab27A pixel intensity 
at the cell periphery compared to cytosol, in control cells and cells expressing the Indicated 
Muncl8-1 protein (F) Localisation of endogenous Rab3A in control cells, and cells expressing high 
levels of Muncl8-1 (E466K). (G) Quantification of the ratio of mean a-Rab3A pixel intensity at the 
cell periphery compared to cytosol, in control cells and cells expressing the indicated Muncl8-1 
protein. Cells on each coversilp were selected for high or background levels of Muncl 8-1 
expression. The data are mean ±s.e.m, derived from 10 cells for each condition.
EGFP-Rab3A. In order to address this possibility, additional experiments 
were carried out in which cells were transfected to coexpress each 
munc18-1 protein, and EGFP-Rab27A (Fig.4.8, A-E). It was found that
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overexpression of Munc18-1(E466K) caused a redistribution of EGFP- 
Rab27A-labeled granules similar to that of EGFP-Rab3A-labeled granules. 
As before, overexpression of the other Munc18-1s had no effect.
Since both EGFP-Rab3A, and EGFP-Rab27A, predominantly label 
relatively newly synthesised secretory granules (Handley et al., 2007), it 
was possible that the effects of Munc18-1(E466K) overexpression were 
selectively exerted on this granule population. This possibility was 
addressed by transfecting cells with Munc18-1(E466K), and comparing the 
distribution of endogenous Rab3A in transfected, and untransfected cells 
(Fig.4.8, F-G). No differences in granule distribution were identified in 
these experiments.
The experiments described above, in which overexpression of Munc18- 
1 (E466K) was shown to redistribute EGFP-Rab3A and EGFP-Rab27A- 
labeled secretory granules to the periphery of cells, indicate that this 
protein potentiates the tethering/docking of these granules at the plasma 
membrane. The fact that overexpression of Munc18-1(E466K, R39C) did 
not produce such redistribution, is a strong indication that direct interaction 
between Munc18-1(E466K), and the ‘closed’ conformation of Syntaxin, is 
required for this potentiation. However, elsewhere, Semliki forest virus 
(SFV)-mediated Munc18-1 overexpression has been suggested to 
increase numbers of tethered granules indirectly, through disruption of 
cortical actin (Toonen et al., 2006). The effects of Munc18-1(E466K) 
overexpression on cortical actin were therefore investigated. As previously,
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Figure 4.9. Effects of Munc18-1(E466K) expression on cortical actin in PC12 cells. (A) Phalloidin 
staining in control cells, and cells expressing high levels of Munc18-1(E466K). (B) Quantification of 
the ratio of mean phalloidin pixel intensity at the cell periphery compared to cytosol, in control cells 
and cells expressing Munc18-1(E466K). Cells on each coversilp were selected for high or 
background levels of Munc18-1 expression. The data are mean ±s.e.m, derived from 10 cells for 
each condition.
Munc18-1(E466K)-transfected cells were fixed and immunostained. 
Cortical actin was labeled with a phalloidin conjugate. No difference was 
observed in the distribution of cortical actin in transfected as compared to 
untransfected cells (Fig.4.9). This data further supports the suggestion that 
Munc18-1(E466K) participates in tethering/docking directly.
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4.3 Discussion
This chapter has described a series of experiments designed to further 
characterise the known exocytotic Rab effectors Rabphilin, Granuphilin, 
Noc2 and a novel interactor Munc18-1. In the course of these experiments, 
each effector has shown distinct properties, and so this discussion will 
focus on the possible structural basis for, and functional implications of, 
each of these differences with respect to each effector in turn.
4.3.1 Rabphilin
The findings showing that exogenous EGFP-Rabphilin localises to 
secretory granules in PC12 cells (Fig.4.2, A-C, J-L) are consistent with 
previous reports suggesting that the effector is recruited by Rab proteins 
associated with these structures (Fukuda et at, 2004). Since the 
Rabphilin(AAA)-EGFP mutant, which is unable to interact with Rab 
proteins, was found to be largely cytosolic (Fig.4.6, C), it is unlikely that 
other interactions, such as that with the phospholipid phosphatidylserine 
(PS)(Yamaguchi et al., 1993; Montaville et at, 2007), are sufficient to 
mediate such recruitment. It has been suggested that Rabphilin interacts 
physiologically with both Rab3 and Rab27 isoforms (Fukuda et at, 2004; 
Deak et at, 2006). Because a 5-1 Ox stronger interaction is seen with 
Rab27A, than with Rab3A in vitro, it is thought that Rabphilin preferentially 
interacts with Rab27A in PC12 cells, which express both Rabs (Fukuda et 
at, 2004). It is therefore surprising that like EGFP-Rab3A, but in contrast 
to EGFP-Rab27A (Fig.3.7), EGFP-Rabphilin was shown by FRAP
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experiments to associate with secretory granules in a dynamic manner 
(Fig.4.5, M). In fact, the recovery profile of EGFP-Rabphilin indicates that 
the rate of its exchange between cytosolic and granular localisations was 
even faster than that of EGFP-Rab3A. Further, recovery was virtually 
complete, indicating that most, if not all, of the cellular compliment of the 
protein was subject to this exchange.
One possible explanation for a dynamic interaction between EGFP- 
Rabphilin and granular Rab proteins might be that the effector has a 
relatively low binding affinity for these Rabs, and so is susceptible to 
continual displacement by other effectors. Indeed, a previous study has 
suggested that the differing affinities of the Rab27A effectors Slp2a and 
Melanophilin for this Rab are important for their sequential binding, and 
their sequential function in melanosome transport (Fukuda, 2006). 
However, in this case, this explanation is unlikely, since Rabphilin has 
been shown to bind to Rab27A with very high affinity, and with higher 
affinity than either Granuphilin or Noc2, which were shown here to exhibit 
a sustained interaction with granules (Fukuda, 2006)(Fig.4.5, M-N). The 
FRAP data presented here might support the suggestion that the 
interaction between Rab27A and Rabphilin is stronger than that between 
Rab27A and Noc2 in vivo, since EGFP-Rabphilin fluorescence 
immediately following bleaching is much lower than Noc2-EGFP 
fluorescence indicating that a larger proportion of expressed EGFP- 
Rabphilin is granule-associated (Fig.4.5, M-N). While it also appears from 
the FRAP data that an even larger proportion of expressed Granuphilin-
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EGFP is granule-associated, it is possible that this finding is not solely 
related to the affinity of Granuphilin for Rab27A (see 4.3.2 ‘Granuphilin’ 
below).
Since Rabphilin is known to bind only GTP-bound Rab protein (Stahl et a!., 
1996; Fukuda et al., 2004), it is possible that its disassociation from Rab 
proteins is coupled to their hydrolysis of bound GTP. In support of this 
hypothesis, antibodies against Rabphilin can coimmunoprecipitate Rab3A 
and Rab27A from PC12 cell extracts in the presence of GTPyS, indicating 
that interaction between Rabphilin and the ‘active’ forms of these proteins 
must be relatively stable (Fukuda et al., 2004). Further, while the effects of 
Rabphilin on the intrinsic GTPase activity of Rab27A are unknown, it is 
notable that the protein has been reported to show a weak GAP activity 
towards Rab3A in vitro (Kishida et al., 1993). Thus, binding of Rabphilin to 
a GTP-bound Rab protein might potentiate GTP hydrolysis and the 
effector’s subsequent dissociation from the resulting GDP-Rab; Rabphilin 
might mediate its own rapid association and dissociation from granules. 
While the RBD1 domain of Noc2 or Granuphilin, which do not show such 
rapid association and dissociation, is found to be sufficient for interaction 
with GTP-Rab27A, Rabphilin requires its RBD1 and RBD2 domains as well 
as an intervening cysteine-rich region for this interaction (Fukuda, 2003b; 
Fukuda et al., 2004). Speculatively, this requirement might be linked to the 
structural basis for a GAP activity not identified in the other effectors.
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Whatever the reason for the transience of the Rab-Rabphilin interaction, its 
possible functional importance should be considered. Rabphilin has been 
variously suggested to function through binding to factors including (3- 
adducin, GTP cyclohydrolase I, Rabaptin5 and AnnexinA4 (Imazumi et at., 
1994; Miyazaki et at., 1994; Ohya et at., 1998; Willshaw et at., 2004). 
However, most interest has surrounded its identified interactions with the 
SNARE protein SNAP-25, and the actin-bundling protein a-actinin (Kato et 
at., 1996; Baldini et at., 2005; Tsuboi and Fukuda, 2005; Deak eta!., 2006; 
Tsuboi et at., 2007).
Binding of Rabphilin to SNAP-25 has been suggested to enhance 
tethering/docking and increase fusion events in response to stimulation 
(Tsuboi and Fukuda, 2005; Tsuboi et at., 2007). TIRF microscopy showed 
that where wild type Rabphilin was overexpressed, there was an increased 
number of NPY-Venus labeled granules in the evanescent field very close 
to the plasma membrane of cells, and an increase in NPY-Venus- 
associated release events on exposure of cells to high K+ (Tsuboi and 
Fukuda, 2005). In contrast, overexpression of a Rabphilin mutant unable to 
interact with SNAP-25 led to a reduction in granules at the plasma 
membrane and reduced release events (Tsuboi et at., 2007). The authors 
of these studies have speculated that Rabphilin binding to SNAP-25 
promotes initial docking/tethering, while an additional activity of the protein 
might promote fusion. However, the data they present might also suggest 
a role for Rabphilin earlier in the exocytotic pathway. They show that 
overexpressed Rabphilin increased the number of docked/tethered
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granules prior to stimulation, and increased release events expressed as a 
proportion of this number, but also show that the numbers of 
docked/tethered granules following stimulation are similar to those prior to 
stimulation (Tsuboi and Fukuda, 2005). These data indicate that Rabphilin 
must enhance mobilisation of granules towards the plasma membrane, 
either to replenish the pool of docked/tethered granules, or to contribute to 
the enhanced exocytotic response. Since the proportion of the granules 
that were docked/tethered prior to stimulation that actually underwent 
fusion was not reported, the extent of the contribution to the exocytotic 
response from granules entering the evanescent field during stimulation in 
these experiments was not clear. However, it should be noted that the 
probability of release from initially mobile undocked/cytoplasmic granules 
is reported to be substantially higher than that from initially static 
docked/tethered granules in PC12 cells (Han, 1999).
It is reported that the association between secretory granules and cross- 
linked F-actin is enhanced in the presence of Rabphilin (Baldini et al., 
2005). It is also reported that binding of Rabphilin to a-actinin enhances 
the cross-linking activity of a-actinin towards such actin filaments (Kato et 
al., 1996). These data have been interpreted as suggesting that Rabphilin 
facilitates actin remodelling, and the localisation of granules to F-actin-rich 
areas, such as the cortical regions of PC12 cells (Kato et al., 1996; Baldini 
et al., 2005). However, the findings presented here, indicating that 
Rabphilin interacts transiently with Rab proteins, and those discussed 
above, indicating that the effector enhances mobilisation of granules, might
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add a new dimension to such interpretation. The transient interaction 
between Rabphilin and Rab proteins might be seen as implying that the 
protein functions, through a-actinin, in the local remodelling of actin 
filaments surrounding cortical granules, rather than in their attachment to 
this actin. The enhanced mobilisation of granules where Rabphilin is 
overexpressed could be the result of such remodelling.
4.3.2 Granuphilin
Overexpressed Granuphilin-EGFP was found to predominantly label 
granules at the periphery of PC12 cells (Fig.4.1, C). Unlike EGFP- 
Rabphilin or Noc2-EGFP, it did not appear to colocalise completely with 
mRFP-tagged Rab3A or Rab27A, but instead labeled an overlapping pool 
of granules (Fig.4.2, D-F, M-O). A possible basis for this difference might 
be the characterised interactions of the protein with Munc18 and/or 
Syntaxin isoforms, and/or Phosphatidylinositol (4,5)-bisphosphate 
(PIP2)(Coppola et a i, 2002; Torii et a i, 2002; Torii et a i, 2004; Fukuda et 
a i, 2005; Gomi et a i, 2005; Tsuboi and Fukuda, 2006b; Osborne et a i, 
2007). Granuphilin can bind to Munc18 in a manner independent of any 
interaction with Rab proteins (Fukuda et a i, 2005), while Munc18 can bind 
Syntaxin at the plasma membrane (Rickman et a i, 2007). Some reports 
have suggested that Granuphilin can bind Syntaxin directly (Torii et a i, 
2002; Torii et al., 2004). The binding of Granuphilin to PIP2 is less well 
defined, but like Syntaxin, this lipid is localised to the plasma membrane 
(Osborne et a i, 2007). These interactions might suggest that Granuphilin 
is targeted to peripheral granules because it is here that the protein can
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stably bind to both Rab proteins present on secretory granules, and to its 
other binding partners present on the plasma membrane. Indeed, such a 
targeting mechanism has been described previously for other Rab 
effectors (Pfeffer, 2003). For example, the Rab9 effector TIP47, which also 
binds to mannose-6-phosphate receptor (M6PR), is preferentially targeted 
to late endosomes, where both of these proteins are present (Carroll et a/., 
2001). In this case Rab9 and M6PR are suggested to constitute a ‘two- 
component address’ (Pfeffer, 2003).
The FRAP data presented here might provide some support for the above 
hypothesis. The lower recorded fluorescence for Granuphilin-EGFP than 
for Noc2-EGFP following bleaching and recovery of cytosolic fluorescence 
(compare initial post-bleaching datapoints in (Fig.4.5, M) shows that a 
greater proportion of expressed Granuphilin-EGFP is granule-associated, 
even though Granuphilin and Noc2 are found to bind to Rab27A with 
similar affinity (Fukuda, 2006). While there are other explanations for this 
finding, one explanation is that as suggested, Granuphilin-EGFP 
localisation is stabilised through interaction with both Rab27A on granules, 
and another binding partner at the plasma membrane. It should be noted 
here that the FRAP recovery profiles of Granuphilin-EGFP and Noc2- 
EGFP, like that of EGFP-Rab27A, indicate that where these proteins do 
interact with granules, they do so in a relatively sustained manner (Fig.4.5, 
N). Since the localisation of EGFP-Granuphilin is different from that of the 
EGFP-tagged Rab proteins and other effectors, its recovery profile may not 
be directly comparable to theirs. However, it does appear that Granuphilin-
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EGFP fluorescence recovery occurs at a slightly faster rate than that of 
either Noc2-EGFP or EGFP-Rab27A. An explanation of this finding might 
be that while stable interactions between granule membrane, Granuphilin- 
EGFP, and plasma membrane can exist, granular and plasma membranes 
may occasionally be drawn apart, releasing bleached Granuphilin-EGFP, 
and granular and plasma membranes may be occasionally drawn together, 
creating optimal binding sites for unbleached protein.
As may be inferred from the above discussion, Granuphilin is widely 
suggested to be involved in the tethering/docking of secretory granules to 
the plasma membrane (Torii et al., 2002; Torii et al., 2004; Tsuboi and 
Fukuda, 2006b). Its overexpression is found to increase numbers of 
peripheral granules in PC12 cells and Min6 cells (this study Fig.4.2, D-F, 
M-0)(Torii et al., 2004; Tsuboi and Fukuda, 2006b), while the numbers of 
such granules are reduced in its absence (Gomi et al., 2005). It is likely 
that multiple Granuphilin molecules are required to mediate granule 
tethering, because of the relatively large size of these organelles, and the 
likely kinetic forces to which they are subject. Therefore, tethering may be 
potentiated if the protein’s binding partners are arranged in clusters. 
Indeed, this may well be the case. Rab proteins have already been shown 
to form clustered ‘domains’ on other membrane compartments (Zerial and 
McBride, 2001), and Rab27A may do so on secretory granules (see 
Discussion in Chapter 3). At the same time, clusters of syntaxin molecules 
are identified at the plasma membranes of PC12 and Min6 cells (Lang et 
al., 2001; Ohara-lmaizumi etal., 2004).
178
If closely apposed Rab and Munc18/Syntaxin/PIP2 clusters can create a 
microenvironment with high affinity for Granuphilin, and thereby facilitate 
tight association between secretory granules and the plasma membrane, 
what is the physiological purpose of this process? It has been suggested 
that Granuphilin acts to constrain stimulation-evoked fusion, because while 
its overexpression increases numbers of docked/tethered granules at the 
plasma membrane, it also reduces the size of exocytotic responses (Torii 
eta!., 2002; Tsuboi and Fukuda, 2006b). This reduction may be due to the 
formation of complexes that reduce the probability of SNARE engagement, 
docking and fusion. It was found in one study that Granuphilin could bind 
to Syntaxin2/3 only in a Muncl 8-2-dependent manner, and that the 
interaction was reduced when the L165A/E166A ‘open’ mutant of Syntaxin 
was expressed (Fukuda et al., 2005). In another study, Granuphilin could 
not bind to ‘open’ Syntaxinla (Torii et al., 2002). This data suggests that 
Granuphilin might be involved in sequestering ‘closed’ Syntaxin, and 
preventing its incorporation into functional SNARE complexes. Such 
sequestration might limit the fusion-competence of Granuphilin-tethered 
Granules, and may also limit the availability o f ‘free’ Syntaxin at the plasma 
membrane, thereby reducing the likelihood of any granule undergoing 
fusion.
Where Granuphilin was moderately overexpressed in hGH cotransfection 
experiments carried out here, no effect on ATP-stimulated hGH secretion 
was seen (Fig.4.3, A). It may be that an increase in fusion-incompetent
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granules at the plasma membrane has a limited effect on exocytotic 
responses, while these responses are reduced only where enough 
Granuphilin is present to severely limit ‘free’ Syntaxin. This might be 
considered likely, since as previously noted, initially undocked/cytoplasmic 
granules in PC12 cells make a very substantial proportionate contribution 
to exocytotic responses in PC12 cells (Han, 1999). It has been found that 
in the absence of Granuphilin, cellular levels of Syntaxin and Munc18 are 
reduced, while exocytotic responses are enhanced (Gomi et al., 2005). 
This might be seen as suggesting that an important physiological function 
of Granuphilin is in the stabilisation of these proteins, as well as in their 
sequestration.
In adrenal chromaffin cells, it has been found that while granules can 
remain tethered at the plasma membrane for extended periods of time, 
older granules are usually found in the cell interior, away from the 
membrane (Duncan et al., 2003). This could suggest that physiological 
Granuphilin-mediated tethering is reversible, a suggestion that might also 
be supported by the recovery profile of Granuphilin-EGFP described here 
(see above). Speculatively, a mechanism for Granuphilin complex 
disassembly might involve Rab27A GTP-hydrolysis or might involve its 
binding to membrane lipids. While Granuphilin interacts with both GTP and 
GDP bound Rab27A, different regions are involved in this binding. RBD1 is 
necessary and sufficient to bind to GTP-Rab27A, while RBD2 is required 
for the interaction with GDP-Rab27A, since mutations of residues in the 
SGAWFY motif can selectively abolish this interaction (Fukuda, 2003b).
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Therefore, the conformation of the Granuphilin may differ according to the 
nucleotide-bound state of associated Rab27A, and this may regulate its 
binding to other factors. While Granuphilin interacts with Munc18 isoforms 
via a central ‘linker’ domain between its N-terminal Rab-interacting domain 
and C-terminal C2 domains (Tsuboi and Fukuda, 2006b), it is likely that 
one or both of its C2 domains are required for its possible interaction with 
PIP2. It has been found elsewhere that stimulated exocytosis is associated 
with the local phospholipase C (PLC)-catalysed breakdown of PIP2 at 
exocytotic sites (Robert Woolley, Personal Communication). Loss of any 
PIP2 interaction might also lead to conformational change and altered 
binding to other factors.
4.3.3 Noc2
The findings presented here showing that fluorescently labeled Noc2 
colocalises with fluorescently labeled Rab27A (Fig.4.2, G-l, Fig.4.4, A-C), 
and that this colocalisation is largely abolished in the Rab-binding deficient 
‘AAA’ mutant but unaffected by the Rab3A-binding deficient V58A mutant 
(Fig.4.4, D-J) are consistent with reports that the protein is recruited to 
granules through interaction with Rab27A (Fukuda et al., 2004). Another 
finding that might support this suggestion is that the FRAP recovery profile 
of Noc2-EGFP is similar to that of EGFP-Rab27A, while EGFP-Rab3A 
recovery is faster than that of these proteins (Fig.4.5, N). This finding, 
indicating that Noc2 interacts with granular Rab27A in a sustained manner, 
might be explained in several ways. Apart from Granuphilin (Fukuda, 
2003b), most Rab effectors are thought to interact with GTP-bound Rab
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proteins preferentially, and the interaction between Noc2 and GTP- 
Rab27A at the granule membrane may be stable. However, in one study, 
Noc2 appears to interact with GDP-Rab27A more strongly than with GTP- 
Rab27A (Cheviet et a/., 2004a), and this interaction might also be stable. 
This suggestion would be controversial, since Rab27A(T23N), a mutant 
that is largely GDP-bound, shows reduced binding to Noc2 (Fukuda et at., 
2004). However, it is possible that this is a direct result of the mutation, 
rather than of the mutant’s nucleotide binding.
Whatever the specifics of Noc2 recruitment to granules, a major finding 
reported here and elsewhere is that moderate Noc2 overexpression can 
inhibit regulated secretion (Fig.4.3, B, Fig.4.4, K)(Haynes et at., 2001; 
Cheviet et at., 2004a). Since the interaction between Noc2 and Rab27A 
appears to be sustained, overexpression might produce such inhibition by 
saturating available Rab27A binding sites, and thereby reducing their 
availability to other effectors. However, it was found here that the 
Noc2(V58A) mutant produced less inhibition than the unmutated protein 
(Fig.4.4, K)(Haynes et at., 2001), despite its reportedly equivalent binding 
to Rab27A (Cheviet et at., 2004a). That might reflect a functional deficit in 
the mutant protein since the V58 residue of Noc2 is thought to be involved 
in interactions with the ‘switch’ regions of Rab proteins and may therefore 
be involved in functional transduction of nucleotide binding information 
(Haynes et at., 2001). It is also relevant that the ‘AAA’ Noc2 mutant 
produced a small but significant inhibition of secretion, even though it 
barely bound to granules (Fig.4.4, H, J, K).
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The function of Noc2 is relatively poorly characterised, and so it is difficult 
to say why its activity should reduce secretion. However, the existing 
literature may provide some clues. Experiments on a Noc2 knockout 
mouse have suggested that the protein may be involved in the 
suppression of signalling downstream of Gj in pancreatic p-cells, in a 
manner dependent on its interaction with Rab proteins (Cheviet et al., 
2004b; Matsumoto et al., 2004). A mechanism for this activity has not been 
uncovered. However, it has been found in another study that increased 
protein kinase A (PKA) activity in a [3-cell line can lead to the 
transcriptional repression of Rab3A, Rab27A, Granuphilin and Noc2 
(Abderrahmani etal., 2006). Since Noc2-mediated suppression of Gi might 
potentiate PKA activity, the endogenously expressed protein may 
exquisitely regulate the level of its own expression, and that of the other 
proteins mentioned, through negative feedback. Where Noc2 is 
overexpressed on a non-native promoter, however, the expression of 
these other proteins might be reduced, as the feedback system is 
dysregulated.
The timescale on which PKA-mediated reduction in Rab and effector 
protein levels in (3-cells operates, might be consistent with the suggestion 
that overexpressed Noc2 might have reduced levels of these proteins in 
PC12 cells in the hGH cotransfection experiments carried out in this study 
(Abderrahmani et al., 2006). However, it has been found elsewhere that 
acute treatment of permeablised parotid acinar cells, with an antibody that
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disrupts the interaction between Noc2 and Rab proteins, reduces the 
isoproterenol-stimulated secretory responses of these cells (Imai et al., 
2006). This indicates that Noc2 is likely to participate directly in the 
secretory process, as the effects of the antibody cannot be due to any 
effect Noc2 has at the transcriptional level. It is possible that this 
participation might involve Gr suppression, however, since isoproterenol is 
a p-adrenoceptor agonist, and P-adrenoceptor activation is linked to Gi and 
Gs signalling in parotid cells (Watson et al., 1992; Shimomura et al., 2004). 
Other possibilities relate to interactions between Noc2 and the priming 
factor Munc13, and the cytoskeletal protein Zyxin. These have been 
identified by in vitro binding experiments and yeast 2-hybrid experiments 
respectively (Kotake etal., 1997; Cheviet etal., 2004a).
4.3.4 Munc18-1
The major findings reported here with respect to Munc18-1 function, were 
those showing that overexpression of the Munc18-1(E466K) mutant 
caused a redistribution of EGFP-Rab3A or EGFP-Rab27A-labeled 
secretory granules to the periphery of cells (Fig.4.7, F-J, Fig.4.8, A-E). It 
may be inferred that this effect is related to the enhanced secretion seen 
where this mutant is expressed in adrenal chromaffin or PC12 cells (Ciufo 
et al., 2005; Graham et al., 2008). In support of this inference, 
overexpression of the Munc18-1(E466K, R39C) double mutant was unable 
to produce either effect (Fig.4.7, F-J, Fig.4.8, A-E)(Graham et al., 2008). It 
might also be suggested that both effects are linked to the increased 
binding of Munc18-1(E466K) to Rab3Afrom bovine brain lysate(Graham et
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al., 2008). The E466 residue is exposed in the characterised structures of 
rat Munc18-1 and squid Sec1, consistent with its possible direct 
involvement in protein-protein interactions (Bracher et al., 2000; Misura et 
al., 2000). Further, peptides corresponding to the E466-containing domain 
III loop region of Munc18 are found to inhibit neurotransmitter release at 
the squid giant synapse, and plasma membrane translocation of Glut4 
vesicles in adipocytes, consistent with a conserved functional role for this 
region (Dresbach etal., 1998; Thurmond etal., 2000).
Despite the coincident findings described above, previous reports mean 
that it may at first seem counterintuitive that the E466K mutation should 
enhance docking/tethering and secretion by promoting a Munc18-1-Rab3A 
interaction. The mutation is based on a mutation in the yeast SM protein 
S lylp that suppresses the effects of deletion of yeast Rab protein Ypt1 
(Dascher et al., 1991; Ossig et al., 1991): how could this effect be 
explained in terms of altered Rab-binding characteristics? Recent work 
characterising the S lylp mutant suggests an answer to this question. It 
was reported that expression of the mutant allowed another Rab protein, 
Ypt6p, to substitute for Yptlp in its role in ER-Golgi trafficking (Ballew et 
al., 2005). The authors of this study suggested that mutant Slylp 
bypassed a requirement for Yptlp in membrane fusion, while Ypt6p was 
able to substitute in a role pre-fusion (Ballew et al., 2005). However, a 
simpler explanation for their findings is that a putative requirement for a 
direct Sly1p-Ypt1p interaction was substituted by a Sly1p-Ypt6p interaction 
where S lylp was mutated. Thus, the data from yeast may argue that the
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E466K mutation influences the Munc18-1-Rab3A interaction directly, and 
may indicate that SM protein-Rab protein interactions are functionally 
significant in multiple membrane trafficking steps, and conserved through 
evolution.
Whatever the specific effect of the E466K mutation on protein-protein 
interactions, it is important to consider the mechanism by which enhanced 
binding of Rab3A to Munc18-1 might affect exocytosis. The function of 
Munc18-1 in exocytosis has long been the subject of great interest. It is 
known to have an essential role in neurotransmitter release, as no 
neurotransmission occurs in Munc18-1 -/- mice (Verhage et at., 2000), and 
it is thought that this role is exerted through its interactions with the 
SNARE protein SyntaxinIA (Burgoyne and Morgan, 2007). Several modes 
of Muncl8-1-SyntaxinIA binding have now been identified. Initially, 
Munc18-1 was shown to bind to and stabilise a ‘closed’ conformation of 
SyntaxinIA, unable to interact with other SNARE proteins, and therefore 
unable to mediate membrane fusion (Dulubova eta/., 1999). More recently 
however, a positive effect of M uncl8-1 in in vitro membrane fusion assays 
has been found to be dependent on its binding to an N-terminal region of 
the Syntaxin (Shen et at., 2007). This interaction can occur when 
SyntaxinIA forms part of an assembled SNARE complex, and can occur in 
vivo (Dulubova eta/., 2007; Rickman eta/., 2007). Binding of Munc18-1 to 
the N-terminal domain of SyntaxinIA is likely to occur in a manner 
analogous to the binding of SM proteins S lylp and Vps45p to their 
appropriate Syntaxins (Bracher and Weissenhorn, 2002; Dulubova et at.,
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2002). However, where Munc18-1 binds an assembled SNARE complex, 
binding to the N-terminal region of SyntaxinIA may be combined with 
additional interactions including interaction with the v-SNARE VAMP2, 
reflecting an additional binding mode. Binding of Munc18-1 to VAMP2 has 
been found critical for its stimulation of in vitro membrane fusion (Shen et 
al., 2007), and it is possible that Munc18-1 interacts with assembled 
SNARE complexes in a manner analogous to that of Sec1 (Carr et at., 
1999; Scott et al., 2004).
The binding of Munc18-1 to ‘closed’ SyntaxinIA has been previously 
suggested to stabilise the Syntaxin, and prevent its inappropriate 
incorporation into SNARE complexes (Rowe et al., 1999). Such a role may 
be important while the protein is trafficked to the plasma membrane 
(Rickman et al., 2007), and as discussed, where ‘inert’ granules are 
docked/tethered by a mechanism involving Granuphilin (Fukuda et al., 
2005). However, it was found in this laboratory that the Munc18-1 R39C 
mutation, which selectively reduces the binding of Munc18-1 to ‘closed’ 
Syntaxin, was able to abolish the positive functional effects of the E466K 
mutation in terms of granule distribution (Fig.4.7, l-J, Fig.4.8, D-E) and 
secretion (Graham et al., 2008). This was not due to an effect on the 
Rab3A interaction, as enhanced binding to this protein was retained in 
pull-down experiments using the double mutant (Graham et al., 2008). 
Therefore, these findings suggest that ‘closed’ Syntaxin may also 
represent a ‘conformational precursor’ early in a system of sequential 
interactions driving SNARE engagement and leading docking or fusion.
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Different Munc18-1-Syntaxin binding modes may operate at different 
points in this system, while it is likely that Munc18-1(E466K) 
overexpression -  increased Rab3A-Munc18-1 interaction - potentiates the 
system at a point upstream of a transition between ‘closed’ and ‘open’ 
Syntaxin. This is supported by findings showing that microinjection of 
GTPase-deficient Rab3A into Aplysia neurones can delay the onset of 
inhibition of neurotransmitter release produced by Clostridial neurotoxins 
that cleave the SNARE proteins VAMP and SNAP-25 where these proteins 
are isolated, but not where they form parts of assembled SNARE 
complexes (Johannes et al., 1996).
If Rab3A-Munc18-1 interaction can potentiate SNARE engagement, the 
nature of its regulation should be discussed. In order to discuss this, it is 
necessary to consider the regulation of exocytotic machinery in endocrine 
and neuroendocrine cells as a whole. Regulated exocytosis in these cells 
differs from other membrane trafficking pathways, in that it is important for 
cells to be predictably responsive to a range of temporally unpredictable 
stimuli. Thus, cells maintain releasable and readily releasable pools of 
secretory granules, through a number of different mechanisms (Burgoyne 
and Morgan, 2003). While granules are continually synthesised, it is 
thought that newly synthesised secretory granules are more fusion 
competent than older granules (Duncan et al., 2003). Immature granules 
are transported to the periphery of cells for maturation, while such 
granules may still undergo exocytosis (Tooze et al., 1991; Rudolf et al., 
2001). Mature granules may remain at the periphery of cells and may
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become tethered or docked at the plasma membrane, while over time it is 
thought that these granules progressively lose mobility and fusion 
competence and are finally displaced and sequestered in the cell body 
(Rudolf et al., 2001; Duncan et al., 2003). However, it is not only tethered 
or docked granules that can contribute to exocytotic responses. Where 
cells are stimulated, undocked granules may be mobilised towards the 
plasma membrane and these granules may be efficiently exocytosed (Han, 
1999). Therefore, mechanisms by which granules lose fusion competence 
with time are likely to be complimented by mechanisms that promote 
granule mobilisation, tethering, docking, priming and fusion under 
stimulation, and that thereby mediate exocytosis of both docked and 
undocked granules. In this context, it is likely that there is a cellular 
requirement to control the degree to which the Rab3A-Munc18-1 
interaction is promoted or repressed under many different circumstances.
Because Munc18-1(E466K) overexpression causes peripheral 
redistribution of relatively newly synthesised EGFP-Rab3A/EGFP-Rab27A- 
labeled secretory granules (Fig.4.7, F-J, Fig.4.8, A-E), but not all granules 
(Fig.4.8, F-G), it is likely that mechanisms limiting tethering/docking of 
older granules still function under these conditions. While Munc18- 
1(E466K) may preferentially increase tethering/docking of more fusion 
competent granules, its overexpression in adrenal chromaffin cells led to 
an increased frequency of exocytotic events compared to controls, and this 
increase was sustained over three minutes of stimulation (Ciufo et al., 
2005). This suggests that mechanisms modulating fusion competence of
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more fusion competent granules per se may be dysregulated when the 
mutant is expressed. In PC12 cells, siRNA knockdown of Rab3A 
expression leads to a -40% reduction in exocytotic responses compared 
to controls (Tsuboi and Fukuda, 2006a), while in neurones lacking Rab3A, 
the release probability of a subset of synaptic vesicles of the readily 
releasable pool is reduced (Schluter et al., 2004). In the previous chapter, 
it was speculated that differential interactions between synaptic vesicles, 
and the cycling pool of Rab3A, according to vesicle age, might underlie 
corresponding differences in fusion competence. The data presented in 
this chapter might support this speculation, since it indicates that fusion 
competence may be determined in part, by a complex system coordinating 
Munc18-1 function via Rab3A.
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Chapter 5:
RabGAPs in neuroendocrine exocytosis
5.1 Introduction
Successive targeting of GDI-associated Rab protein to a specific 
membrane compartment, GEF-catalysed exchange of bound GDP for 
GTP, association between the Rab protein and its effectors, and in some 
cases the formation of Rab domains, have been suggested to constitute 
the Rab activation pathway (Takai et al., 2001). Successive RabGAP- 
promoted Rab GTP-hydrolysis and GDI-mediated Rab membrane 
extraction have been suggested to constitute their inactivation pathway 
(Takai et al., 2001). While Rab activation and inactivation may be grossly 
associated with the progression and termination of a given membrane 
trafficking step respectively (Sudhof, 1997; Takai et al., 2001), the work 
carried out in this study has suggested that continual dynamic transitions 
of Rab proteins between different activation states may also define their 
influence on cellular events (Handley et al., 2007). Therefore, 
characterisation of the protein regulators of such transitions may be of 
critical importance in the future investigation of Rab protein function. Given 
the limitations of time, the final portion of this study was focused on one 
class of regulatory protein: the RabGAP.
RabGAPs interact with GTP-bound Rab proteins and increase their 
hydrolytic activity. The majority of identified RabGAPs are TBC (Tre-2, 
Bub-2, Cdc16) domain-containing proteins, and are thought to accelerate 
Rab GTP-hydrolysis by a common mechanism (Pan et al., 2006). While 
GAPs for each Rab protein have not yet been identified, sequence
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analysis has identified >35 TBC domain-containing proteins, and it is 
thought likely that each of these putative GAPs acts on a specific Rab 
subtype or isoform (Haas et a i, 2005; Itoh et al., 2006). Since this study 
initially focused on the distribution, dynamics and function of Rab3A and 
Rab27A, and their effectors in PC12 cells, work was directed towards 
characterisation of candidate RabGAPs specific for these Rab isoforms.
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5.2 Results
5.2.1 Characterisation of proteins reported to function as GTPase- 
activating proteins for Rab3A and Rab27A
RabGAPs interact with GTP-bound Rab proteins and potentiate GTP- 
hydrolysis (Takai et al., 2001; Pan et al., 2006). As GTP-bound Rab 
proteins are generally considered ‘active’ while GDP-bound Rab proteins 
may be vulnerable to GDI-mediated membrane extraction, RabGAP 
activity is important for the termination of discrete membrane trafficking 
steps. Where a transport vesicle fuses with its target organelle, for 
example, GTP-hydrolysis by the Rab protein regulating the process, and 
the subsequent extraction of the GDP-bound Rab is required to prevent 
accumulation of this protein (Novick and Brennwald, 1993; Simons and 
Zerial, 1993; Sudhof, 1997; Takai et al., 2001). However, it is possible that 
GAP activity may also be required in order to maintain the size of a 
vesicle-associated pool of a Rab protein, or to maintain rates of Rab GTP- 
hydrolysis and reassociation (see previous chapters). Evidence supporting 
this suggestion includes findings that overexpression of specific RabGAPs 
can dramatically reduce the membrane-association of their target Rabs. 
For example, RabGAP5 overexpression is associated with dispersal of 
Rab5 in HeLa cells (Haas et al., 2005).
The protein p130 Rab3GAP is suggested to potentiate Rab3A GTP- 
hydrolysis (Fukui et a i, 1997; Oishi et a i, 1998; Sakane et a i, 2006), and 
this is suggested to be coupled to exocytotic signalling and/or the fusion of
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synaptic vesicles with the plasma membrane (Sudhof, 1997). Because 
RabGAP activity might also underlie extraction of granular Rab3A under 
resting conditions in PC12 cells, the effects of p130 Rab3GAP-myc 
overexpression on EGFP-Rab3A-granule association were analysed. In 
order to increase the likelihood of observing an effect, cells imaged were 
those with relatively strong anti-myc staining, and relatively weak EGFP- 
Rab3A fluorescence. To maximise the number of cells fitting this 
description, transfection mixes were made-up to contain 0.75pg of the 
GAP-encoding plasmid, and 0.25pg of the EGFP-Rab3A-encoding plasmid 
per transfection. Consistently, EGFP-Rab3A showed a similar localisation 
in these cotransfected cells to that previously shown where it was 
transfected alone; the protein was localised to punctae distributed 
throughout the cytosol and at the periphery of cells (Fig.5.1, A). p130 
Rab3GAP-myc was also associated with punctae in some cells (Fig.5.1, 
B), while in others, it had a more diffuse distribution (Fig.5.1, E). p130 
Rab3GAP-myc-labeled punctae did not colocalise with those labeled with 
EGFP-Rab3A (Fig.5.1, A-C). Similarly, Rab3GAP-myc did not colocalise 
with, or affect the punctuate distribution of, EGFP-Rab27A (Fig.5.1, D-F).
While overexpression of p130 Rab3GAP-myc produced no observable 
effects on EGFP-Rab3A or EGFP-Rab27A localisation in resting cells, it 
was possible that it might produce functional effects on exocytosis. In 
order to identify such effects, the protein was expressed in an hGH 
cotransfection assay. However, no change in ATP-stimulated hGH 
secretion was identified (Fig.5.1, G). Similar findings have been reported
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Figure 5.1. p130 Rab3GAP-myc localisation and effects In PC12 cells. (A-F) Cells were 
cotransfected with p130 Rab3GAP-myc, and either EGFP-Rab3A (A-C), or EGFP-Rab27A (D-F), 
fixed 18 hours following transfection, and then immunostained with anti-myc. Each overlay image 
on the right of the figure is a composite of green from the left image and red from the centre image. 
Areas of overlap appear In yellow.. Bars, 4p.m. (G) Secretion of exogenous human growth hormone 
(hGH) from cells cotransfected with plasmids encoding EGFP or p130 Rab3GAP-myc was assayed. 
Stimulated cells were exposed to 300 pM ATP, hGH release over 15 minutes was assayed and 
expressed as a percentage of total hGH (shown to the right of the figure). Data are expressed as 
mean ± s.e.m. (n=6)
previously (Oishi et al., 1998), and may indicate a minimal role for p130 
Rab3GAP upstream of the exocytotic fusion event.
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The proteins TBC1D10A and TBC1D10B have recently been reported to 
exert GAP activity towards Rab27A, both in vitro and in vivo (Itoh and 
Fukuda, 2006). On this basis, the localisation and effects of myc-tagged 
forms of these proteins were explored. When TBC1D10A-myc was 
coexpressed with either EGFP-Rab27A (Fig.5.2, A-F), or EGFP-Rab3A 
(Fig.5.2, G-L), in PC12 cells, anti-myc staining was concentrated at the 
periphery of cells (Fig.5.2, B, E, H, K). This staining pattern would be 
consistent with the protein’s localisation to cortical F-actin, given its 
similarity to that produced previously when cells were stained with 
phalloidin (see Fig.4.9, A). When cells coexpressing EGFP-Rab27A were 
imaged, EGFP-Rab27A fluorescence was largely cytosolic in -50% of 
cases (Fig.5.2, A-C). In the remainder of cells, this fluorescence was 
punctate, and characteristic of typical EGFP-Rab27A localisation (Fig.5.2, 
D-F). In these cells, EGFP-Rab27A-labeled punctae were not excluded 
from cortical areas of high anti-myc fluorescence.
The capacity of TBC1 D10A-myc to promote dispersal of EGFP-Rab27A in 
a proportion of cotransfected cells might be consistent with direct GAP 
activity. However, where corresponding experiments were carried out in 
cells cotransfected with EGFP-Rab3A, this protein was largely cytosolic in 
a similar proportion of cells, a possible indication that any GAP activity was 
non-specific (Fig.5.2, G-L). Despite this, the functional effects of 
TBC1D10A-myc overexpression were explored. Since Rab27A may act 
through multiple effectors in PC12 cells, the effects of any GAP-mediated 
increase in its rate of its GTP-hydrolysis may be difficult to predict.
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Figure 5.2. TBC1D10A-myc localisation and effects In PC12 cells. (A-L) Cells were cotransfected 
with TBC1D10A-myc, and either EGFP-Rab27A (A-F), or EGFP-Rab3A (G-L), fixed 18 hours 
following transfection, and then Immunostained with antl-myc. Each overlay image on the right of 
the figure is a composite of green from the left image and red from the centre image. Areas of 
overlap appear in yellow. Bars, 4p.m. [contd. on next page]
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Figure 5.2 contd. (M) Secretion of exogenous human growth hormone (hGH) from cells 
cotransfected with plasmids encoding EGFP or TBC1D10A-myc was assayed. Stimulated cells 
were exposed to 300 pM ATP, hGH release over 15 minutes was assayed and expressed as a 
percentage of total hGH (shown to the right of the figure). Data are expressed as mean ± s.e.m.
(n=6)
However, it is possible that the resulting reduction in GTP-Rab27A levels, 
and in the protein’s granule-association, could be expected to mirror the 
inhibitory effects of a partial siRNA knockdown (Waselle et al., 2003; 
Tsuboi and Fukuda, 2006a). When the effects of TBC1D10A-myc 
overexpression were assessed in an hGH cotransfection assay, it was 
found to cause a small reduction in ATP-stimulated hGH secretion (Fig.5.2, 
M).
TBC1D10B-myc overexpression produced similar effects on the 
distribution of the coexpressed EGFP-tagged Rab3A and Rab27A proteins 
to those produced by TBC1D10A-myc (Fig.5.3, A-L). In -50% of the cells 
imaged, the EGFP-Rab fluorescence was diffuse, while in the remainder, it 
was characteristically punctate. Again these results may indicate that the 
putative GAP exerts a non-specific GAP activity. Like TBC1D10A-myc, 
TBC1D10B-myc localised to the periphery of cells (Fig.5.3, B, E, H, K). 
However, in some cells it was seen to label large vesicular/vacuolar 
structures (Fig.5.3, E, K). Given the size of these structures, and in some 
cases, their visible exclusion of EGFP-Rab-labeled punctae from regions 
of the cytosol (Fig.5.3, E), it is very likely that they constitute a dramatic 
change in normal cellular physiology, perhaps resulting from dysregulation 
of some aspect of membrane trafficking. This dysregulation, rather than a 
specific effect of the protein on Rab27A function, may underlie the large
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Figure 5.3. TBC1D10B-myc localisation and effects in PC12 cells. (A-L) Cells were cotransfected 
with TBC1D10B-myc, and either EGFP-Rab27A (A-F), or EGFP-Rab3A (G-L), fixed 18 hours 
following transfection, and then immunostained with anti-myc. Each overlay image on the right of 
the figure is a composite of green from the left image and red from the centre image. Areas of 
overlap appear in yellow. Bars, 4pim. [contd. on next page]
EGFP-Rab3A
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Figure 5.3 contd. (M) Secretion of exogenous human growth hormone (hGH) from cells 
cotransfected with plasmids encoding EGFP or TBC1D10B-myc was assayed. Stimulated cells 
were exposed to 300 p,M ATP, hGH release over 15 minutes was assayed and expressed as a 
percentage of total hGH (shown to the right of the figure). Data are expressed as mean ± s.e.m. 
(n=6)
reduction in ATP-stimulated exogenous hGH secretion produced where 
TBC1D10B-myc was coexpressed (Fig.5.3, M).
5.2.2 Screening of putative RabGAPs to identify potential activity 
towards Rab3A and Rab27A
In the experiments described above, it was found that p130 Rab3GAP-myc 
overexpression produced no effect on the localisation of EGFP-Rab3A in 
cotransfected cells or on secretory responses as gauged by hGH 
cotransfection assays. It was also found that overexpression of myc- 
tagged forms of the putative Rab27 GAPs TBC1D10A and TBC1D10B 
was associated with variable redistribution of both EGFP-Rab27A and 
EGFP-Rab3A, and that TBC1D10B-myc overexpression was associated 
with changes in cellular morphology. Given these data, it is possible that 
p130 RabGAP does not function as a GAP for Rab3A in PC12 cells, or 
does so only following the exocytotic event. Further, it is possible that 
TBC1D10A and TBC1D10B show non-specific GAP activity, and are not 
physiological regulators of Rab27A function. It was therefore decided to 
screen an additional 34 putative RabGAPs to identify alternative candidate 
Rab3A and Rab27A-specific GAPs.
Following on from the previous work, initial experiments were directed 
towards identification of GAPs capable of altering the localisation of the
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EGFP-labeled Rab proteins on their overexpression. cDNAs encoding the 
putative RabGAPs were previously subcloned into a modified form of the 
pcDNA3.1(+) vector (Invitrogen, UK) encoding a myc-tag, and the resulting 
plasmids were kindly provided for this study by F Barr (School of Cancer 
Studies, University of Liverpool). As before, cells were cotransfected using 
0.75pg of each GAP-encoding construct, and 0.25pg of either EGFP- 
Rab3A or EGFP-Rab27A, in order to maximise the numbers of cells 
coexpressing relatively high levels of GAP, and moderate levels of Rab 
protein. Because each recombinant GAP carried the same epitope tag, 
and was labeled in cells using the same antibody and according to the 
same protocol, it was possible to identify cells expressing comparable 
levels of these proteins for analysis, despite some differences in their 
expression efficiency.
Multiple cells expressing each combination of GAP and Rab protein were 
imaged, but given the volume of data that was produced in the screening 
process, it is presented here in tabulated form (Table 5.1). The effects of 
each GAP on the localisation of coexpressed Rab protein were scored 
qualitatively, according to the proportion of cells in which the specified Rab 
appeared uncharacteristically diffuse. In the table, '+’, '++’ and '+++’ 
indicate that the Rab was largely diffuse in ~25%, ~50% or >75% of the 
cells imaged respectively, and the localisation of each GAP protein is 
characterised as either cytosolic, vesicular, perinuclear, or peripheral (see 
Fig.5.4). Where a particular GAP seemed to adopt different localisations in 
different cells, it usually appeared diffuse in some, but either vesicular or
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GAP Localisation Rab3A Rab27A Probable Target
RabGAP-5 Vesicles/Perinuclear Rab5A-C (Haas et al., 2005; Fuchs et al., 2007)
Parisi Vesicles/Cytosolic +
Rab3GAP Vesicles/Cytosolic Rab3 (Fukui et at., 1997)
RUTBC2 Vesicles ++
GAPCenA Vesicles/Perinuclear Rab4 (Fuchs et at., 2007)
Gyp6 Vesicles
USP6 Peripheral +
TBC1D22B Vesicles + + Rab33 (Pan et al., 2006)
TBC1D1 Vesicles +
TBC1D16 Vesicles
EVI5 SGs + ++ Rab35 (Fuchs et al., 2007)
RN-tre Peripheral + + Rab41 (Haas et al., 2005; Fuchs et al., 2007)
RUTBC1 SGs +++
TBC1D3 Peripheral ++
TBC1D7 Cytosolic + R a b l7 (Yoshimura et al., 2007)
TBC1D10A Peripheral ++ ++
TBC1D10B Peripheral ++ ++ Rab22a/31 (Fuchs et al., 2007)
TBC1D10C Cytosolic + +
TBC1D12 Vesicles +
TBC1D13 Vesicles +
TBC1D14 Vesicles +
TBC1D15 Vesicles + Rab7 (Zhang et al., 2005)
TBC1D17 Vesicles/Cytosolic + Rab21 (Fuchs et al., 2007)
TBC1D18 Vesicles +
TBC1D19 Vesicles
TBC1D20 Vesicles ++ Rab1/2 (Haas et al., 2007)
TBC1D21 Vesicles
Gyp1 Vesicles + Rab33 (Pan et al., 2006)
AK074305 Vesicles ++
AAH_33712 Vesicles/Cytosolic
KIAA0882 Vesicles +
NM_018309 Vesicles/Perinuclear +
Evi5-like Vesicles Rab23 (Yoshimura et al., 2007)
XM_037557 Vesicles/Perinuclear + Rab8A (Yoshimura et al., 2007)
XMJ370928 Vesicles/Cytosolic
NM_198868 Vesicles
TBC1D4 Vesicles
Table 5.1. Screening putative RabGAPs. Cells were transfected to coexpress a myc-tagged version 
of each RabGAP listed, and either EGFP-Rab3A, or EGFP-Rab27A, fixed 18 hours following 
transfection, and then immunostained with anti-myc. RabGAP localisation was subjectively 
characterised according to anti-myc staining. For each condition, cells stained strongly with anti- 
myc, and weakly with EGFP-Rab, were selected and scored for EGFP-Rab dispersal.'+’ indicates 
dispersal in >25% cells,'++’ -50%, and '+++’ 75%. A minimum of 10 cells were scored where'++' 
and '+++’ dispersal is indicated.
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XM_037557-myc
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Figure 5.4. Subjective characterisation of RabGAP localisation (A-H) Imaged cells were fixed 18 
hours after transfection with plasmids encoding the RabGAPs indicated, and immunostained with 
anti-myc. Localisations were characterised as indicated. Bars, 4pm.
perinuclear in others. Since a large diffuse component to GAP 
fluorescence might mask a more restricted localisation underlying it, the 
appearance of a cytosolic localisation was discounted in such cases.
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Broadly, the results of the screen appear to indicate that a relatively high 
proportion of the RabGAPs tested can exert some effect on the localisation 
of either or both of the EGFP-Rab proteins, and that more can affect 
EGFP-Rab27A than can affect EGFP-Rab3A. However, caution should be 
taken before drawing these conclusions, as effects were typically noted in 
only a small proportion of cells and may represent false positives. Where 
EGFP-Rab protein fluorescence was diffuse in 50% or more of imaged 
cells, this is much more likely to reflect an effect of the coexpressed GAP. 
If only these cases are considered, the screen identified two RabGAPs 
associated with dispersal of EGFP-Rab3A, and four associated with 
dispersal of EGFP-Rab27A.
RabGAPs associated with dispersal of EGFP-Rab3A were TBC1D20, and 
RUTBC1, both of which showed a vesicular localisation. The effects of 
TBC1D20-myc overexpression on EGFP-Rab3A were more variable than 
those of RUTBC1-myc, and the available information suggests that they 
were indirect. TBC1D20 is reported to function as a GAP for Rab1, and its 
overexpression is found to disrupt trafficking from the ER, and to cause 
loss of the Golgi complex (Haas et al., 2007). Therefore, where it is 
overexpressed, EGFP-Rab3A may be mislocalised as a result of reduced 
or aberrant secretory granule synthesis.
The effects of RUTBC1-myc overexpression were striking. Expression of 
this protein was associated with diffuse EGFP-Rab3A fluorescence in 
almost all of the coexpressing cells imaged, while no such effect on
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coexpressed EGFP-Rab27A was apparent (Fig.5.5, A-F). Further analysis 
showed that in fact, punctae labeled with RUTBC1-myc colocalised with 
those labeled with EGFP-Rab27A, suggesting that the protein is targeted 
to secretory granules (Fig.5.5, D-F). These results are significant, because 
while its dispersal of EGFP-Rab3A suggests only possible Rab3GAP 
activity, the protein’s localisation on granules may support the suggestion 
that such activity could be physiologically relevant.
As a candidate GAP for Rab3A, it was possible that RUTBC1 
overexpression might affect PC12 cell secretory responses by reducing the 
quantity and/or activity of endogenous Rab3A on secretory granules. 
However, when the effects of RUTBC1-myc overexpression were 
quantified in an hGH-cotransfection assay, ATP-stimulated secretion was 
unaffected (Fig.5.5, G). Whereas the siRNA knockdown of Rab3A in PC12 
cells is found to reduce PC12 cell secretory responses by -40%, its 
overexpression can produce even more dramatic reduction in secretion 
(Chung et al., 1999; Tsuboi and Fukuda, 2006a). Because reduced 
secretion resulting from Rab3A overexpression depends on the protein’s 
membrane-association (Johannes etal., 1996), while immunocytochemical 
data suggested that RUTBC1-myc overexpression might reduce this, the 
effects of cooverexpression of EGFP-Rab3A and RUTBC1-myc were 
investigated. Transfection of cells with 0.25pg of a plasmid encoding 
EFGP-Rab3A was found to cause a -50% reduction in ATP-stimulated 
secretion as compared to controls. When cells were simultaneously 
transfected with 0.75pg of a plasmid encoding RUTBC1-myc, no reduction
205
GFigure 5.5. RUTBC1-myc localisation and effects in PC12 cells. (A-F) Cells were cotransfected with 
RUTBC1-myc, and either EGFP-Rab3A (A-C), or EGFP-Rab27A (D-F), fixed 18 hours following 
transfection, and then immunostained with anti-myc. Each overlay image on the right of the figure is 
a composite of green from the left image and red from the centre image. Areas of overlap appear in 
yellow. Bars, 4p.m. (G-H) Secretion of exogenous human growth hormone (hGH) from cells 
cotransfected with the indicated plasmids was assayed 48 hours following transfection. Stimulated 
cells were exposed to 300 pM ATP, hGH release over 15 minutes was assayed and expressed as 
a percentage of total hGH (shown to the right of the figure). Data are expressed as mean ± s.e.m. 
(In G, n=6)(ln H, n=3)
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Figure 5.6. RUTBC2-myc localisation and effects In PC12 cells. (A-l) Cells were cotransfected with 
RUTBC2-myc, and either EGFP-Rab27A (A-F), or EGFP-Rab3A (G-l), fixed 18 hours following 
transfection, and then immunostained with antl-myc. Each overlay image on the right of the figure Is 
a composite of green from the left image and red from the centre image. Areas of overlap appear in 
yellow. Bars, 4p.m. (J) Secretion of exogenous human growth hormone (hGH) from cells 
cotransfected with the indicated plasmids was assayed 48 hours following transfection. Stimulated 
cells were exposed to 300 pM ATP, hGH release over 15 minutes was assayed and expressed as 
a percentage of total hGH (shown to the right of the figure). Data are expressed as mean ± s.e.m. 
(n=3)
was seen (Fig.5.5, G). This data indicates that RUTBC1 may efficiently
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promote membrane-extraction of supraphysiological Rab3A. In support of 
the suggestion that RUTBC1 exerts Rab3-specific effects, RUTBC1-myc 
overexpression was not found to suppress the inhibitory effects of EGFP- 
Rab27 on secretion (Fig.5.5, H).
RabGAPs associated with the dispersal of EGFP-Rab27A were RUTBC2, 
Evi5, TBC1D3 and AK_074305. Rab27 and Rab3 isoforms are more 
closely related to one another in terms of phylogeny than they are to any 
other Rabs (Pereira-Leal and Seabra, 2000), RUTBC2 and RUTBC1 are 
similarly related (Itoh etal., 2006), and so the possibility that RUTBC2 may 
function as a GAP for Rab27A was addressed. The effects of RUTBC2- 
myc on cooverexpressed EGFP-Rab27A were dramatic in some cells 
(Fig.5.6, A-C). However, they were also more variable than those of 
RUTBC1-myc on EGFP-Rab3A, with EGFP-Rab27A displaying a punctate 
distribution in ~50% of imaged cells (Fig.5.6, D-F). Additionally, unlike 
RUTBC1-myc, RUTBC2-myc did not appear to be concentrated on 
secretory granules, as it did not colocalise with punctae labeled with either 
EGFP-Rab27A, or EGFP-Rab3A (Fig.5.6, A-l). In hGH cotransfection 
assays, it was found that RUTBC2-myc overexpression did not suppress 
the inhibitory effects of EGFP-Rab27A on secretion (Fig.5.6, J).
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5.3 Discussion
5.3.1 Rab3 GTPase-activating proteins
The atypical RabGAP, ‘Rab3GAP’, was originally isolated following 
multiple fractionations of a soluble synaptic fraction of rat brain that was 
found to promote Rab3A [y-32P]GTP-hydrolysis. Following sequence 
analysis of the major protein, p130, in the highly purified ‘GAP’ 
preparation, it was identified, cloned, found to possess Rab3 GAP activity 
in vitro, and named accordingly (Fukui et al., 1997). Another protein 
present in the ‘GAP’ preparation, p150, was later characterised as a 
noncatalytic subunit of Rab3GAP (Nagano et al., 1998). While it does not 
affect GAP activity in vitro, it may be important for GAP function in vivo 
since mutations in both proteins are associated with related genetic 
disorders characterised by ocular and neurodevelopmental defects; 
Warburg micro syndrome and Martsolf syndrome (Aligianis et al., 2005; 
Aligianis et al., 2006). Rab3GAP is structurally very different from other 
characterised GAPs, although it is thought to function in an analogous 
manner, and orthologues exist in several species (Clabecq et al., 2000). 
Like other RabGAPs, Rab3GAP has relatively low affinity for its substrate 
GTP-Rab, but greater affinity where the Rab adopts a conformation 
thought to constitute an intermediate state associated with GTP hydrolysis, 
and an argenine residue in its catalytic site is critical for its GAP activity 
(Clabecq eta!., 2000).
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Consistant with the crude inference that altered Rab3 regulation of 
neurotransmission in Warburg micro syndrome may result in the 
neurodevelopmental defects seen in this disorder, a number of studies 
have provided evidence that Rab3GAP is involved in Rab3 GTP-hydrolysis 
in vivo. The protein colocalises with Rab3 in synaptic terminals (Oishi et 
al., 1998), and it is found that GTP-Rab3A accumulates in the brains of 
Rab3GAP knockout mice (Sakane et al., 2006). Further, CA1 hippocampal 
neurones taken from these mice show enhanced short-term plasticity 
(STP) on repetitive stimulation, and enhanced paired-pulse facilitation 
(PPF), a nearly identical phenotype to that observed in GDIa knockout 
mice (Ishizaki et al., 2000; Sakane et al., 2006). This is significant, 
because both GAP-catalysed Rab3 GTP hydrolysis and GDIa-mediated 
GDP-Rab3 sequestration regulate the extraction of Rab3 from synaptic 
vesicles, and so the effects of both deletions might arise from parallel 
increases in vesicle-associated Rab3. In support of this suggestion, 
another report showed that relative STP and PPF were also enhanced 
when cellular levels of the Rab3 orthologue apRab3 were directly 
increased in Aplysia neurones through microinjection, though it should be 
noted that the net stimulus-evoked ACh release from these cells was 
reduced (Doussau et al., 1998).
Given the findings described above, the characterisation of Rab3GAP in 
this study produced some unexpected results: myc-tagged p130 Rab3GAP 
was not found to dissociate coexpressed EGFP-Rab3A from secretory 
granules, and did not colocalise with granules labeled with EGFP-Rab3A
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or with EGFP-Rab27A (Fig.5.1, A-F), or produce any effects on secretion 
in hGFI cotransfection assays (Fig.5.1, G). The absence of any 
colocalisation between myc-Rab3GAP and granules was not unexpected 
in itself, because RabGAPs do not always strongly localise to the same 
membrane compartment as their target Rabs. For example, RN-tre, which 
is thought to act as a GAP for the Golgi localised Rab43, localises to the 
cell surface (Haas et al., 2007). However, it was surprising that the protein 
failed to disperse EGFP-Rab3A or affect secretion, as this suggests that it 
was unable to promote Rab3A GTP-hydrolysis, at least prior to fusion 
between secretory granules and plasma membrane.
It is possible that as previously suggested, Rab3A is not susceptible to 
GAP activity under resting conditions as a result of its interaction with 
effector proteins (Grosshans et al., 2006). However, it was shown earlier in 
this study that EGFP-Rab3A is exchanged between granules and cytosol 
under resting conditions (Handley et al., 2007), a process very likely to 
require GAP-stimulated GTP hydrolysis. Furthermore, it has been shown 
that overexpression of RabGAP5 efficiently dissociates EGFP-Rab5 from 
endosomes, despite the capacity of this protein to form stable domains 
resistant to GAP activity (Haas et al., 2005; Grosshans et al., 2006). An 
alternative possibility might be that the availability of its noncatalytic 
subunit p150 Rab3GAP, and/or the vesicular protein Rabconnectin3, 
restricts the in vivo activity of p130 RabGAP. In brain tissue, the majority of 
p130 Rab3GAP is present in a soluble synaptic fraction, while these
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factors have been suggested to transiently direct the protein to its site of 
action (Nagano eta!., 1998; Kawabe et al., 2003; Aligianis et al., 2006).
Following the screening of a panel of putative RabGAPs in this study, a 
novel candidate Rab3-specific RabGAP, RUTBC1, was identified. In PC12 
cells, myc-tagged RUTBC1 was found to colocalise with coexpressed 
EGFP-Rab27A on secretory granules, while it efficiently dissociated 
coexpressed EGFP-Rab3A from these structures (Fig.5.5, A-F). In 
subsequent experiments, it was found to suppress the inhibitory effects of 
EGFP-Rab3A overexpression on secretion of exogenous hGH from these 
cells, while it had no effect on the inhibition produced by EGFP-Rab27A 
overexpression (Fig.5.5, G-H). Although RUTBC1 overexpression alone 
did not affect secretion of cotransfected hGH (Fig.5.5, G-H), GAP- 
promoted Rab3A extraction from granules is unlikely to be complete, 
because it does not affect the protein’s initial targeting to these organelles, 
and because the extraction process itself requires GDIa (Sakisaka et al., 
2002; Goody et al., 2005). Further, it is likely that in cells overexpressing a 
Rab3-specific GAP, some fraction of Rab3A would be present on granules 
in a GAP-resistant state, through interactions with effectors, or through 
incorporation into hypothesised ‘Rab domains’ (Grosshans et al., 2006). It 
is possible, then, that a reduced granule-associated pool of Rab3A is 
adequate to fulfil its cellular functions. Together, therefore, the findings 
presented here are consistent with the suggestion that RUTBC1 
specifically regulates Rab3 activity. Also consistent with this suggestion,
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mRNA expression profiling published on Symatlas (symatlas.gnf.org) 
suggests that like Rab3, it is strongly expressed in the brain.
Future work will be required to directly characterise RUTBC1 GAP activity, 
while it is interesting to speculate that RUTBC1 and p130 RabGAP may 
each regulate Rab3 GTP-hydrolysis, but may act in distinct locations. It 
has been suggested that RabGAP-5 regulates Rab5 activity associated 
with early endosome fusion, while RN-tre, although primarily a GAP for 
Rab41, regulates its function in macropinocytosis (Schnatwinkel et al., 
2004; Haas et al., 2005; Pfeffer, 2005a). By analogy therefore, RUTBC1 
and p130 Rab3GAP may regulate Rab3 activity on secretory granules and 
synaptic vesicles respectively, or may differentially regulate Rab3 activity 
pre- and post-fusion.
5.3.2 Rab27 GTPase-activating proteins
In a recent study, it was suggested that the proteins TBC1D10A and 
TBC1D10B function as GAPs for Rab27 (Itoh and Fukuda, 2006). These 
proteins were identified after a panel of putative RabGAPs was screened 
for their capacity to strongly induce melanosome aggregation, an effect 
seen in the melanocytes of ashen mice in which Rab27A is inactive 
(Wilson et al., 2000; Itoh and Fukuda, 2006). On subsequent testing, their 
overexpression was also found to reduce the levels of exogenous GTP- 
Rab27A that could be extracted from Cos-7 cell lysates, and TBC1D10A 
was found to show GAP activity towards Rab27A, but not Rab3A, in vitro 
(Itoh and Fukuda, 2006).
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Despite initially appearing conclusive, the data described above, and the 
experimental procedures used to generate it, may be open to criticism. 
Where melanosome aggregation was induced by TBC1D10A or 
TBC1D10B overexpression, melanosomes appeared to adopt a restricted 
perinuclear localisation (Itoh and Fukuda, 2006). This localisation differs 
markedly from that in ashen mice, in which melanosomes are more widely 
distributed within the central regions of cells, and so it may well have had 
an unrelated cause (Wilson et al., 2000; Wu et al., 2001). Where the 
effects of the proteins’ overexpression on GTP-Rab27A extraction from cell 
lysates was judged, each of five putative GAP proteins, included in 
experiments alongside TBC1D10A and TBC1D10B, also appeared to 
reduce this extraction. Although TBC1D10A and TBC1D10B produced a 
more dramatic effect, it is notable that their expression levels were greater 
than those of the other GAPs tested (Itoh and Fukuda, 2006). Where the 
GAP activity of TBC1D10A towards Rab27A and Rab3A was compared, 
GTP-hydrolysis was not measured directly. Furthermore, incubation times 
were varied so that Rab27A was exposed to the protein for 40 minutes, 
while Rab3A was exposed for only 20 minutes (Itoh and Fukuda, 2006; 
Itoh et al., 2006). These times were varied to account for the differing 
intrinsic GTPase activity of the two Rab proteins, though a specific GAP 
would be expected to accelerate GTP hydrolysis dramatically, and though 
there is no evidence to suggest that rates of intrinsic and GAP-catalysed 
Rab-GTP hydrolysis correlate (Clabecq et al., 2000).
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When TBC1D10A-myc was expressed in PC12 cells in this study, it was 
largely localised to the cell periphery, with a similar staining pattern to that 
previously seen with phalloidin (Fig.5.2, B, E, H, K). This localisation is 
consistent with reports suggesting that the protein binds to the ezrin- 
binding protein EBP50, since ezrin is an ezrin/moeisin/radixin family 
member, and involved in linking F-actin to the plasma membrane (Reczek 
and Bretscher, 2001; Hanono et at., 2006). When coexpressed with either 
EGFP-Rab3A or EGFP-Rab27A, the effects of TBC1D10A-myc 
coexpression were variable. In some cells the exogenous Rab proteins 
showed characteristic localisation to punctae, while in others, they 
appeared more diffuse (Fig.5.2, A-L). These data may indicate that 
TBC1D10A has a relatively promiscuous GAP activity, although the effects 
of its overexpression do mirror those of siRNA knockdown of Rab27A in 
terms of reduced secretory responses (Fig.5.2, M)(Waselle et at., 2003; 
Tsuboi and Fukuda, 2006a).
Like TBC1D10A-myc, overexpressed TBC1D10B-myc was largely 
localised to the periphery of PC12 cells (Fig.5.3, B, E, H, K). Its 
overexpression, like that of TBC1D10A-myc, was found to disperse 
cotransfected EGFP-Rab3A and EGFP-Rab27A with similar, albeit 
variable, efficiency (Fig.5.3, A-L), and was found to inhibit secretion as 
judged through hGH cotransfection assays (Fig.5.3, M). There was a 
propensity of TBC1D10B-myc overexpression to cause the formation of 
large intracellular vacuole-like structures not seen when TBC1D10A-myc 
was overexpressed in this study, but this was the only finding presented
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here that distinguishes the behaviour of these proteins (Fig.5.3, E, K). In 
recent work elsewhere, TBC1D10B was screened for GAP activity against 
a panel of 46 different Rab proteins, and was found to have in vitro activity 
against Rab22a, Rab31 (22b), and Rab35, while it showed no activity 
against Rab27A (Fuchs et al., 2007). This report not only draws into 
question the previous characterisation of TBC1D10B as a Rab27GAP, but 
because of their similarities, may also draw into question that of 
TBC1D10A.
In screening experiments carried out in this study, several additional 
candidate GAPs for Rab27A were identified. RUTBC2-myc showed some 
capacity to disperse EGFP-Rab27A but not EGFP-Rab3A when 
coexpressed with these proteins. However, it did not colocalise well with 
EGFP-Rab3A, and its overexpression did not affect secretion, or suppress 
the inhibitory effects of EGFP-Rab27A overexpression on the process 
(Fig.5.6). These data may not give a strong indication that the protein 
possesses Rab27GAP activity, but equally, they do not rule out this 
possibility. Future work may be directed towards clarification of this point, 
along with characterisation of the other potential Rab27GAPs, TBC1D3 
andAK 074305.
216
Chapter 6:
Summary and discussion
6.1 Summary and discussion
The work described in this study characterised several aspects of Rab3A 
recruitment and dynamics in PC12 cells, and may indirectly support a 
speculative model for its regulation. It was shown through fluorescence 
microscopy, immunocytochemistry, and ‘temperature-block’ experiments 
that Rab3A was preferentially recruited to newly synthesised secretory 
granules, a process beginning between 10 and 20 minutes after exit of 
immature granules from the TGN. FRAP experiments showed that at least 
a component of cellular Rab3A cycles between secretory granule 
membranes and cytosol under resting conditions. Further, the rate of this 
cycling was found to increase slightly over time, and to occur in an HSP90- 
independent manner. In a series of hGH cotransfection assays, EGFP- 
Rab3A expression, but not HSP90 inhibition, was found to inhibit 
secretion, and in live-cell imaging experiments, exocytosis of secretory 
granules was not found to be associated with the dispersal of the protein. 
These data may support a model in which the recruitment of Rab3A can 
lead to its stable association with granules through interaction with GEF 
protein in a multimolecular ‘Rab domain’, as is the case for Rab5A where it 
associates with endosomes (Zerial and McBride, 2001; Grosshans et al., 
2006). Sequestration of Rab3GEF in domains containing Rab3A may be 
accompanied by a reduction in the capacity of granules to bind additional 
cycling Rab3A. Also, the disassembly of these domains following 
exocytosis and Rab GTP-hydrolysis may require an additional factor(s).
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Like Rab3A, Rab27A was found to be preferentially recruited to newly 
synthesised secretory granules, its overexpression was found to inhibit 
secretion, and it was not found to disperse on cell stimulation. However, 
FRAP experiments showed that unlike Rab3A, it formed a stable 
association with secretory granules once recruited. Additionally, an ECFP- 
Rab27A Q78L ‘constitutively active’ mutant protein was found to be largely 
cytosolic, though a fraction of the protein did associate with secretory 
granules, and its overexpression did inhibit secretion. Speculatively, these 
data may support the suggestion that Rab27A may saturate stable binding 
sites on new granule membranes, and subsequently be protected from 
GDI-mediated membrane extraction following GTP hydrolysis. A possible 
mechanism for such protection might be incorporation of the Rab into a 
highly stable Rab domain, or dimerisation of the GDP-bound Rab as has 
been suggested for Rabs 9A, 11A and 27B (Pasqualato et al., 2004; 
Wittmann and Rudolph, 2004; Chavas et al., 2007). The Q78L mutation 
may reduce Rab27A membrane association by reducing its affinity for its 
GEF, or its capacity to dimerise.
When the localisation, dynamics and function of Rab effectors was 
explored, Noc2 overexpression was found to produce the most 
pronounced effect on secretion in PC12 cells, and through FRAP 
experiments, the protein was found likely to interact with secretory 
granules in a sustained manner. Mutational analysis supported previous 
suggestions that Noc2 is recruited to secretory granules via Rab27A in 
PC12 cells (Haynes et al., 2001; Cheviet et al., 2004a; Fukuda et al.,
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2004) . Rabphilin and Granuphilin also localised to secretory granules, 
although Granuphilin preferentially localised to granules at the cell 
periphery. Because Granuphilin was largely granule associated, but 
showed some degree of exchange between granules and cytosol, it is 
possible that this localisation was the result of binding to both Rab27A, 
and an additional factor at the plasma membrane, possibly Munc18, 
Syntaxin or PIP2 (Coppola et al., 2002; Torii et al., 2002; Torii et al., 2004; 
Fukuda et al., 2005; Gomi et al., 2005; Tsuboi and Fukuda, 2006b; 
Osborne et al., 2007). It is also possible that such interactions promoted 
the redistribution of granules to the cell periphery as previously described 
(Gomi et al., 2005). The exchange of Rabphilin between granules and 
cytosol was very rapid, possibly the result of repeated rounds of Rab3A or 
Rab27A GTP-hydrolysis and reassociation at the plasma membrane. 
Coupled a previous study apparently showing that Rabphilin improves 
granule mobility at the plasma membrane, and studies showing that it can 
interact with the actin bundling protein a-actinin, this finding may be 
consistent with a model in which Rabphilin locally remodels 
subplasmalemmal cortical actin to promote the passage of granules 
through it (Kato et al., 1996; Baldini et al., 2005; Tsuboi and Fukuda,
2005) .
When an E466K mutation was introduced into the Syntaxin-binding protein 
Munc18-1, it allowed the discovery that this protein also interacts with 
Rab3A (Graham et al., 2008). Expression of Munc18-1 bearing the E466K 
mutation was shown in this study to promote peripheral localisation of
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newly synthesised secretory granules labelled with either EGFP-Rab3A or 
EGFP-Rab27A. The effects of the mutant protein were consistent with 
recent work in this laboratory showing that its overexpression enhanced 
adrenal chromaffin cell secretory responses (Graham et a/., 2008). Given 
findings showing that Munc18-1(E466K) interacts more strongly with 
Rab3A than the wild-type protein, these data also suggest that the 
interaction between these proteins promotes calcium-regulated exocytosis. 
On the basis that a Munc18-1(E466K/R39C) double mutant, capable of 
interacting with Rab3A in vitro, but binding with reduced affinity to the 
‘closed’ conformation of Syntaxin, was unable to promote peripheral 
granule localisation, or secretion, it may be speculated that a Rab3A- 
Muncl 8-1-Syntaxin interaction facilitates controlled assembly of trans- 
SNARE complexes. Testing of this hypothesis may be important in future 
work, if transient interactions between Rab and SM proteins represent a 
conserved mechanism for Rab function in membrane fusion across 
multiple trafficking pathways, as is consistent with some of the data 
available from studies in yeast (Dascher et at., 1991; Ossig et at, 1991; 
Ballew et at., 2005).
The regulation of Rab3A and Rab27A GTP-binding was investigated in this 
study through analysis of proteins reported to show GAP activity towards 
them, and of a panel of other putative RabGAPs. It was found that the 
previously studied p130 Rab3GAP (Fukui et at., 1997) was not able to 
disperse granular EGFP-Rab3A or EGFP-Rab27A on its overexpression, 
and that it adopted a different localisation in PC12 cells, perhaps indicating
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that it is not the major physiological Rab3GAP. TBC1D10A and 
TBC1D10B, which have been reported to act as GAPs for Rab27A (Itoh 
and Fukuda, 2006) were each found to indiscriminately disperse both 
EGFP-Rab3A and EGFP-Rab27A in a proportion of PC12 cells, while they 
localised to the cell periphery, possibly to the cortical cytoskeleton. This 
study identified RUTBC1 as a potential Rab3GAP on the basis of its 
dispersal of EGFP-Rab3A in over 75% of coexpressing cells, its 
colocalisation with EGFP-Rab27A on secretory granules, and its capacity 
to suppress the inhibitory effects of EGFP-Rab3A on secretion. Further 
work including direct analysis of its effect on Rab3A GTPase activity will be 
required to substantiate the possibility that RUTBC1 is the bona fide 
Rab3A GAP. In addition, the identity of the Rab27A GAP still remains to be 
determined.
To conclude, it has been shown here, that Rab3A and Rab27A interact 
with secretory granules in a dynamically distinct manner, and that the ways 
in which their diverse effectors are recruited and released may be similarly 
distinct. It has been suggested that Rab and SM protein interactions may 
coordinate membrane fusion events, and a putative Rab3GAP has been 
identified and partially characterised. This study supports a view in which 
Rab proteins dynamically establish asymmetry on the communication 
between membrane compartments, and in which this asymmetry is 
conferred in the form of arrayed, ephemeral, multimolecular assemblies, 
and the delicate transitions between them. It is hoped that their 
characterisation will continue.
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